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ABSTRACT
The effects of somatotropin on ovarian reproductive function has become a keen
research area in mammalian species over the past decade. However, to date, very little
information is available as to the effects o f somatotropin administration on reproduction
in the domestic mare. Therefore, the purpose o f these experiments was (1) to determine
the potential effects (if any) o f administration o f exogenous equine somatotropin on
ovarian follicular development and plasma and follicular fluid hormone concentrations
in cyclic and noncyclic mares, (2) to determine the mechanism(s) of action o f
somatotropin treatment on these parameters in the mare, (3) to develop an efficient
protocol for stimulating ovarian follicular development using somatotropin treatment to
mares and (4) to develop a repeatable method for the induction o f ovulation in
seasonally anestrous mares treated with somatotropin.

It was determined that

somatotropin treatment increased the number o f ovarian follicles in both cyclic and
noncyclic mares. In addition, plasma and follicular fluid levels o f IGF-I were increased
in mares treated with somatotropin.

In seasonally anestrous mares, somatotropin

treatment in conjunction with daily administration of a GnRH agonist was effective in
inducing a 5-fold increase in the number o f mares ovulating when compared with
treatment with the GnRH agonist alone. In equine granulose cells cultured in vitro, both
somatotropin and IGF-I were successful in enhancing cellular proliferation and steroidal
output, providing evidence that these compounds act directly at the ovarian level to
affect follicular development. In addition, it was determined that treatment to cyclic
mares with somatotropin caused a significant delay in the process o f follicular atresia,
suggesting that it may be through this mechanism that somatotropin increases the
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number o f ovarian follicles in the mare. Further studies are needed in this area of
equine reproduction so that the exact mechanism(s) through which somatotropin affects
follicular development can be determined.
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INTRODUCTION
Recently, the role that somatotropin (ST) plays on ovarian follicular dynamics
and normal reproductive function has come under intense investigation in various
mammalian species. It has been well documented that administration o f exogenous ST
increases follicle numbers on the ovaries o f pigs (Echtemkamp et a l , 1994), cattle
(Gong et al., 1991; Lucy et al., 1993) and women (Hugues et a l, 1991; European and
Australian Multicenter Study, 1995). For example, Spicer et al. (1992) demonstrated
that female pigs given exogenous pST had more follicles (1 to 4 mm in diameter)
present on their ovaries after treatment than did contemporary control gilts.

This

response seems to be the most common, since most studies report increases in follicles
in the small- to medium-size range (1 to 9 mm), with little to no difference in the
numbers o f larger follicles (Gong et al., 1991). The exact mechanism through which
ST affects ovarian follicular populations is not currently known, however, its ability to
stimulate IGF-I production from the liver, thereby increasing systemic IGF-I
concentrations, may play a crucial role in this process (Homburg et a l, 1988). It should
be noted, though, that a direct effect of ST at the ovarian level cannot be ruled out, as
ST receptors have been detected in ovarian tissue o f cattle (Gong et al., 1991).
Since most studies dealing with the effects o f ST on reproductive function have
used animal models in which circulating concentrations of ST were brought to
supraphysiological levels as a result o f exogenous administration, the question o f
whether ST at normal physiologic levels was critical to proper reproductive
performance was raised. One study using hypophysectomized ewes demonstrated that,
in the absence of ST, gonadotropin administration alone was insufficient in returning

1
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these animals to a normal reproductive state (Eckery et al., 1997). However, when ST
was administered in addition to LH and FSH, the animals began showing normal
ovarian follicular development (Eckery et al., 1997). These researchers were able to
isolate ST receptors located on the surface o f the follicular granulosa cells, and
presumed that ST acted locally within the follicle to enhance the ability o f the follicular
cells to respond to available gonadotropins, which is currently one o f the most
prevailing hypotheses concerning the effects o f ST on reproduction. Also, in Ames
dw arf mice, a condition that is brought about due to a genetic defect which causes the
absence o f the development o f the somatotrophs within the adenohypophysis, a
significant reduction in both gonadotropic output as well as ovarian follicular
development was noted and the administration o f bST reversed these conditions (Bartke
et al., 1996). These studies provide strong evidence that ST provides a physiologic,
rather than a pharmacologic, effect on reproductive function in domestic species.
It has been proposed that one o f the mechanisms o f action for ST on ovarian
follicle populations arises from its ability to stimulate IGF-I production and secretion,
and that IGF-I then works synergistically with available gonadotropins to enhance their
response at the ovarian level (European and Australian Multicenter Study, 1995;
deMoura et al., 1997). In one study using perifused rabbit ovaries, it was demonstrated
that ST caused an approximate 3-fold increase in IGF-I mRNA within the granulosa
cells o f the ovarian follicles, showing that ST can indeed cause effects at the ovarian
level (Yoshimura et al., 1996a), and that these effects were directly correlated with
follicular IGF-I concentrations (Yoshimura et al., 1994). Also, it is known that IGF-I
stimulates the formation o f LH receptors in rat granulosa cells (Liu et al., 1998), which

2
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would account for its ability to enhance the follicular response to LH. Also, IGF-I
increases FSH-stimulated progesterone production in rat granulosa cells cultured in
vitro, further demonstrating an effect o f IGF-I at the level o f the ovary (deMoura et al.,
1997). It is therefore likely that many o f the effects o f ST are due to increased IGF-I
concentrations, which increase the follicular response to available gonadotropins.
A second hypothesis involves an ability o f ST and/or IGF-I to increase the
number o f actively growing follicles present within a follicular wave.

Since the

discovery o f cyclical, wave-like growth patterns o f follicular growth in most
mammalian species, the mechanism for selection o f small antral follicles to become
responsive to growth and development within the follicular wave has been a major
research focus (for review see Ginther, 1992). It is not currently known what factors
are involved with follicular selection and recruitment to begin the growth process, but
increased blood flow to the ovary may play a role (Staigmiller, 1982; Driancourt et al.,
1991; Bao and Garverick, 1998). It is known, however, that these early-antral follicles
are gonadotropin insensitive, so it is possible that various proteins and growth factors
are involved in follicular selection (Britt, 1988).

Therefore, it is possible that ST,

through its ability to stimulate IGF-I, could play a role in early follicular activation into
a follicular wave.
Another possibility is that the increased IGF-I concentrations could prolong the
lifespan o f the follicle by delaying the process of atresia, during which a follicle ceases
to grow and begins to regress until it is no longer detectable on the ovary. The atretic
response is thought to be brought about primarily through spontaneous apoptosis, or
cellular death, o f the follicular granulosa cells (Guthrie et al., 1998).

3
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It has been

demonstrated that FSH is the most potent inhibitor o f apoptosis in rat granulosa cells
cultured in vitro, and it is well known that the mechanism for the ability o f FSH to
“superstimulate” follicular growth in mammals is by rescuing these follicles from the
process o f atresia (Chun et al., 1996). Since IGF-I has also been shown to have potent
inhibitory actions on granulosa cell apoptosis (Chun et al., 1996), this hypothesis should
not be overlooked.
Another possibly important aspect o f this facet of follicular dynamics is the
ability o f both ST and IGF-I to increase steroidogenesis within the follicle.
Administration o f ST increases levels o f intrafollicular 3P-hydroxysteroid dehydro
genase and aromatase mRNA, allowing for more progesterone and estradiol to be
produce by the follicular cells (Tapanainen et al., 1992). Although IGF-I causes higher
granulosa cell production o f both progesterone (Xia et al., 1994) and estradiol
(Echternkamp et al., 1994; Howard and Ford, 1994), it is the ability o f IGF-I to enhance
estradiol output that gives greater insight to this hormonal system and its effects on
reproduction. It is known that large, pre-ovulatory follicular development and estradiol
output are highly correlated in women (Thierry Van Dessel et al., 1996), and it has been
recently shown that intrafollicular IGF-I concentrations are greatest in pre-ovulatory
follicles in cattle (Yuan et a l, 1998). Thus, it is possible that another mechanism o f
action for IGF-I on follicle development is through stimulation o f steroidogenesis
within the follicle, allowing for an increased likelyhood for follicular dominance to
occur (Yuan et al., 1998).
During the winter months, which correspond to periods o f shortened daylength,
m ost mares undergo a period o f reproductive inactivity termed “seasonal anestrous”.
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During this anovulatory period, GnRH production and output from the hypothalamus is
very low, and normal ovarian reproductive activity ceases (Hart et al., 1984). For many
years, scientists have attempted to stimulate these mares to begin normal follicular
growth and ovulation using GnRH therapy, with very limited success (Hyland et al.,
1987; Mumford et al., 1994). Given that one o f the mechanisms o f action for ST/IGF-I
is to enhance the follicular response to available gonadotropins, It is possible that the
addition o f daily administration o f ST in conjunction with GnRH treatment could
improve the response o f seasonally anovulatory mares to GnRH therapy.
In addition, the development o f an efficient, repeatable method to collect large
numbers o f viable oocytes from mares, for the purpose of in vitro fertilization (IVF)
techniques, would benefit the scientific as well as the commercial horse industry. Since
IVF has become a routine method o f treating clinical infertility in cattle and women, the
development o f this technique in horses has been under intense study (Meintjes et al.,
1995). One o f the largest obstacles to overcome is the lack o f response seen when
traditional stimulation protocols involving gonadotropins are used. It is well known
that the administration of exogenous gonadotropins collected from ovine, bovine and
equine sources to mares has little to no effect on stimulating ovarian follicular
development, even when extremely large doses are given (Ginther, 1992). Therefore, it
is difficult to obtain the numbers o f oocytes necessary to develop a method o f producing
equine embryos in vitro.
Also, conventional methods o f IVF have yielded limited success in the horse,
with only one foal being reported to date (Palmer et al., 1991). However, in one study
using pregnant mares, Meintjes et al. (1995) demonstrated that acceptable numbers o f
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oocytes could be collected and that fertilization o f these oocytes could be achieved
using a pre-fertilization technique o f drilling a small hole in the zona pellucida of the
oocytes to allow the sperm access to the oocyte. Unfortunately, no pregnancies were
obtained using this technique. More recently, intracytoplasmic sperm injection (ICS1)
has been used to produce equine embryos in vitro with success (Meintjes et al., 1996;
Dell’Aquila et al., 1997), and two pregnancies have been reported using this technique
(Meintjes et al., 1996; Squires et al., 1996). Since it has been shown that treatment with
ST increases the ovarian response in women undergoing controlled ovarian hyper
stimulation procedures (Owen et al., 1991b; Schoolcraft et al., 1997), and that the
fertilization rate o f the oocytes from ST-stimulated women are greater than those from
contemporary control subjects (Owen et al., 1991a), it is possible that the same may
hold true for the domestic mare. Therefore, the purpose o f the experiments reported
herein was to (1) determine the effects o f ST administration on cyclic and seasonally
anovulatory mares, (2) determine the mechanism(s) o f action o f ST on reproductive
function in cyclic and noncyclic mares and (3) develop an efficient, repeatable protocol
for the production o f equine embryos in vitro using ST for ovarian stimulation and ICSI
for fertilization o f the collected oocytes.

6
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CHAPTER I
LITERATURE REVIEW
THE FOLLICULAR WAVE PHENOMENON
Cyclic Animal Model
In recent years, the study o f the pattern o f growth and development o f ovarian
follicles has been a key research interest in domestic animals. It has been shown that, in
most mammals, a group o f follicles, termed a “cohort”, grows and regresses in a
cyclical, wave-like pattern, hence the term “follicular wave” (Sirois and Fortune, 1988;
Adams et al., 1992b; Lucy et al., 1993; Pursley et al., 1993). The one exception is the
domestic pig, as there is no evidence to date that suggests the follicular wave
phenomenon occurs (Ryan et al., 1994b). Currently, the exact mechanisms involved in
early follicle activation and introduction into the cohort are not fully understood. It is
believed, however, that various factors such as increased blood flow, changes in local
growth factor concentrations and dietary energy intake are involved, since these preantral and early-antral follicles are not gonadotropin-dependent at this time (Staigmiller,
1982; Britt, 1988; Bao and Garverick, 1998). It is known that once these small, antral
follicles are recruited into the cohort a surge o f FSH secretion by the adenohypophysis
preceeds the visible (via transrectal ultrasonography) initiation o f the new follicular
wave in both cattle and mares (Evans and Irvine, 1975; Adams et al., 1992b; Badinga et
al., 1992; Ginther and Bergfelt, 1993; Pursley et al., 1993; Beam and Butler, 1997).
The number o f follicular waves per estrous cycle varies between individual
animals and species, but in general cattle demonstrate 2 to 3 waves o f follicular growth
during each estrous cycle (Adams et al., 1992a,b), while mares exhibit 1 to 2 follicular
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waves per cycle (Ginther, 1990; Pursley et al., 1993; Buratini et al., 1997). Likewise,
the duration of growth for each wave varies, with cattle showing ~7 days o f growth per
follicular wave while mares exhibit ~10 days o f follicular growth per wave. In general,
the cohort o f follicles begins to grow synchronously, but during this growth phase oneor
more follicles are “selected” for dominance, at which time these follicles begin to grow
at a more rapid pace, while simultaneously deterring the further growth o f the remaining
subordinate follicles within the cohort. Depending upon which stage o f the estrous
cycle this cohort begins to grow, the dominant follicle can either ovulate and release its
oocyte to be made available for fertilization, or it can regress at the time a new wave o f
follicular growth is initiated (for review see Ginther, 1992).
It has been proposed that the surge o f FSH detected just prior to wave
emergence is necessary for the promotion o f normal growth and development o f the
new follicular wave, however, definitive evidence for this hypothesis is currently
lacking, as it is generally accepted that these small antral follicles are gonadotropin
insensitive (Britt, 1988). It is believed, however, that changes in FSH secretion are
primarily responsible for the divergence in growth of the dominant follicle, which then
decreases the growth o f the remaining subordiate follicles within the current follicular
wave (Mihm et al., 1997).

For example, Mihm et al., (1997) demonstrated that in

cyclic beef cows, a decline in circulating FSH concentrations by 2 days post-wave
emergence could cause a change in available growth factors within the cohort o f
growing follicles that would promote follicular divergence o f the dominant follicle and
atresia o f the subordinate follicles. It has also been shown that treatment with a bolus
injection o f FSH to heifers caused a delay in the divergence of the dominant follicle

8
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from its subordinates, further suggesting the importance o f the decline in FSH
concentrations on follicular divergence and follicular dominance (Adams et al., 1993).
Another important facet o f follicular wave growth and development revolves
around the fate o f the dominant follicle. Once selected, this follicle will usually either
ovulate or regress, depending upon the stage o f the estrous cycle.

It has been

demonstrated that the decline in FSH is related to subsequent increases in intrafollicular
content o f estradiol and IGF-I within the dominant follicle, as well as with a decrease in
intrafollicular IGF-I binding proteins (IGFBP) that allows for an overall increase in the
bioavailable IGF-I within the follicle, which has important roles in follicular growth and
ovulation (Mihm et al., 1997). Also, it has been demonstrated that, in cattle, a decline
in LH pulse frequency from the adenohypophysis results in atresia o f the dominant
follicle, and therefore no ovulation (Lucy et al., 1993). Therefore, for ovulation to
occur, the animal must be in the proper stage o f the estrous cycle where progesterone
concentrations are low so that an increase in LH pulse frequency can take place
propagating the final growth and maturation o f the dominant follicle for ovulation to
occur (Lucy et al., 1993).
As previously stated, the exact mechanisms allowing for follicular recruitment
into a follicular wave, as well as some o f the mechanisms involved in follicle growth
and selection and continued growth of the dominant follicle, in addition to ovulation of
the selected follicle(s), are not fully understood. It has been proposed that ST as well as
IGF-I and, to a lesser extent insulin, are all involved in this dynamic process of
follicular growth and development, but the exact mechanisms o f action for these growth
factors are as yet unclear (Bartke et al., 1996; Cox, 1997). It is known that increases in

9

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

intrafollicular IGF-I and insulin can enhance the ability of the follicle to respond to
available gonadotropins in the pig, but whether or not these growth promotors can
influence early follicle growth and/or the selection process by which one or more
follicles becomes dominant over the other follicles within a follicular wave remains to
be determined (Cox, 1997).
Follicular Waves During Pregnancy
Interestingly, both cows and mares continue to exhibit waves o f follicular
growth and development throughout early pregnancy (Ginther et al., 1989; Ginther and
Bergfelt, 1992). In cattle, follicular wave growth has been demonstrated to continue
during pregnancy as well as during treatment with exogenous progesterone up to 100
days (Bergfelt et al., 1991).

Also, pregnant cows usually exhibit follicular growth

patterns similar to that o f cyclic cows up to the last 22 days of gestation, when follicular
activity seems to temporarily shut down, possibly due to high levels o f estrogens being
produced by the developing fetus (Ginther e t al., 1996). O f interest is the fact that,
during pregnancy, follicles rarely ovulate in cattle, and the diameter o f the largest
follicle has been shown to be smaller in pregnant compared with nonpregnant cows
(Ginther et al., 1989).
In mares, the ovaries are extremely active during the first 30 to 50 days of
gestation, with large numbers o f follicles growing and regressing in wave-like patterns
(Ginther and Bergfelt, 1992).

Unlike cattle, mares have developed a mechanism to

produce addition corpora lutea during pregnancy as a method to ensure that adequate
concentrations o f progesterone are maintained throughout early pregnancy so as to
support continued growth o f the fetus (Ginther, 1992). It has been demonstrated that, as
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is the case with cyclic animal models, surges o f FSH secretion are associated with
initiation o f new follicular waves during pregnancy for mares (Ginther and Bergfelt,
1992).

However, individual follicular growth characteristics are extremely variable

between mares, with some mares exhibiting few waves o f follicular growth while others
show a great deal more follicles per wave, more total number o f waves, and a higher
number o f secondary corpora lutea during early pregnancy (Ginther and Bergfelt,
1992). In general, however, unlike the cow model, the ovaries o f pregnant mares tend
to cease new follicular growth by day 70 to 100 o f pregnancy, at which time the ovary
becomes quiescient for the remainder o f pregnancy (Ginther, 1992). This decrease in
follicular activity is thought to be caused primarily by elevated circulating
concentrations o f estrogens present at this time (McKinnon and Voss, 1993). Currently,
the reason for continued growth and development o f ovarian follicles during pregnancy
is not fully understood in cattle, since these follicles rarely ovulate and therefore would
not serve the same function as in the mare, where supplemental corpora lutea formation
is a necessary event to ensure the continued survival o f the early conceptus. However,
one possible explanation for continued follicular wave emergence in early pregnancy in
cattle may be to provide a source of oocytes in the event of abortion.
MECHANISMS OF FOLLICULAR GROWTH AND DEVELOPMENT
Follicle Activation
Early follicular growth, from the pre-antral to early-antral stages, is a complex
and puzzling series o f events that is not well understood at present.

The exact

mechanisms involved in the process o f follicular activation, when a quiescent pre-antral
follicle suddenly begins to grow and develop, as well as the mechanisms involved in
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recruitment o f early-antral follicles into a newly emerging follicular wave, are not
currently known, although it is known that these follicles are gonadotropin-insensitive
at this time (Britt, 1988; Findlay, 1994; Gong et al., 1996b). One possibility is that
increased blood flow into local areas containing pre-antral and early-antral follicles is
involved in the processes of follicular activation and recruitment, as evidenced by the
fact that, in dairy heifers, it has been demonstrated that the ovary bearing the corpuus
luteum has significantly more visible ovarian follicles than the ovary without a corpus
luteum within the same animal (Staigmiller, 1982; Driancourt et al., 1991; Bao and
Garverick, 1998).
This theory is inadequate, however, since follicular waves can occur on opposite
ovaries simultaneously, even though one ovary may not have a corpus luteum present at
the time o f wave emergence (Ginther, 1992; McKinnon and Voss, 1993).

Recent

evidence suggests that estradiol, ST, IGF-I and other growth factors may play a role in
follicular activation and recruitment (Bergh et al., 1994; Liu et al., 1998). For example,
it has been suggested that higher concentrations o f ST may be involved in early follicle
growth, and that protocols involving ST administration to increase the number o f
follicles should be given for relatively long durations, since it is estimated that it takes
30 to 60 days for a follicle to develop from a pre-antral state until the time it becomes
visible via ultrasound (Bergh et al., 1994). Also, in in v/Yro-cultured ovarian follicles
collected from mice, it has been demonstrated that ST as well as activin can enhance
pre-antral and early-antral growth even though these follicles are gonadotropinindependent (Liu et al., 1998). It is clear, however, that further research is needed in
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this area o f follicular dynamics to better understand the underlying mechanisms
involved in early follicle activation and recruitment.
Gonadotropin Input
Once the growing follicles have become part o f a new follicular wave, they
reach a stage in which they become gonadotropin-dependent, that is, gonadotropic input
is required for further growth and development. This input starts at the level o f the
hypothalamus, with the production and secretion of gonadotropin-releasing hormone
(GnRH) into the median eminence. This in turn supplies the adenohypophysis with
blood flow so that the GnRH, along with other releasing factors, can stimulate the
production and secretion o f various hormones by the adenohypophysis that are
necessary for normal function o f the entire body.

GnRH from the hypothalamus

stimulates gonadotropes, which are the cells responsible for producing gonadotropins,
within the adenohypophysis to produce and secrete LH and FSH (Evans and Irvine,
1976; Alexander and Irvine, 1987; Johnson et al., 1988; Pantke et al., 1991; Irvine and
Alexander, 1993; Porter et al., 1997), both o f which are vital to the continued growth
and development o f ovarian follicles in the horse.
GnRH secretion is regulated through neuronal input, and the primary substances
that are believed to be responsible for the regulation o f GnRH secretion are nitric oxide,
PGE 2 and leptin. Using an immortalized cell line derived from rats, it has been shown
that leptin has both direct and indirect effects on GnRH secretion, primarily through
OB-R neuronal receptors (Magni et al., 1999). Nitric oxide is a necessary component
o f this pathway, as it has been demonstrated that nitric oxide inhibitors can block leptininduced GnRH and LH secretion (Yu et al., 1997). Adequate feed intake is essential for
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normal leptin production, as fasting and feed restriction both decrease basal leptin
concentrations in pigs (Mao et al., 1999) and rats (Nagatani et al., 1998). Therefore, in
order to ensure normal GnRH production, and hence normal LH and FSH secretion,
proper nutrition should be maintained at all times.
Normal secretion o f GnRH is crucial to the reproductive cycle in most
mammalian species. In the domestic mare, this is shown by the fact that during times of
decreased daylength (winter), GnRH secretion by the hypothalamus is severly
depressed or absent, causing the animal to undergo a period o f acyclicity termed
“seasonal anestrous” (Ginther, 1992), during which time the mare ceases to have a
normal cycle, and becomes anovuiatory. In the cyclic mare, it has been demonstrated
that up to 98% o f all GnRH pulses secreted by the hypothalamus were associated with a
subsequent pulse o f LH secretion by the adenohypophysis, and 83% o f these GnRH
pulses caused a pulse o f FSH secretion (Alexander and Irvine, 1987). Also, Irvine and
Alexander (1993) demonstrated that secretion o f FSH and LH usually occurred within 5
minutes after a GnRH pulse, showing that GnRH is the primary hormone controlling
gonadotropin secretion.

However, in mares immunized against GnRH, basal LH

secretion is more severly affected than that o f FSH, and when these mares are given a
GnRH agonist, FSH secretion appears normal relative to control animals, while LH
response to the agonist is minimal, suggesting a differential regulatory mechanism for
the two hormones (Garza et al., 1986).
Conversely, it has been shown that basal FSH is not affected by GnRH
administration in mares, while basal LH increases dramatically in response to GnRH
therapy (Nett et al., 1989). However, other studies have shown that there is a greater
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response of FSH secretion to GnRH administration in mares when compared with LH
secretion (Evans and Irvine, 1976). It is believed that increasing the pulsatile frequency
o f GnRH release, along with increasing estradiol levels in the blood, is the major cause
for the “surge” o f LH secretion noted during behavioral estrus in the mare, and it is this
LH surge that is ultimately involved in ovulation of the dominant follicle (Irvine and
Alexander, 1994). Therefore, it is clear that GnRH is the primary secretagogue for both
LH and FSH, and therefore critical for normal reproductive cyclicity in the domestic
mare (Irvine and Alexander, 1994).
Administration o f GnRH and/or one of its agonists is usually carried out to
achieve ovulation, and this type o f approach has been very successful in the horse
(Meinert et al., 1993; Swinker et al., 1993; Skidmore et al., 1996; Meyers et al., 1997).
Since GnRH is secreted in a pulsatile manner, it should come as no surprise that this is
the preferred manner o f administration o f GnRH for the purpose o f inducing ovulation
in the horse (Becker and Johnson, 1992).

Also, this route o f administration yields

superior results for inducing ovulation in cattle (Gong et al., 1996b). This is primarily
due to the fact that the ultimate cause o f ovulation is the rise in cirulating levels o f LH,
and that pulsatile GnRH input is more effective in inducing LH secretion in treated
animals (Vivrette and Irvine, 1979).

Also, while large doses o f GnRH can cause a

substantial rise in plasma LH, the biological activity o f this LH is reduced, and it is
therefore not as effective in inducing ovulation in the mare (Pantke et al., 1991).
Both FSH and LH are necessary hormones for normal reproductive cyclicity in
most mammalian species. FSH is required for follicular growth and maturation, and
increasing the amount o f available FSH can increase the growth o f small- and medium-
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sized follicles by up to 7-fold (Gibbons et al., 1997). Unfortunately, there has been no
clear establishment o f a relationship between the amount o f FSH secreted and ovulation
rate in the mare, and mares are much less sensitive to ovarian stimulation by
administration o f exogenous FSH than other animals (Urwin and Allen, 1983). In the
mare, FSH is low during the anovulatory season, but during vernal transition, which is
the period o f tim e that the animal goes from an acyclic to a cyclic state, FSH production
and secretion increases, with larger and larger peak levels o f FSH secretion occurring
until the first ovulation o f the breeding season (Hines et al., 1991). Once cyclicity has
resumed, lower baseline concentrations o f FSH are detected, possibly due to the
secretion o f inhibitory substances by the growing follicles (Hines et al., 1991). Also, it
has been demonstrated that certain steroids, such as testosterone, may affect the amount
o f FSH accumulation within the adenohypophysis, further causing a decrease in basal
FSH secretion (Thompson et al., 1984). Although different iso forms o f FSH do exist,
there is no evidence o f a difference in sensitivity to these different isoforms (Cooke et
al., 1997).
LH is the hormone primarily responsible for the final growth and maturation of
the pre-ovulatory follicle, with serum concentrations being low during diestrus, high
during behavioral estrus, and reaching peak levels 1 to 2 days post-ovulation (Evans and
Irvine, 1975). The key events seem to be (1) an increase in pulsatile amplitude, i.e.
higher amounts o f LH secreted per secretion episode, which is important in inducing
final growth and maturation o f the pre-ovulatory follicle (Evans et al., 1997) and (2) an
increase in LH pulse frequency just prior to ovulation, which appears to be a triggering
mechanism for ovulation to occur (Stagg et al., 1998). As stated earlier, GnRH is the
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primary regulatory hormone for LH release in the mare (Garza et al., 1986), so it is
apparent that pulsatile secretion o f GnRH must follow a similar pattern throughout the
estrous cycle.

That LH is the primary hormone responsible for the induction o f

ovulation in the mare is evidenced by the fact that human chorionic gonadotropin
(hCG), a compound secreted by the live human conceptus, has strick LH-like
capabilities in the mare and is extremely useful for inducing ovulation in this species
(Duchamp et al., 1987), even though its administration causes a decrease in the release
o f both GnRH and LH (Mores et al., 1996).
Hormonal Regulation of LH and FSH
The female reproductive system is composed o f a highly complex, interactive
set o f checks and balances, which serve to ensure normal reproductive cyclicity. The
production and secretion o f both FSH and LH are governed not only by GnRH input,
but also by several other steroid and protein hormones that allow for the process o f
follicle growth, ovulation and corpus luteum formation to proceed at a normal pace.
For instance, estradiol, a steroid hormone produced by growing ovarian follicles, has
many implications in the production and secretion o f gonadotropins (Vivrette and
Irvine, 1979; Ireland, 1987; Pinaud et al., 1991). In the granulosa cells, estradiol is
important in the amplification o f the actions o f FSH, specifically the “priming” action
FSH has on granulosa cells to render them more susceptible to the further stimulatory
actions o f LH (Ireland, 1987), and it is well known that, within the follicle, only the
granulosa cells are capable o f producing estradiol (Watson and Thomson, 1996). It has
been suggested that estradiol production by the ovarian follicles is an indicator that the
follicles are in a healthy, growing state, with much higher production o f estradiol in
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largest, dominant follicle within a follicular wave in cattle (Ireland and Roche, 1983;
Badinga et al., 1992).
Unfortunately, this difference in estradiol secretory rates between the dominant
and subordinate follicles does not manifest itself until after follicular divergence has
occurred, which rules out the notion that one o f the factors influencing the divergence
of the dominant follicle from its subordinates is an innate ability to produce higher
amounts o f estradiol (Ginther et al., 1997).

In addition, although the tendency for

atretic follicles is to decrease estradiol output while increasing the production o f
follicular androgens, this is not a sure sign o f follicular atresia, since growing follicles
produce androgens in addition to estradiol (Kenney et al., 1979; Davis and Sharp,
1991). Interestingly, it has been demonstrated that androgens have a positive effect on
FSH, as well as LH, secretion during diestrus by allowing for an accumulation o f FSH
within the adenohypophysis prior to its release, causing larger amounts to be secreted
per secretion episode (Thompson et al., 1983b; Reville-Moroz et al., 1984; Thompson
e t a l , 1987).
However, other studies have shown that androgens have either a negative effect
on FSH secretion (Evans et al., 1997), or no effect at all (Thompson et al., 1987). It is
known, though, that the increased production o f estradiol by the dominant follicle
inhibits FSH secretion by the adenohypophysis, decreasing the amount o f FSH available
for stimulation o f the subordinate follicles (Ginther, 1992; Evans et al., 1997). This is
thought to be one o f the primary mechanisms through which the dominant follicle
suppresses the growth of the other subordinate follicles within the follicular wave,
thereby ensuring that it will remain the follicle destined to ovulate (Evans et al., 1997).
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Estradiol also affects the production and secretion o f LH, by both direct and
indirect pathways (Pinaud et al., 1991). First, estradiol directly stimulates production o f
LH in the adenohypophysis while inhibiting its secretion to allow for an accumulation
o f LH so that greater than normal amounts are available for release (Vivrette and Irvine,
1979). This increase in pituitary stores o f LH can be detected within 24 hours after
estradiol exposure (Vivrette and Irvine, 1979).

Estradiol can then increase GnRH

output by the hypothalamus to cause the release o f the LH stored within the pituitary,
creating a net increase in pituitary production o f LH (Vivrette and Irvine, 1979). It is
primarily through this mechanism that estradiol causes the pre-ovulatory surge o f LH
noted in most domestic species (McKinnon and Voss, 1993).
Once ovulation o f the pre-ovulatory follicle has occurred, the formation o f the
corpus luteum begins and progesterone production by this gland increases (Ginther,
1992).

Progesterone is the steroid hormone most important for the maintenance o f

pregnancy, hence its name (“pro” meaning for, “gesterone” meaning gestation). It is
also intricately involved in the regulation o f LH production and secretion (Adams et al.,
1992a). It has been shown that progesterone can inhibit LH secretion, probably through
decreasing GnRH pulse frequency (Evans et al., 1982; Adams et al., 1992a).

In one

study using Bos indicus cattle, administration o f progesterone during the follicular
phase of the estrous cycle delayed ovulation and the timing o f the LH peak,
demonstrating its ability to suppress LH secretion (Cavalieri et al., 1997). This should
be expected since, in cyclic animals, there is normally no need for ovulation to occur at
the time that functional corpora lutea are present. Finally, although progesterone is very
important in the regulation o f LH secretion, most evidence to date suggests a minimal
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role for this steroid in the regulation of FSH synthesis and release (Evans et al., 1982;
Adams et al., 1992a).
In addition to steroidal influence, there are also protein hormones produced by
the developing follicles that aid in the regulation o f pituitary FSH (Miller et al., 1981).
Most notable o f these is inhibin, a protein produced primarily by the dominant follicle,
which regulates FSH secretion (Britt, 1988). Inhibin functions to directly inhibit FSH
secretion by the pituitary, as another mechanism o f reducing the amount o f FSH
available to the subordinate follicles within a follicular wave (Britt, 1988; Roser et al.,
1994).

It has been demonstrated in mares that peripheral inhibin concentrations

increase beginning on day 8 post-ovulation and continue rising until the day o f
ovulation, closely following the emergence and growth o f the dominant follicle (Roser
et al., 1994). These levels o f inhibin then decline rapidly until day 7 post-ovulation
(Roser et al., 1994).

Interestingly, the circulating concentrations of FSH show the

opposite pattern, with higher levels during the first 7 days post-ovulation and then a
decrease as inhibin levels rise (Roser et al., 1994). In mares, inhibin antiserum has been
shown to increase both plasma FSH as well as the number o f ovulations in treated
mares, with no effect on circulating LH concentrations (Nambo et al., 1998). This
demonstrates the ability o f inhibin to negatively regulate FSH release from the
adenohypophysis.
Finally, a second protein hormone produced by growing follicles, activin, aids in
the regulation o f pituitary FSH. Activin directly stimulates the release of pituitary FSH
to aid in follicular growth and development, and may actually cause some o f the
somatotropes within the adenohypophysis, which produce ST, to undergo a
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conformational change into gonadotropes capable o f secreting FSH in the rat (Childs
and Unabia, 1997).

Further study into the mechanisms of action o f these protein

hormones in gonadotropin regulation and follicular development is needed.
The Ovulatory Response
The final response o f the growing follicle, after follicular activation,
recruitment, growth and selection of the dominant follicle has occurred, is the process
o f ovulation. Ovulation has been described as an inflammatory process (Watson et al.,
1991), which is thought to be ultimately mediated by prostaglandins (Jochle et al.,
1987; Yamauchi et al., 1997). After the ovulatory surge of LH has been released, a
complex pathway o f events involving prostaglandin production and release is set in
motion, which culminates in the ovulation o f the pre-ovulatory follicle (Yamauchi et
al., 1997). It is believed that nitric oxide is intricately involved in this pathway, and it
has been shown that nitric oxide inhibitors can block ovulation primarily through the
blockage o f prostaglandin formation (Yamauchi et al., 1997).

Once ovulation has

occurred, the ovum is released and made available for fertilization, and the resultant
ruptured follicle begins the process of forming a corpus luteum, which is responsible for
progesterone production for the maintenance o f pregnancy.
Nutritional Effects on Follicular Development
The body condition o f the animal, as well as the overall nutritional plane on
which the animal is maintained, can have profound effects on reproductive
performance.

Cows undergoing feed restriction and those that have a low body

condition score, which reflects the nutritional status o f the animal, have lower numbers
o f ovarian follicles than those with a high body condition score or those fed adequate
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energy intake (Rutter and Manns, 1991; Ryan et al., 1994a).

Also, increasing the

dietary energy has been shown to be beneficial in increasing the number o f follicles
(Lammoglia et al., 1997), without affecting gonadotropin concentrations (Gutierrez et
al., 1997b). It appears that the effects o f dietary energy on follicular development occur
during the time o f early follicular activation and subsequent recruitment into a follicular
wave, since the process seems to be gonadotropin-independent (Gutierrez et al., 1997b).
In addition, adequate dietary energy is crucial in maintaining normal reproductive
cyclicity, since restricting the dietary energy intake lowers basal estradiol and
progesterone production by the follicles and corpora lutea in Brahman cattle,
respectively (Lammoglia et al., 1997).
One mechanism for the stimulation o f ovarian follicular development may be
through dietary effects on circulating ST and IGF-I, two growth promoters that also
have effects on the reproductive axis (Rhind and Schanbacher, 1991). It is known that,
during periods of feed restriction, serum ST rises, presumably due to its repartitioning
abilities so that available nutrients are routed away from fat deposition (Rhind and
Schanbacher, 1991), but also in part due to the ability of blood glucose to suppress ST
secretion (Barb et al., 1995).

In contrast, IGF-I is higher in pigs that are on diets

consisting o f adequate energy intake, presumably due to its growth promoting abilities
in many cell-types throughout the body (Ryan et al., 1994a). In addition, it has been
demonstrated that the circulating levels o f high-density lipoproteins can influence
hepatic IGF-I production by increasing the amount of IGF-I produced (Bao et al.,
1995). Finally, circulating insulin levels are affected by nutritional status, and insulin
can also have effects in reproduction (Conway et al., 1990).

For example, insulin
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treatment to pigs increases the number o f ovarian follicles, but this stimulation is
primarily through the IGF-I type-I receptor, essentially making the effects o f insulin
virtually identical to those o f IGF-I (Edwards et al., 1996).
SOMATOTROPIN AND IGF-I IN REPRODUCTION
Somatotropin is secreted by the adenohypophysis in response to growth
hormone releasing-hormone (GHRH) secreted by the hypothalamus (Dubreuil et al.,
1990; Hugues et a l, 1991). Its primary role is to promote growth in most cell-types
within the body, however it appears to be very important in reproductive function as
well. It has been demonstrated that immunization o f prepubertal heifers against GHRH
significantly delays the onset o f puberty and reduces the number o f ovarian follicles
(Cohick et al., 1996). Furthermore, administration o f GHRH significantly raises plasma
ST as well as follicular steroids, and increases follicle growth in cattle (Spicer and
Enright, 1991) and women (Hugues et al., 1991). It has been proposed that ST plays a
permissive role in reproduction, and that only in cases of ST deficiency should one
expect ST treatment to show a benefit (Piaditis et al., 1995). However, this may not be
entirely true, as numerous studies have demonstrated positive effects on ovarian
follicular dynamics with ST administration to normally cycling cattle (Gong et al.,
1991; Rieger et al., 1991; Spicer et al., 1992; Lucy et al., 1993; Echtemkamp et al.,
1994b; Gong et al., 1996a).

It has also been reported that cows deficient in ST

receptors have lower numbers of follicles on their ovaries at any given time, shorter
waves o f follicular growth and depressed growth o f the dominant follicle within each
follicular wave compared with normal cattle (Chase et al., 1998). It is therefore evident
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that ST plays some role in ensuring normal reproductive function in mammalian
species.
The administration of exogenous ST has been shown to be beneficial in
increasing follicular numbers in cattle (Lucy et al., 1993), pigs (Echtemkamp et al.,
1994a) and women (Owen et al., 1991a). It is thought that these effects are brought
about, at least in part, through the ability o f ST to stimulate hepatic as well as locally
produced IGF-I (Homburg et al., 1988), although a direct effect of ST at the level o f the
ovary has been suggested (Gong et al., 1991). Early studies have shown that exogenous
ST increases ovarian follicle numbers in the small- to medium-size categories, and this
effect seems to be highly correlated to circulating IGF-I concentrations (Owen et al.,
1991a). Since daily ST secretion patterns are variable and pulsatile in nature, with
frequent sampling times needed in order to establish baseline patterns for individual
animals (Thompson et al., 1992), it may be important to establish baseline IGF-I values,
since ST stimulates IGF-I production and baseline IGF-I concentrations tend to be less
variable within individual animals (Stewart et al., 1993). However, it is also likely that
ST exhibits direct effects at the ovarian level as well, since some studies have
demonstrated positive effects of ST administration on the number of follicles without an
effect on IGF-I concentrations (Tapanainen et al., 1992). In light of these findings, it is
likely that ST has both direct effects at the level o f the ovary, as well as indirect effects
through the stimulation o f systemic and intrafollicular of IGF-I production.
Many reports have demonstrated that ST administration increases ovarian
follicle numbers, and also that the administration o f ST affects follicular and systemic
steroid concentrations (Spicer et al., 1992; Tapanainen et al., 1992; Echtemkamp et al.,
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1994b; Gong et al., 1996a). However, other studies in women have shown that ST
administration has no effect on ovarian follicular dynamics, since exogenous treatment
with ST resulted in no noticeable effect on follicular growth and development (Hofferer
et al., 1991; Owen et al., 1991b; Shaker et al., 1992; Eckery et al., 1994; Driancourt and
Disenhaus, 1997). However, it is important to note that most o f these studies involved
normally cycling experimental subjects, in which additional ST may not be beneficial to
reproductive function. In addition, several factors including the time o f the cycle, the
amount o f ST given, as well as the duration o f treatment could all have affected the
outcome o f these studies.

It is evident, in any case, that ST is important in normal

reproductive function as evidenced in animals with little to no endogenous ST input
(Bartke et al., 1996; Eckery et al., 1997).
In Ames dwarf mice, a genetic condition in which no somatotropes develop
within the adenohypophysis, resulting in no ST production, normal patterns of ovarian
follicular development do not occur, but treatment with exogenous ST can completely
reverse this phenomenon (Bartke et al., 1996).

In addition, in hypophysectomized

ewes,

insuffucient

gonadotropin administration alone

is

in

restoring

normal

reproductive cyclicity (Eckery et al., 1997). However, once ST is given in addition to
gonadotropins, the animals will begin to cycle and ovulate in a normal fashion once
again. (Eckery et al., 1997).

These findings demonstrate the importance o f ST in

normal reproductive function.
It is well documented that treatment with exogenous ST causes plasma IGF-I
concentrations to rise within 2 to 3 days o f the initiation of treatment, and it is believed
that this growth factor is responsible for many o f the ovarian effects demonstrated with
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ST administration in cows (Gong et al., 1991; De La Sota et al., 1993; Eckery et al.,
1994; Lucy et al., 1994; Samaras et al., 1994; Gong et al., 1997). For example, ST
administration to cyclic gilts resulted in an increase in the number of small ovarian
follicles, which was highly correlated to rises in both plasma and intrafollicular IGF-I
concentrations (Spicer et al., 1992).

Interestingly, most studies in domestic species

have only reported increases in small- to medium-sized follicles, with no difference
seen in large follicle numbers per animal in animals treated with ST (Gong et al., 1991;
Spicer et al., 1992; Lucy et al., 1993). However, in one study using gonadotropinstimulated Holstein heifers, ST administration significantly increased both large follicle
numbers as well as the number o f ovulations per heifer when compared with those
heifers receiving gonadotropin treatment only (Rieger et al., 1991).
Similar findings have been reported in clinically infertile women, especially
those with polycystic ovarian disease, in which ST treatment in conjunction with
gonadotropin administration significantly increased the number of large follicles
available for transvaginal oocyte collection procedures for use in in vitro fertilization
protocols (Homburg et al., 1988; Owen et al., 1991a,b). It is proposed that elevated
levels o f ST as well as IGF-I act synergistically with available gonadotropins, causing
an enhancement of the follicular response to gonadotropin stimulation, which could
explain the apparent lack o f large follicle stimulation in experimental subjects receiving
no gonadotropin stimulation (European and Australian Multicenter Study, 1995). This
could be important in the treatment o f clinical infertility in not only cattle and humans,
where gonadotropin treatments alone are often successful, but also in the domestic
mare, since various protocols involving treatment with gonadotropins have shown little
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to no real success (Rosas et al., 1998). In a recent study in cyclic mares, it was shown
that treatment with both porcine ST as well as bovine ST resulted in significantly higher
plasma IGF-I concentrations when compared with untreated control mares, dem
onstrating that ST from other species has biological activity in the domestic mare
(Buonomo et al., 1996).

However, in this study, no reproductive parameters were

monitored, and the study was discontinued due to severe local reactions with the
commercial preparation o f these compounds.
Further studies showing the synergistic effects o f ST/IGF-I on gonadotropic
action in follicular development involve a reduction in the amount o f gonadotropins
necessary to elicit the desired response (Homburg et al., 1988; Owen et al., 1991a;
Yoshimura et al., 1994). In women undergoing controlled ovarian hyperstimulation
treatments for use with in vitro fertilization protocols, ST administration significantly
reduced the total amount o f gonadotropins needed to successfully stimulate the desired
number o f follicles when compared with women receiving no ST treatment (Homburg
et al., 1988; Owen et al., 1991a; Bergh et al., 1994; European and Australian
Multicenter Study, 1995). In addition, using perifused rabbit ovaries, Yoshimura et al.
(1994) demonstrated that ST enhanced the follicular response to available gonado
tropins by increasing both follicular growth as well as oocyte maturation. Furthermore,
it was demonstrated that these effects were highly correlated to increased intrafollicular
IGF-I production, providing further evidence that many o f the effects o f ST treatment
are IGF-I mediated (Yoshimura et al., 1994). From a practical sense, it should be noted
that treatment with ST in no way impairs the fertility o f the resultant oocytes, which
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would obviously limit its use in ovarian stimulation protocols (Homburg et al., 1988;
Owen et al., 1991a,b; Bilby et al., 1998).
Finally, treatment with exogenous ST can also affect follicular wave patterns. In
lactating dairy cattle, ST administration has been shown to decrease the interval
between follicular waves (Kirby et al., 1997b).

That is, when cows were given

exogenous ST, the emergence o f the subsequent follicular wave was hastened by ~48
hours (Kirby et al., 1997a). This same phenomenon has been reported in young dairy
heifers, where treatment with both ST and placental lactogen hastened follicular wave
emergence (Lucy et al., 1994). Since serum IGF-I was increased in all treated animals,
an IGF-I-mediated response cannot be ruled out (Lucy et al., 1994). That ST/IGF-I
seems to have the ability to affect follicular wave patterns in this fashion lends further
evidence that these growth factors may be involved in early follicular activation and
recruitment into a follicular wave.
Effects of ST on Hormone Production
Conflicting results have been reported in relation to the effects o f ST on
gonadotropin as well as steroid production.

In both cattle (Gong et al., 1991) and

women (Tapanainen et al., 1992), it has been demonstrated that ST treatment had no
effect on plasma LH or FSH concentrations.

Also, it was also reported that ST

administration has no effects in cattle on estradiol or progesterone production in cyclic
animals (Gong et al., 1991). However, women treated with ST exhibited a decrease in
serum estradiol as well as serum progesterone levels, with an increase in intrafollicular
steroid production (Tapanainen et al., 1992). This in contrast to a study by Lanzone et
al. (1996), in which it was demonstrated that ST administration to subfertile women
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caused a rise in serum estradiol concentrations throughout the duration o f treatment. In
addition, pigs treated with ST exhibited no differences in serum concentrations of LH,
FSH, estradiol or progesterone, however, intrafollicular estradiol production was
affected, with a decrease in estradiol production noted in medium-sized follicles in pigs
(Spicer et al., 1992).
Interestingly, in rats treated with equine chorionic gonadotropin (eCG), it was
shown that, while ST treatment had no effect on absolute serum values o f LH,
administration o f ST did cause slightly different (pleiomorphic) forms o f LH to be
secreted, which appear to have a lower biological activity than LH secreted in the
absence o f ST treatment (Wilson et al., 1985). In any case, it currently remains unclear
what effects, if any, ST administration may have on the production and secretory
patterns o f gonadotropins and steroid hormones in mammalian species.
Insulin-like Growth Factor-I
Since treatment with either GHRH and/or ST causes significant rises in both
plasma and intrafollicular IGF-I concentrations, it is important to gain a better
understanding o f the exact mechanisms through which IGF-I may affect mammalian
reproductive function (Owen et al., 1991b; Kirby et al., 1993; Stanko et al., 1994; Gong
et al., 1997; Sirotkin et al., 1998a). It has been demonstrated that IGF-I increases the
growth and development o f ovarian follicles in the rat (Yoshimura et al., 1996a,b), as
well as stimulating resumption o f meiosis in the oocyte (Zhou and Bondy, 1993;
Yoshimura et al., 1996a), and that blocking the IGF-I Type-I receptor reverses these
effects (Yoshimura et al., 1996a). In addition, treatment o f granulosa cells collected
from growing ovarian follicles with IGF-I increases the responsiveness o f the granulosa
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cells to the stimulatory effects o f FSH, possibly through increasing FSH receptor
numbers (Owen et al., 1991a). This seems to be the most likely mechanism o f action
for the synergistic effect detected between IGF-I and the gonadotropins, since treatment
with IGF-I also increases LH receptor numbers in cultured rat granulosa cells (Liu et
al., 1998). This synergistic effect can be detected in lactating dairy cows during the
first 14 days postpartum, as it was demonstrated that all cattle that ovulate within this
time frame have 40 to 50% higher basal IGF-I concentrations, with no differences in
plasma steroid or gonadotropin levels (Beam and Butler, 1997). This clearly shows that
higher IGF-I concentrations in the plasma can be important for the resumption of
reproductive cyclicity in cattle, and that IGF-I is involved in reproductive function.
Since there was no difference in circulating plasma levels o f LH or FSH in this study, it
is probable that the elevated IGF-I allowed for an enhancement o f the response to the
available gonadotropins in these postpartum cattle (Beam and Butler, 1997). Also, it
has been demonstrated in subfertile women that the circulating concentration o f IGF-I is
inversely related to the amount o f gonadotropins needed to achieve an adequate
stimulatory response when undergoing treatment for use in in vitro fertilization
protocols (Rabinovici et al., 1990).
It has been suggested that intrafollicular IGF-I concentrations may play a role in
the selection and continued growth o f the dominant follicle within a follicular wave
(Yuan et a l, 1998).

This is due to the fact that, in some reports, intrafollicular

concentrations o f IGF-I are higher in dominant compared with subordinate follicles
(Rabinovici et al., 1990; Monget and Monniaux, 1995; Yuan et al., 1998). Also, it has
been shown that IGF-I receptor numbers are higher in dominant follicles when
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compared to those of subordinate follicles (Stewart et al., 1996; Zhou et al., 1996; Yuan
et al., 1998).

However, others have reported no difference in intrafollicular con

centrations o f IGF-I between dominant and subordinate follicles (De La Sota et al.,
1996; Thierry Van Dessel et al., 1996). Aside from total concentrations o f IGF-I within
the follicular fluid of dominant and subordinate follicles, the bioavailability o f the IGF-I
that is present may play an even greater role in dominant follicle growth and
development. It is known that, in the dominant follicle, intrafollicular concentrations o f
IGF-I binding proteins change over time, allowing for an overall increase in the IGF-I
available for cellular stimulation (Monget et al., 1993; Monget and Monniaux, 1995;
Yuan et al., 1998).

It is therefore possible that this increase in bioavailable IGF-I,

through its interactions with gonadotropins, allows for the stimulation of growth o f the
dominant follicle(s) over that o f the subordinate follicles within a follicular wave.
Finally, it has been demonstrated in mares (Malinowski et al., 1996) as well as women
(Klein et al., 1996) that basal IGF-I concentrations decrease as age increases, which
may partially explain the age related decrease in fertility noted in these species.
Other Factors Influencing IGF-I
Aside from ST stimulation, IGF-I production can be influenced by various other
compounds within the body. It has long been known that estradiol effects both IGF-I
production as well as IGF-I receptor formation (Monget and Monniaux, 1995; Johnson
et al., 1996; Johnson et al., 1998; Wilson, 1998a,b). However, there seems to be an
age-related uncoupling o f the estradiol-IGF-I axis, since prepubertal and adolescent
females respond differently than adults (Wilson, 1998a,b). In adolescent female Rhesus
monkeys, estradiol increases systemic IGF-I production, but in adults the opposite
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effect occurs (Wilson, 1998b). In addition, in these adult monkeys, estradiol increases
IGF-I binding protein concentrations within the follicle, which would further limit the
amount o f IGF-I available for use by the granulosa cells (Wilson, 1998a).
In addition to estradiol, progesterone has also been shown to effect IGF-I
production by

decreasing

systemic concentrations o f IGF-I

(Manikkam

and

Rajamahendran, 1997). Also, treatment o f both sheep (Khalid et al., 1997) as well as
pigs (Hammond et al., 1988) with gonadotropins or GnRH has been shown to increase
intrafollicular IGF-I concentrations, however, no effects were detected in systemic IGFI levels. In addition, glucocorticoids have been shown to negatively affect follicular
growth (Asa and Ginther, 1982; Asa et al., 1983), and this is correlated to a reduction in
intrafollicular IGF-I levels (Peter and Asem, 1996).

Finally, other factors, such as

tumor necrosis factor alpha (TNFa) have been reported to inhibit IGF-I binding to
granulosa cells, however, no effects were detected in actual IGF-I production (Spicer,
1998b).
Intrafollicular Effects o f ST and IGF-I
Both ST and IGF-I have potent stimulatory effects at the level o f the granulosa
cells within ovarian follicles.

ST increases the FSH-stimulated differentiation o f

cultured rat granulosa cells (Gong et al., 1991), and it synergizes with FSH and LH to
enhance the effects o f both o f these gonadotropic hormones within the granulosa cells
(Homburg and Ostergaard, 1995). Also, granulosa cells o f antral follicles do possess
ST receptors, however, those o f pre-antal follicles do not, suggesting that the increases
in small follicle numbers noticed during ST treatment is not a result o f an increase in
early follicle activation (Sharara and Nieman, 1994). Also, since ST administration to
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granulosa cells collected from women has been shown to have no effect on subsequent
steroidal output by these granulosa cells, it is assumed that most of the effects noted
with ST treatment are, in fact, mediated through IGF-I (Foster et al., 1995).
The effects of IGF-I on granulosa cells function are similar to those o f ST, but
perhaps more broad in nature.

It is well documented that IGF-I synergizes with

available gonadotropins within the follicle, and it is through this mechanism that IGF-I
causes most o f its ovarian effects (Homburg and Ostergaard, 1995; De La Sota et al.,
1996; deMoura et al., 1997; Singh and Armstrong, 1997). It has been shown that
granulosa cells from most domestic species have the capacity to produce IGF-I, and also
that these granulosa cells possess IGF-I receptors, which would suggest that IGF-I has
both paracrine and autocrine functions within the granulosa cells (Xia et al., 1994;
Stewart et al., 1997; Sirotkin et al., 1998b).
Since FSH seems to be required for optimal IGF-I production, and since FSH
increases IGF-I receptor numbers within the granulosa cells, the interrelationship
between FSH and IGF-I is very important in the growth and development o f the
follicular granulosa cells (Hammond et al., 1988; Samaras et al., 1996; Beam and
Butler, 1997; Pawshe et al., 1998). In addition, IGF-I has been shown to increase the
number o f LH receptors in cultured rat granulosa cells, and this, along with the ability
o f IGF-I to increase inhibin secretion (De La Sota et al., 1996) may be an important
mechanism in the selection o f the dominant follicle within a follicular wave (Beam and
Butler, 1997).

In most domestic species, only the dominant follicle exhibits LH

receptors within the granulosa cells (England et al., 1981; Staigmiller, 1982), and since
IGF-I and IGF-I receptors are higher in the follicular fluid collected from dominant
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follicles, the hypothesis that intrafollicular IGF-I is necessary for the selection o f the
dominant follicle is supported (Beam and Butler, 1997).

However, unlike most

domestic species, ovarian follicles in mares have been shown to possess LH receptors
from sizes o f 5 mm in diameter upwards (Goudet et al., 1999).

Since the ovarian

follicles o f mares grow to very large sizes (>40 mm in diameter) when compared with
most other species evaluated, this phenomenon o f only dominant follicles possessing
LH receptors does not hold true. However, even in mares, those granulosa cells from
subordinate follicles have less total number o f LH receptors than do those from
dominant follicles, which leaves the possibility that intrafollicular IGF-I could play a
role in dominant follicle selection in the mare as well (Goudet et al., 1999). Finally,
unlike those o f LH, FSH receptors are found in all follicles from 0.5 mm in diameter
upwards, so the potential effect of IGF-I on dominant follicle selection may be limited
to increasing LH receptor numbers rather than an overall increase in both FSH and LH
receptors (Findlay, 1994).
Both IGF-I and insulin have mitogenic effects on the growth and development
o f granulosa cells in mammalian species.

IGF-I has been shown to increase DNA

synthesis in cultured bovine granulosa cells (Khamsi and Armstrong, 1997), which in
turn leads to an increase in cell proliferation.

Numerous studies have clearly

demonstrated that IGF-I greatly increases granulosa cells proliferation in vitro in
virtually every farm animal species studied (Xia et al., 1994; Spicer and Echtemkamp,
1995; Armstrong et al., 1996b; Campbell et al., 1996; Gutierrez et al., 1997a; Mariana
et al., 1998). Furthermore, while insulin has similar effects (Matamoros et al., 1991;
Simpson et al., 1994; Whitley et al., 1998), insulin is not as potent an ovarian stimulator
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as is IGF-I, probably due to the fact that it appears that both factors work through the
type-I IGF-I receptor, which has a greater affinity for IGF-I (Monget and Monniaux,
1995; Gutierrez et al., 1997a; Willis et al., 1998).

In addition, when FSH is

administered to these in vitro cultured granulosa cells, the cellular response is increased
by 2- to 3-fold (Xia et al., 1994; Armstrong et a l, 1996b; Campbell et a l, 1996).
Finally, while cumulus cell expansion in mature follicles is generally thought to be
FSH-dependent, there is growing evidence that this process is also IGF-I mediated, and
therefore, IGF-I is required for proper maturation o f the ovarian follicle (Lorenzo et al.,
1994; Singh and Armstrong, 1997).
In addition, IGF-I has potent stimulatory actions on steroid production by the
granulosa cells, which are, again, augmented by the presence o f FSH (Gong et al.,
1991; Spicer and Echtemkamp, 1995; Armstrong et al., 1996b; deMoura et al., 1997).
It has been demonstrated that the addition o f IGF-I to the culture medium o f caprine
(Behl and Pandey, 1999), bovine (Schams et al., 1988; Armstrong et a l, 1996b), ovine
(Mariana et al., 1998), human (Mason et a l, 1993; Foster et al., 1995) and porcine
(Howard and Ford, 1994; Xia et al., 1994; Sirotkin et al., 1998a) granulosa cells
increases the steroidal output of these cells. In general, both progesterone and estradiol
production is enhanced through IGF-I treatment, and insulin can cause similar effects
(Spicer, 1998a). It appears that IGF-I increases aromatase enzyme activity within the
granulosa cells, and thereby increases estradiol production (De La Sota et a l, 1996). In
addition, it has been shown that IGF-I increases the production of steroid acute
regulatory protein (StAR protein), and in this way augments progesterone production by
the granulosa cells (Bao et al., 1998; LaVoie et al., 1999). It is therefore evident that
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IGF-I is crucial to maintaining normal granulosa cells proliferation and steroid
production to ensure that follicular growth and development proceed in a normal
manner.
IGF-I Binding Proteins
In addition to stimulating IGF-I production, ST administration has been shown
to increase the production o f IGF-I binding proteins (IGFBP) within the follicle
(Echtemkamp et al., 1994a; Rabinovici et al., 1997). Other factors, including epidermal
growth factor (stimulatory) and FSH (inhibitory), affect IGFBP production within the
follicle (Mondschein et al., 1990; Yap et al., 1998).

These binding proteins are

responsible for regulating the amount o f available IGF-I in the plasma and follicular
fluid, since without them, the IGF-I found in plasma and follicular fluid would be
utilized by the various cells throughout the body in a short period o f time. IGFBP are
therefore used to increase the half-life o f circulating IGF-I so that it will be available for
longer periods o f time. Incidentally, an ST binding protein has also been isolated (Amit
et al., 1993). IGFBP are produced within the follicle by both theca and granulosa cells
(San Roman and Magoffin, 1992), and they act primarily by binding IGF-I and making
it less available for cellular utilization (Samaras and Hammond, 1995), which would
block the stimulatory effects of IGF-I (Spicer and Chamberlain, 1999). Other factors
involved in regulating IGFBP production are LH and FSH, which seem to increase
intrafollicular IGFBP concentrations (Armstrong et al., 1996a). In addition, both IGF-I
as well as insulin are potent inhibitors of IGFBP production, with IGF-I having stronger
inhibitory actions on IGFBP production than insulin (Poretsky et al., 1996).
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Several IGFBP have been identified to date, and they can be classed as follows:
(1) small molecular weight IGFBP and (2) large molecular weight IGFBP (Gerard and
Monget, 1998).

The small molecular weight IGFBP include IGFBP-2, -4 and -5,

whereas the large molecular weight IGFBP are limited to IGFBP-3 (Funston et al.,
1996). Typically, growing follicles have less amounts o f intrafollicular IGFBP than do
atretic follicles in both pigs and cattle (Samaras et al., 1993; Stanko et al., 1994;
Funston et al., 1996; Stewart et al., 1996). In addition, it appears that the types o f
IGFBP present are also important, since follicular fluid from dominant follicles usually
contain IGFBP-3, with little to no small molecular weight IGFBP present (San Rom an
and Magoffin, 1993; Echtemkamp et al., 1994a; Funston et al., 1996; Gerard and
Monget, 1998). This is probably due to the fact that IGFBP-3 tends to bind IGF-I less
tightly than the smaller molecular weight IGFBP, and therefore more IGF-I would be
bioavailable in large, dominant follicles for the stimulation o f the granulosa cells
(Mondschein et al., 1991; Echtemkamp et al., 1994b; Thierry Van Dessel et al., 1996).
It has been suggested that decreasing concentrations o f IGFBP, which in turn
increases bioavailable IGF-I, thereby increasing the number o f LH receptors within the
granulosa cells, is necessary for the establishment of follicular dominance (Stewart et
al., 1996; Zhou et al., 1996). In addition, IGFBP appear to play a prominant role in
follicular atresia (De La Sota et al., 1996). It has been hypothesized that the onset o f
folliclular atresia may be determined more by changes in intrafollicular IGFBP
concentrations than by absolute levels o f IGF-I (Monget et al., 1993). This is supported
by the finding that, during follicular atresia, the ratio o f IGFBP to IGF-I changes, and
that less IGF-I is available for granulosa cells stimulation (De La Sota et al., 1996).
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Also, it is known that FSH stimulates proteases designed to break down IGFBP, which
may be one mechanism o f avoiding follicular atresia (Erickson et al., 1994). Further
studies are needed to more clearly define the precise role o f IGFBP in ovarian follicular
dynamics.
IMPLICATIONS OF SOMATOTROPIN TREATMENT IN THE MARE
Seasonality
The reproductive cycle in the domestic mare is seasonal in nature, with peak
breeding activity coinciding with periods o f increasing daylength (summer), while
during reduced daylength conditions, mares typically undergo a period o f reproductive
inactivity termed “seasonal anestrous” (Ginther, 1992). The term “anestrous” is not
entirely accurate, since sporatic exhibitions o f behavioral estrus are often detected in
these anovulatory mares (Thompson et al., 1983a). However, this is currently the most
widely accepted term used to describe this part o f the mare's seasonal cycle.
Interestingly, although the majority of mares do undergo this anovulatory state, up to
25% of mares actually continue reproductive cyclicity complete with an ovulatory
response virtually year-round (Hughes et al., 1972). The current theory for this winter
inactivity in the mare is that, when daylength is decreased, melatonin production from
the pineal increases, and this increase in melatonin production decreases GnRH
production and secretion from the hypothalamus (McKinnon and Voss, 1993).
However, it should be noted that, to date there has been no direct evidence
linking melatonin to GnRH production or secretion (McKinnon and Voss, 1993). It is
known, though, that hypothalamic GnRH is severely decreased or absent in the mare
during the winter, and this is the direct cause o f the anovulatory season (Hart et al.,
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1984).

It has been shown that ovarian follicular development and ovarian size is

dramatically decreased in seasonally anovulatory mares, and this can be directly
correlated to decreased GnRH output from the hypothalamus (Hart et al., 1984). That
actual daylength is involved in this process is evidenced by the fact that exposure of
seasonally anovulatory mares to artificial lighting regimes (~16 hours o f light per day)
can hasten the onset o f reproductive cyclicity within a relatively short period o f time
(Kooistra and Ginther, 1975; Sharp et al., 1975; Oxender et al., 1977; Nequin et al.,
1989). This occurs presumably through increased hypothalamic GnRH, which then
stimulates both LH and FSH production, and this aids in restoring reproductive function
(Cleaver et al., 1991).
Since most o f the major breed registries require a mandatory birthdate of
January 1 for foals bom within a year in the United States, along with the fact that the
gestation length in the domestic mare is ~11 months, it is o f importance to the
commercial breeder to have mares cycling in February, which is during the seasonal
anovulatory state for most mares in North America. Artificial lighting regimens are the
most repeatable method o f inducing seasonally anovulatory mares to begin reproductive
cyclicity (Ginther, 1992). However, this method of inducing cyclicity in the mare is
labor intensive, expensive and time consuming, since it takes 60 to 70 days from the
onset of treatment with increasing light exposure until ovulation is achieved (Ginther,
1992).
For this reason, GnRH treatment to these anovulatory mares has become an
intense area o f study in recent years. It has been demonstrated that continuous infusion
with GnRH can induce ovulation in up to 50% of seasonally anovulatory mares within 4
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weeks (Hyland et al., 1987). However, in all studies to date, the ovulatory response in
seasonally anovulatory mares treated with GnRH has been shown to be highly variable,
and that either continuous infusion, multiple daily injections or long-term subcutaneous
depots are required for any response at all (Johnson, 1986; Hyland et al., 1987; Johnson,
1987; Ginther and Bergfelt, 1990; Fitzgerald et al., 1993). The variability exhibited in
the ovulatory response to these different GnRH therapy regimes is probably primarily
reflected by the state o f anestrous that the mares in question are actually in, since mares
in a deeper state o f anestrous, as determined by plasma progesterone concentrations as
well as ovarian follicular activity, tend to be less responsive to GnRH treatment
(Fitzgerald et al., 1993; Mumford et al., 1994; Hyland et al., 1987).
The ability o f GnRH to stimulate both LH and FSH production is critical to its
ability to promote ovulation in some seasonally anovulatory mares (M cKinnon and
Voss, 1993). It is well known that pituitary and serum concentrations o f LH (Hart et
al., 1984; Thompson et al., 1986b), as well as serum levels of FSH (Alexander and
Irvine, 1991), are reduced during the winter months in mares, and that GnRH can
increase both LH and FSH output by the pituitary (Thompson et al., 1986a ; Johnson,
1987). It is this action o f GnRH that allows for the resumption of reproductive cyclicity
in seasonally anovulatory mares treated with GnRH or one o f its more potent agonists.
It is known that prolactin is also decreased during the winter months (Thompson
et al., 1986b), and that treatment o f anovulatory mares with prolactin can hasten the
date o f the first ovulation in these mares, possibly through an increase in LH receptors
among the granulosa cells (Thompson et al., 1997). It is possible that, through a similar
mechanism, treatment o f anovulatory mares with ST could enhance the response of
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these mares to GnRH therapy by increasing intrafollicular IGF-I concentrations, which
could in turn increase LH and FSH receptor production on the granulosa cells (deMoura
et a l, 1997). Since it is well documented that ST administration significantly increases
the response o f both cattle and women to available gonadotropins, this could prove to
be a viable method o f reducing the variability noticed with traditional GnRH treatment
to seasonally anovulatory mares, and it could make this type o f treatment regimen
economically viable for the commercial horse breeder.
OBJECTIVES
The objectives o f the present study were, therefore, to: (1) determine the effects
o f ST administration to both cyclic as well as seasonally anovulatory mares, (2)
determine if ST administration to seasonally anovulatory mares receiving GnRH
treatment would enhance the ovulatory response over that o f GnRH treatment alone, (3)
determine if a repeatable protocol, including ST administration, could be developed for
the stimulation and subsequent collection o f viable oocytes from the ovaries of cyclic
mares for use in in vitro fertilization treatments and (4) determine the mechanism o f
action of ST administration to stimulate ovarian follicular development.
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CHAPTER n
THE EFFECTS OF EQUINE SOMATOTROPIN (eST) ON OVARIAN
STIMULATION AND SYSTEMIC HORMONE CONCENTRATIONS IN
CYCLIC MARES TREATED AT TWO STAGES OF THE ESTROUS CYCLE
INTRODUCTION
In recent years, the role o f somatotropin (ST) and its effects on ovarian function
has become a major area o f interest to reproductive physiologists studying follicular
development. However, little research has been reported defining the function o f ST in
reproduction in the cyclic mare. Short-term daily ST secretion in mares is pulsatile in
nature, much like that o f other species (Thompson et al., 1994). With a large variation
exhibited in the quantity and in the number o f daily pulses o f ST secreted among
individual mares, frequent blood sampling over an extended period o f time is needed to
establish baseline secretion patterns for an individual animal (Thompson et al.,
1992; 1994). Several studies in the human and the cow suggest that ST may have direct
effects on ovarian activity based on the identification o f ST receptors and binding
proteins (BP) in the ovary (Spicer and Enright, 1991; Amit et al., 1993; Cohick et al.,
1996).

Also, it has been demonstrated that ST administration increases circulating

levels o f IGF-I in cattle, pigs, horses and women (Owen et al., 1991a; Spicer et al.,
1992; European and Australian Multicenter Study, 1995; Buonomo et al., 1996).
Furthermore, treatment with ST has been shown to affect follicular dynamics and
estradiol and progesterone secretion patterns in cattle, pigs and humans (Owen et al.,
1991a; Rieger et al., 1991; Spicer et al., 1992; 1993; Lucy et al., 1994).
It is well known that ST mediates many o f its effects through insulin-like growth
factor-I (IGF-I), and apparently it is through this mechanism that growth hormone alters

42

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

ovarian function (Spicer and Echtemkamp, 1995).

Since IGF-I levels can be

determined with much less frequent blood sampling, it may be more feasible to monitor
circulating IGF-I rather than ST in mares. Also, follicular fluid from larger follicles
tends to have higher concentrations o f IGF-I, and this IGF-I could play an important
role in the selection o f dominant follicles, as has been suggested in humans and in cattle
(Rabinovici et al., 1990; Spicer and Enright, 1991).
The purpose o f this experiment was to (1) determine if treatment with
exogenous equine somatotropin (eST) would increase the number o f small- and/or
medium-size follicles on the ovaries o f cyclic mares and (2) to determine the effects o f
eST treatment on circulating levels o f LH, estradiol, progesterone and IGF-I in cyclic
mares.
MATERIALS AND METHODS
Experimental Design
A group of mixed-breed horse and pony mares (n=20), maintained on
bermudagrass pasture and in good body condition (body condition scores ranged from 5
to 8 on a scale of 1 to 9), was selected for this experiment. Experimental animals were
randomly allocated to one o f four treatment groups during the breeding season o f 1996
(June through July). Since mares were to be monitored over parts o f two successive
estrous cycles, the estrous cycles were designated as “T ” for the treated cycle and “P”
for the post-treated cycle. Treatment A consisted o f mares (n=8) each receiving an
intramuscular (i.m.) injection o f 25 pg/kg of body weight o f equine somatotropin (eST,
BresaGen Ltd., Thebarton, South Australia) daily beginning on day T6 and ending on
day T12. The time o f treatment for this group was determined so that elevated plasma
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ST and/or IGF-I levels would be present at the time o f follicular wave emergence,
which is at approximately day 9 post-ovulation.

The ovaries o f these mares were

monitored daily by ultrasound to determine the day o f ovulation (day o f ovulation = day
TO) and then were monitored every other day beginning on the first day o f treatment
(day T6) and ending on the subsequent day o f ovulation (day PO) using an Aloka 500-V
ultrasound unit with a 5 MHz rectal probe (Corometrics Medical Systems, Wallingford,
Connecticut). A blood sample was collected from each of the mares in this group at 24hour intervals during the same time period. The blood samples were collected on ice
using sterile glass collection tubes (Monoject Vacutainers®, Sherwood Medical, St.
Louis, Missouri). Treatment B consisted o f mares (n=8) each similarly receiving an
i.m. injection o f eST daily beginning on day T13 and ending on day T19. This time
period was used so as to coincide with divergence of the dominant follicle from the
subordinate within the ovulatory follicular wave, which occurs at approximately day 14
post-ovulation.

Blood sample collection and ultrasonographic monitoring of ovarian

structures were performed on these mares beginning on day T13 and ending on day
P5.
Mares randomly assigned to Treatments C and D (n=2/treatment) were used as
controls, and were administered an i.m. injection o f a sodium borate vehicle equal in
volume to that containing the eST given to mares in Treatments A and B. Follicle
growth and ovulation in control mares were monitored by ultrasonography and blood
sample collection was performed in the same manner as the mares allotted to
Treatments A and B, respectively.
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The crystalline eST was reconstituted in sterile water at a concentration o f 2.5
mg/ml. Injection sites were rotated daily on opposite sides o f the neck region. The
volume o f each injection ranged from 2.8 to 5.7 ml, depending upon the body weight o f
the mare (25 pg/kg of body weight).
Ultrasound prints (Sony®, Model No. UP850 thermal printer, Tokyo, Japan) o f
the ovaries o f each mare were collected to monitor follicular development. Each ovary
was scanned from dorsal to ventral and from lateral to medial sides, and still prints were
taken each time a follicle was present at its maximum diameter. Each follicle was then
identified, measured and placed into one o f five follicle classification categories, based
on its diameter (Category I = <7 mm, II = 8 to 16 mm, III = 17 to 24 mm, IV = 25 to 32
mm and V = >32 mm).
Hormone Assays
Blood samples were centrifuged at 300 x g for 10 minutes, and the plasma was
then stored in individually-labeled 7 ml plastic tubes (Curtin Matheson Scientific, Inc.,
Houston, Texas) and frozen within 30 minutes of collection. Validated radio
immunoassay (RIA) (Sticker et al., 1995) was performed on the plasma samples
collected from days 1, 2, 3, 5 and 7 of treatment, the day o f the onset o f standing estrus
and the day o f ovulation to determine circulating IGF-I levels for each mare. Also, LH
(Thompson et al., 1983) and estradiol-170 (Diagnostic Systems Laboratories, Webster,
Texas) levels were determined from samples collected on day P0 and for the 8 days
prior to day P0 (days -8 through P0) for Treatments A and C, or day -8 to day P5 for
Treatments B and D.
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In addition, progesterone (Diagnostic Systems Laboratories) concentrations
were assayed from plasma samples collected every other day beginning on day T6 and
ending on the first day o f standing estrus (Treatments A and C) or on days PI to P5
(Treatments B and D). The selection o f these treatment days was determined based on
cyclic patterns o f endogenous secretion o f these hormones by mares previously
monitored at this laboratory, and to determine if exogenous eST treatment would affect
the circulating plasma levels of progesterone, estradiol, LH and IGF-I in cyclic mares.
Statistical Analyses
Total number o f follicles present in each follicle size category for each mare was
obtained from the ultrasound prints and analyzed across treatment groups using analysis
o f variance (ANOVA). The mean follicle diameter within each size category for each
mare and the number o f ovulations per mare were also analyzed using the same
ANOVA procedure. Hormone levels obtained for each m are from RIA were analyzed
across treatment groups (Treatments A vs. C and Treatments B vs. D, respectively)
using a split-plot ANOVA procedure.
RESULTS
Effect on Follicle Populations
The results o f treatment with exogenous eST on follicle populations in cyclic
mares are shown in Tables 2.1 through 2.3. In this study, eST administration did not
significantly alter the mean number o f follicles >8 mm per mare in cyclic mares treated
daily either on days T6 through T12 (Treatment A) or on days T13 through T19
(Treatment B) when compared with corresponding control mares (Treatments C and D)
on day 7 o f treatment, days 3 and 7 post-treatment, or on the first day o f standing estrus.
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However, mares administered daily eST early in the estrous cycle (Treatment A) had a
significantly greater number o f follicles <7 mm in diameter (P<0.05) when compared
with control mares (Treatment C) on days 3 and 7 post-treatment and at the onset o f
behavioral estrus (mean number o f follicles per mare [± SEM] o f 12.9, 12.8, 13.0 [±
1.68] vs. 5.5, 5.5,4.0 [± 3.36], respectively).
Correspondingly, daily treatment with eST to mares on days T13 through
(Treatment B) did not result in increased numbers o f follicles within follicle size
categories over that of control mares (Treatment D). In addition, the mean number o f
follicles per size category per mare >8 mm in diameter was not different among
treatment and control groups across all days evaluated in this study.

Furthermore,

neither the mean follicular diameter for follicles within each size category nor the
number o f ovulations per mare was affected by treatment with eST or the carrier
vehicle.
Hormone Profiles
Plasma hormone profiles from this study are presented in Figures 2.1 through
2.8. In summary, eST treatment did not affect plasma progesterone concentrations in
either eST treatment group (Treatments A and B) compared with control mares
(Treatments C and D) for any o f the time periods monitored in this study (a total o f 6
days for Treatments A and C and 5 days for Treatments B and D). Also, circulating
estradiol levels were not significantly different from day -8 to day P0 in Treatments A
and B when compared with respective control groups (Treatments C and D). However,
on days PI through P5 mares in Treatment B had significantly lower plasma estradiol
concentrations (P<0.05) than control mares in Treatment D (0.21, 0.24, 0.07, 0.13 and
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0.31 [± 0.33] pg/ml per mare compared with 4.6, 2.6, 2.3,4.1 and 1.9 [± 0.61] pg/ml per
mare, respectively).

While the number o f follicles per mare was not significantly

different between these two groups, it can be speculated that secondary follicles present
in the emerging follicular wave may have contributed to this increase in estradiol
concentrations post-ovulation in the control group. Mares in Treatments A and C were
not monitored past day P0, and therefore plasma estradiol concentrations during this
time for these mares are not known.
In addition, plasma LH concentrations were significantly lower on day -7
through day -1, but not on day -8 (pre-ovulation o f the treated cycle) or day P0 for
mares in Treatment A compared with control mares in Treatment C (0.36, 0.40, 0.34,
0.67, 1.6, 3.6 and 6.0 [± 0.9] ng/ml per mare vs. 5.3, 7.5, 8.1, 7.7, 9.6, 9.5 and 10.5 [±
1.8] ng/ml per mare, respectively). However, this may have been due to the fact that one
of the control mares had unusually high plasma LH concentrations during this time
peroid. Also, there was no detectable difference in circulating LH levels in mares from
Treatment B when compared with mares from Treatment D on day -8 pre-ovulation
through day P5.
Finally, there was a significant increase in plasma IGF-I concentrations for
mares treated with eST by day 3 of treatment when compared with those for control
mares (144.99 [± 12.77] ng/ml vs. 64.19 [± 25.55] ng/ml for Treatments A and C,
respectively and 179.02 [± 16.02] ng/ml vs. 101.08 [± 32.03] ng/ml for Treatments B
and D, respectively).

Increased IGF-I levels were not evident by the first day o f

standing estrus in mares in Treatment A compared with mares in Treatment C.
However, eST treated mares in Treatment B, unlike control mares in Treatment D,
continued to have greater circulating IGF-I levels until the time o f ovulation.
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Table 2.1. Mean number o f follicles within size category per mare per treatment group
on day 3 post-treatment
Treatment

<7 mm

A. eST
C. Control
B. eST
D. Control

12.9“ (±1.7)
5.5b (±3.4)
10.3 (±1.7)
11.0 (±3.4)

8 to 16 mm
8.0
6.5
7.8
4.5

(±1.7)
(±3.4)
(±1.7)
(±3.4)

17 to 24 mm

25 to 32 mm

>32 mm

2.8 (±1.7)
3.0 (±3.4)
2.5 (±1.7)
1.5 (±3.4)

0.9 (±1.9)
0.5 (±4.8)

0.6 (±2.1)
0.5 (±4.8)

0.6 (±2.8)
0.0

0.1 (±4.8)
1.0 (±3.4)

“■‘’Means within columns with different superscripts are different (P < 0.05).

49

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 2.2. Mean number o f follicles within size category per mare per treatment group
on day 7 post-treatment
Treatment

<7 mm

A. eST
C. Control
B. eST
D. Control

12.8a (±1.7)
5.5b (±3.4)
11.8 (±1.7)
12.5 (±3.4)

8 to 16 mm
8.5
8.0
8.6
3.0

(±1.7)
(±3.4)
(±1.7)
(±3.4)

17 to 24 mm

25 to 32 mm

>32 mm

1.4 (±1.9)
3.5 (±3.4)
1.1 (±2.4)
0.0

0.6 (±2.8)
0.5 (±4.8)
0.1 (±4.8)
0.0

0.4 (±2.8)
1.0 (±3.4)

a'bMeans within columns with different superscripts are different (P < 0.05).
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0.3 (±3.4)
1.0 (±3.4)

Table 2.3. Mean number of follicles within size category per mare per treatment group
on the day o f the onset o f standing estrus
Treatment

<7 mm

A. eST
C. Control
B.eST
D. Control

13.0a (±1.7)
4.0b (±3.4)
7.6 (±1.9)
8.0 (±3.4)

8 to 16 mm
7.6
7.0
7.0
5.5

(±1.7)
(±3.4)
(±1.9)
(±3.4)

17 to 24 mm

25 to 32 mm

>32 mm

3.3 (±1.8)
3.5 (±3.4)
3.6 (±2.1)
1.5 (±3.4)

0.9 (±1.9)
1.0 (±3.4)
0.7 (±2.4)
0.0

0.5 (±2.4)
0.5 (±4.8)
0.7 (±2.1)
1.0 (±3.4)

a'bMeans within columns with different superscripts are different (P < 0.05).
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Figure 2.1. Plasma progesterone concentrations (±SEM) for mares treated with eST
early in the estrous cycle (Treatments A and C). T = day o f treatment cycle.
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Figure 2.2. Plasma progesterone concentrations (±SEM) for mares treated with eST late
in the estrous cycle (Treatments B and D). P = day of post-treatment cycle
and PI = day 1 of post-treatment cycle.
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Figure 2.3. Plasma estradiol concentrations (+SEM) for mares treated with eST early in
the estrous cycle (Treatments A and C). P0 = day o f ovulation of the post
treatment cycle.
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Figure 2.4. Plasma estradiol concentrations (±SEM) for mares treated with eST late in
the estrous cycle (Treatments B and D). P = day o f post-treatment cycle and
PO = day o f ovulation o f the post-treatment cycle. (*) Denotes significant
difference within days.
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Figure 2.5. Plasma LH concentrations (±SEM) for mares treated with eST early in the
estrous cycle (Treatments A and C). PO = day o f ovulation of the post
treatment cycle. (*) Denotes significant difference within days prior to
ovulation.
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Figure 2.6. Plasma LH concentrations (±SEM) for mares treated with eST late in the
estrous cycle (Treatments B and D). P = day o f post-treatment cycle and PO
= day o f ovulation o f the post-treatment cycle.
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Figure 2.7. Plasma IGF-I concentrations (±SEM) for mares treated with eST early in the
estrous cycle (Treatments A and C). T = day o f treatment cycle and P0 =
day o f ovulation o f post-treatment cycle. (*) Denotes significant difference
within days.
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difference within days.
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DISCUSSION
Early follicular dynamics in the equine species is not well understood when
compared with other domestics species. Currently, it is believed that follicles <15 mm
are growing and/or regressing in a continuous fashion, in order to provide a reserve for
the selection o f the larger follicles.

The phenomenon o f follicular waves has been

documented in the mare, with mares exhibiting either 1 or 2 waves per interovulatory
interval. In mares with 2 follicular waves, the first wave emerges at or around day -1
(day 0 = day o f ovulation) and peaks at day 10. The second follicular wave (as well as
the first follicular wave in mares with only 1 wave per interovulatory interval) emerges
at approximately day 10 and ends with ovulation of the dominant follicle o f that wave
(for review see Ginther, 1992). Further studies are needed in order to develop a better
understanding o f early follicular dynamics in the horse.
In the present study, we have shown that treating cyclic mares with eST
increases the number of small follicles present on the ovaries on days 3 and 7 post
treatment and at the onset o f standing estrus (post-treatment). This finding is similar to
the ovarian response of swine, in which ST administration has been shown to increase
either small- (Buonomo et al., 1996) or medium-sized follicles (Echtemkamp et al.,
1994a). Also, Hereford x Friesian crossbred heifers treated with recombinant bovine
somatotropin (rbST) responded by increasing the number o f small, but not medium or
large follicles (Gong et al., 1991).

This suggests that ST, either through IGF-I or

directly, may play a more important role in follicle recruitment than in follicle growth
(Buonomo et al., 1996). It should be noted that Spicer and Enright (1991) have shown
that treatment o f Hereford x Friesian heifers with ST releasing factor increased the
mean diameter o f large follicles. In the present study, however, there was no increase in
the mean diameter of follicles within any o f the follicle size categories evaluated.
A multitude o f studies have evaluated the effects o f ST on both systemic and
intraovarian IGF-I production and the possibility of direct effects o f ST on ovarian
60

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

function. It has been well established that ST administration increases both circulating
and follicular fluid levels o f IGF-I in cattle, pigs and humans (Mason et al., 1990;
Rieger et al., 1991; European and Australian Multicenter Study, 1995), and ST has also
been shown to increase plasma IGF-I in horses (Buonomo et al., 1996). Also, a positive
correlation between serum and IGF-I levels in follicular fluid has been established, with
the higher circulating IGF-I levels serving as one source o f ovarian IGF-I, by diffusing
from circulation into the follicles (Amit et al., 1993).
In the present study, plasma IGF-I levels for mares treated with eST did not rise
above that of control mares until the third day of treatment with eST. Correspondingly,
Owen et al. (1991b) noted in women that serum IGF-I levels did not rise until 2 days
after the onset o f ST administration, and it was not until 3 to 4 days after the final
injection of ST that these IGF-I levels began to return to normal baseline levels, which
is in agreement with our findings on circulating IGF-I levels in cyclic mares.
It has also been proposed that the effects of ST on ovarian activity are not a
result o f higher IGF-I levels, but are, instead, indicative o f a direct effect o f ST at the
level o f the ovary (Gong et al., 1991; Spicer et al., 1992; Cohick et al., 1996). This
hypothesis is supported by the data o f Cohick et al. (1996), who detected ST receptors
within the ovary in prepubertal beef heifers. Cohick et al. (1996) have also reported
that immunizing these heifers against ST releasing factor resulted in a change in
follicular development between 3 and 6 months of age, which caused the heifers to
reach puberty at an older age (>14 months). Also, human pre-ovulatory follicles have
been found to contain ST binding proteins, lending more evidence to a direct effect o f
ST on ovarian function (Owen et al., 1991a). Spicer and Enright (1991) found that
administration o f ST releasing factor to Hereford-Friesian crossbred heifers did not
increase follicular fluid IGF-I, providing further evidence that ST may be the mediator
o f the increase in follicular activity noted with ST administration.
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Based on these

findings, it is most probable that ST acts both directly on the ovary and indirectly
through IGF-I.
One very important mode o f action o f ST on reproduction is its ability to act
synergistically with gonadotropic hormones to stimulate ovarian activity. Studies in
women undergoing ovarian stimulation protocols have shown that administration o f ST
in concert with gonadotropins can either increase the ovarian response and/or lower the
dose o f gonadotropins needed to stimulate the ovaries in some women (Homburg et al.,
1988; Gong et al., 1991; Hugues et al., 1991; Owen et al., 1991b; Bergh et al., 1994).
For example, two studies have reported that treatment with ST increased the number of
fertilized oocytes recovered from superovulated women (Owen et al., 1991b; Bergh et
al., 1994), while one study indicated that ST did not increase the overall number of
oocytes collected from superovulated women, but did increase the number o f oocytes
recovered from women with polycystic ovaries (European and Australian Multicenter
Study, 1995).

In contrast, another study indicated no difference in the amount of

gonadotropins needed to stimulate ovarian activity in women treated with ST compared
with those not receiving ST (Tapanainen et al., 1992).
While systemic IGF-I is not affected by treatment with gonadotropins, it is
interesting to note that steroidogenic activity within the ovary can be modified by
exogenous ST and/or IGF-I (Adashi et al., 1985). It has been shown that IGF-I can
enhance FSH activity on bovine and porcine granulosa cells in culture (Spicer et al.,
1992). Furthermore, it has been hypothesized that ST/IGF-I acts in concert with FSH
and possibly insulin to induce its stimulatory effects on the ovary (Gong et al., 1991).
This could be one mechanism for selection o f follicle dominance, since the higher levels
o f IGF-I in large follicles could serve to stimulate their response to available FSH and
thereby enable the follicles to develop at a greater rate than subordinate follicles.
The effects o f ST and IGF-I on blood levels of estradiol, progesterone, LH and
FSH have been reported for cattle and humans (Gong et al., 1991; Tapanainen et al.,
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1992; Lucy et al., 1994). In dairy heifers and in women, ST treatment has been shown
to decrease serum levels o f estradiol and while increasing serum IGF-I levels
(Rabinovici et al., 1990; Tapanainen et a l, 1992). This is similar to our finding in
cyclic mares, where ST-treated mares also had lower circulating estradiol levels on days
1 to 5 post-ovulation.

The finding that the control mares had higher circulating

estradiol levels post-ovulation than pre-ovulation was unexpected, and it can be
speculated that this may be due, in part, to the presence o f secondary follicles in the
newly emerging follicular wave. Why exogenous ST decreases circulating estradiol
concentrations is unclear, but it could involve a reduction in the ability o f the ovarian
follicles to convert progestins to androgens and subsequently to estrogens.
Treatment with bST has been shown to increase plasma progesterone levels in
Holstein heifers, and IGF-I increases progesterone production in both cattle and pigs
(Schams et al., 1988; McArdle et al., 1991; Lucy et al., 1994; Spicer et a l, 1995). This
is in contrast to the present study in cyclic mares, where we found no differences in the
amount o f circulating progesterone levels between animals treated with ST and those
receiving the carrier vehicle. One possibility for this difference could be that the mares
were treated for only 7 days, while animals in most other studies were treated with
sustained release subcutaneous injections or implants, which generally last much longer,
or they were treated for longer intervals. Gong et al. (1991) reported no difference in
estradiol, progesterone, FSH or LH levels in bST-treated heifers compared with control
heifers. In our study, mares treated with ST early in the estrous cycle had significantly
lower levels o f plasma LH, but this was likely due to the fact that one of our control
mares had abnormally high plasma LH and not a result o f the effects of ST treatment
per se.
In summary, exogenous eST treatment increased both the plasma levels o f IGF-I
and the number o f small follicles present on the ovaries o f cyclic mares. Exogenous
equine somatotropin treatment did not result in larger follicle diameters, as has been
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shown in other species, possibly due to the timing o f ST administration with respect to
the stage o f the estrous cycle, or perhaps insufficient quantities and/or num ber o f doses
o f ST administered. It is evident, however, that ST treatment does have physiological
effects on ovarian function in the horse and pony mare.
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CHAPTER m
EFFECTS OF ADMINISTRATION OF EXOGENOUS eST TO SEASONALLY
ANOVULATORY MARES
INTRODUCTION
Recently, the role of ST and insulin-like growth factor-I (IGF-I) in reproduction
have come under intense investigation in domestic species and women. It is known that
treatment with ST causes an increase in circulating IGF-I levels in horses (Buonomo et
al., 1996; Cochran et al., 1999). In addition, treatment with ST has been reported to
cause an increase in the number o f small follicles in horses (Cochran et al., 1999), pigs
(Echtemkamp et al., 1994a) and cattle (Gong et al., 1991). It has been proposed that
ST/IGF-I causes its effects on ovarian function by acting synergistically with
gonadotropins, allowing an increased response o f the follicular cells to available
gonadotropins (European and Australian Multicenter Study, 1995).
During times o f decreased day length, mares undergo a period o f acyclicity,
termed the anovulatory or anestrous season. At this time, GnRH secretion from the
hypothalamus is severely decreased or absent (Hart et al., 1984), causing virtually no
LH to be secreted from the anterior pituitary o f these mares. During this period, the
ovaries o f the mare become small and relatively inactive, with little or no follicular
development taking place.
The purpose o f the present experiment was to determine if eST administration
would increase the ovarian activity of seasonally anovulatory mares.
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MATERIALS AND METHODS
Experimental Design
Anovulatory mares (n=10), all in good body condition, were randomly allocated
to one o f two treatment groups. Treatment A consisted o f anovulatory mares (n=5),
each treated with 25 pg o f eST (EquiGen™, BresaGen Ltd., Thebarton, South Australia)
per kg o f body weight (i.m.) once daily for 28 days. Treatment B also consisted o f
anovulatory mares (n=5) from the same experimental herd, similarly treated with the
eST vehicle. Daily blood sample collections were performed on each mare beginning
on day 1 (first day o f treatment) and continuing until day 28 (last day o f treatment). In
addition, follicular development was assessed at 72-hour intervals, beginning on day 1
o f treatment and ending on day 28 of treatment.
Follicle Assessment and Hormone Analyses
The ovaries o f each mare were examined at 72-hour intervals via transrectal
ultrasonography using an Aloka 500-V ultrasound unit with a 5 MHz rectal probe
(Corometrics, Wallingford, CT). Each ovary was scanned from dorsal to ventral and
from lateral to medial sides, and the size o f each follicle was recorded. Follicles were
assigned to developmental categories based upon their diameter (Category I = <10 mm,
Category II = 10 to 20 mm, Category III = 21 to 30 mm, Category IV = >30 mm). In
addition, jugular blood samples were collected using sterile glass collection tubes
(Vacutainers®, Sherwood Medical, St. Lcuis, MO) and centrifuged at 300 x g for 15
minutes. The plasma was then frozen within 30 minutes of collection. Validated
radioimmunoassay (RIA) (Sticker et al., 1995) was performed on the plasma samples
collected every other day, beginning on day 1 o f treatment and ending on day 28 o f
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treatment to determine circulating IGF-I concentrations for each mare. Similarly, LH
and FSH (Thompson et al., 1983a,b) concentrations were analyzed from these mares.
Experimental Conditions
This study was conducted during the calendar month o f January, 1997 in south
Louisiana, USA. The average daylength (sunrise to sunset) during the experimental
period was 10.2 hours. In addition, the daily low temparature ranged from -5°C to 16°C
and the daily high temperature ranged from 1°C to 26°C. All mares were selected from
the same experimental herd and housed together in the same pasture during the
experimental period. All mares were maintained on ryegrass pastures and bahia grass
hay, free-choice, and supplemented with 2.2 kg o f a commercial 8% protein feed per
mare per day throughout the experimental period. Each mare used in the present study
was determined to be seasonally anovulatory by monitoring plasma progesterone
concentrations as well as ovarian follicular activity for at least 4 weeks prior to the
initiation o f treatment. Briefly, all mares had plasma progesterone levels o f <0.5 ng/ml
in addition to having no follicles >15 mm in diameter for the 4-week period prior to
treatment.
Statistical Analyses
The number o f follicles present in each follicle size category, as well as the total
number o f follicles present for each mare, were analyzed across time among treatment
groups using analysis o f variance (ANOVA).

Hormone concentrations from mares

were analyzed across time among treatment groups using a split-plot ANOVA
procedure (Cochran et al., 1999).
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RESULTS
Overall, there was a positive effect o f treatment of anovulatory mares with eST
on the total number o f follicles per mare (P<0.05) (Figure 3.1), with follicle numbers
being significantly higher in treated mares by the seventh day o f treatment. However,
this observation was largely due to an increase in the number o f small (<10 mm)
follicles present on the ovaries o f each mare (P<0.05) (Figure 3.2).

There was no

significant effect o f eST administration on the number of follicles >10 mm (Categories
II-IV) per mare throughout the experimental period (data not shown).
As expected, plasma IGF-I concentrations were elevated (P<0.05) in mares
treated with eST over those o f control mares by the third day o f treatment (Figure 3.3).
However, circulating plasma concentrations o f LH and FSH in these mares were not
affected by treatment with exogenous eST at any time throughout the experimental
period.
DISCUSSION
In the present study, treatment with exogenous eST caused an increase in the
number o f follicles per mare in seasonally anovulatory mares by the seventh day o f
treatment (Figure 3.1). This was due mostly to an increase in the number o f small (<10
mm) follicles (Figure 3.2), as there was no significant difference in the number o f
follicles >10 mm in diameter per mare for these mares throughout the experimental
period.

This is in agreement with a previous report from this laboratory, which

demonstrated that treatment with eST increased the number o f small follicles per mare
in cyclic mares during the breeding season (Cochran et al., 1999). In addition, similar
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Figure 3.1. Total number o f follicles per mare for seasonally anovulatory mares treated
with eST. (*) Denotes significant differences within days.
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eST. (*) Denotes significant differences within days.
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findings have been previously reported for pigs (Echtemkamp et al., 1994a) and cattle
(Gong et al., 1991).
In addition, plasma IGF-I was elevated in mares treated with eST over that o f
contemporary control mares by the third day of treatment (Figure 3.3).

This is in

agreement with previous reports in the horse (Cochran et al., 1999) and in women
(Owen et al., 1991), where plasma IGF-I concentrations were not significantly elevated
until 2 to 4 days o f exogenous ST administration. This finding has been extensively
demonstrated in various species, and is consistently found whenever exogenous ST is
administered.

Furthermore, there was no difference in circulating LH and FSH

concentrations for seasonally anovulatory mares treated with exogenous eST. Gong et
al. (1991) reported similar findings in a study with Holstein heifers treated with
recombinant bovine ST (rbST), where they found no effect o f treatment with rbST on
plasma LH or FSH concentrations.
It is proposed that ST/IGF-I causes its effects on ovarian stimulation, at least in
part, through its ability to work synergistically with available gonadotropins (European
and Australian Multicenter Study, 1995).

This has been shown in vitro, where

administration o f ST to porcine and bovine granulosa cells enhanced the action o f FSH
on these cells (Spicer et al., 1993). This could be one explanation for the increase in
small follicles in the present study, as it is currently believed that follicles in the 5 to 10
mm range are not responsive to LH, and would therefore be totally dependent on
circulating FSH, or independent o f gonadotropin control (Ginther, 1992). If these small
follicles are at least partially responsive to FSH stimulation, then the ability o f IGF-I to
enhance the ovarian cells to available FSH could cause more follicles o f this size
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category to be present on the ovaries of mares treated with eST, as FSH, unlike LH, is
detectable in jugular blood o f seasonally anovulatory mares, although at highly reduced
levels when compared with cyclic mares during the breeding season (Thompson et al.,
1986a).
Another possible explanation for the ability of ST, via elevated IGF-I, to
increase the number o f small follicles in treated animals could be through a pro
longation o f the time in which follicular atresia occurs. This hypothesis is supported by
a study by Chun et al. (1996), where it was determined that in the granulosa cells o f
rats, FSH treatment decreased the rate o f apoptosis by 60%, while IGF-I treatment
decreased the rate of apoptosis by 45%. Therefore, one explanation for the findings
reported in the present study could be that elevated plasma IGF-I levels, which may in
turn cause elevated IGF-I concentrations in the follicular fluid, could act on the
granulosa cells and reduce the rate of apoptosis, thereby, increasing the time o f
follicular regression and allowing the follicles to remain present on the ovaries for a
longer period o f time. This possible mechanism o f action o f IGF-I could, in effect, be
implied to “rescue” early atretic follicles much the same way as FSH is currently used
in cattle (Britt, 1988). Further studies are needed to clarify this hypothesis.
In summary, we have demonstrated that treatment of seasonally anovulatory
mares with eST can increase the number o f follicles present on their ovaries, with the
greatest response being seen in the number o f small follicles. In addition, plasma IGF-I
was elevated in those mares treated with eST over that of contemporary control mares.
Since there was no difference in circulating LH or FSH concentrations, the observed
response in follicle numbers could be through the ability of IGF-I to enhance the
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responsiveness o f follicular cells to available gonadotropins, or through its apparent
ability to prolong follicular atresia by decreasing the rate o f cell death in the granulosa
cells. However, further studies are needed in order to determine that exact mechanism(s) o f action o f ST and IGF-I on follicular development in the mare.
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CHAPTER IV
THE EFFECTS OF ADMINISTRATION OF eST IN CONJUNCTION WITH A
POTENT GnRH AGONIST ON REPRODUCTIVE FUNCTION IN
SEASONALLY ANOVULATORY MARES
INTRODUCTION
It is well established that the reproductive cycle o f the mare is seasonal in
nature, with peak breeding activity coinciding with extended daylength. During times
of decreasing daylength (winter), mares typically undergo a period o f ovarian inactivity
termed “seasonal anestrous” (Ginther, 1992). During this time, GnRH secretion from
the hypothalamus is severely depressed, resulting in drastically reduced circulating
levels o f LH (Hart et al., 1984).

It has been demonstrated that increasing the

photoperiod can increase GnRH ouput by the hypothalamus, thereby increasing plasma
gonadotropin levels, resulting in cyclic recrudescence (Nequin et al., 1989). From a
practical standpoint, it would be beneficial to be able to find an efficient means of
inducing reproductive cyclicity during the anovulatory season due to the fact that most
major breed registries impose a mandatory birthdate o f January 1 (in the USA) for all
foals bom the previous calendar year, regardless of when the foals were actually bom.
Given that the domestic mare has an ~ 11 month gestation length, mares would need to
be mated in February in order for the foals bom to fit in with their birthdate more
closely.

Unfortunately, this is a time that coincides with the anovulatory season,

therefore, very few mares in this hemisphere would normally be in a cyclic state at this
time.
It has been well demonstrated that increasing photoperiod will enable mares to
begin the breeding season earlier in the year, however, this method can be costly and
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labor intensive when dealing with large numbers o f mares (for review see Ginther,
1992). Also, the administration o f GnRH, along with some o f its more potent agonists,
has shown promise in inducing seasonally anovulatory mares to ovulate (Hyland et al.,
1987; Johnson, 1987; Ginther and Bergfelt, 1990; Fitzgerald et al., 1993; Mumford et
al., 1994).

However, this method has shown extreme variation in response, and

therefore cannot be recommended for commercial purposes at this tim e (Mumford et
al., 1994).

Also, m ost reports o f successful induction o f ovulation in seasonally

anovulatory mares using any o f the GnRH agonists (GnRHa) have come from either (1)
continuous infusion, (2) multiple daily injections or (3) sustained-release formulations,
which can also be costly and labor intensive from a practical standpoint (Hyland et al.,
1987; Johnson, 1987; Ginther and Bergfelt, 1990; Fitzgerald et al., 1993; Mumford et
al., 1994).
Recently, the role o f somatotropin (ST) and insulin-like growth factor-I (IGF-I)
on reproduction has come under intense investigation in various species. It has been
demonstrated that administration o f ST can increase the number o f follicles in mares
(Cochran et al., 1999), cattle (Gong et al., 1996), pigs (Spicer et al., 1992) and women
(Owen et al., 1991b).

It has been proposed that this increase in follicle number is

attributable, at least in part, to the ability of ST/IGF-I to enhance the granulosa cells
within the ovarian follicle to the stimulatory effects o f available gonadotropins, thus,
enhancing follicular growth and maturation (Homburg et al., 1988; Gong et al., 1991;
European and Australian Multicneter Study, 1995).

This could be beneficial in

inducing seasonally anovulatory mares to ovulate by enabling the follicles present to
better respond to available gonadotropins secreted in response to GnRHa, thereby,

76

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

reducing the amount and number o f injections o f GnRHa, as well as reducing the
variation in the treatment response.
Therefore, the purpose of these experiments was (1) to determine if admin
istration o f eST could enhance follicular growth, development and ovulation in
seasonally anovulatory mares treated with once daily injections o f a GnRHa and (2) to
determine if ovulations obtained in this manner were fertile and could result in a viable
pregnancy.
MATERIALS AND METHODS
Experiment 4.1
Experimental Design
Twenty seasonally anovulatory lighthorse mares of mixed breeds were randomly
allocated into one o f two treatment groups. Mares in Treatment A (n=10) were admin
istered 25 pg eST (EquiGen™, BresaGen Ltd., Thebarton, South Australia) per kg body
weight once daily, beginning on day 1 (first day o f treatment) and continuing until day
35 or until ovulation was achieved.

Mares in Treatment B (n=10) were similarly

administered a sodium borate solution (vehicle) beginning on day 1 and continuing until
day 35 or until ovulation was achieved.

All mares (Treatments A and B) were

administered 40 ng per kg body weight o f a GnRHa (des-Glyl0,[D-His(Bzl)6]Luteinizing Hormone Releasing Hormone Ethylamide, Sigma No. L-2761) once daily
beginning on day 10 and continuing until day 35 or until ovulation was achieved. Also,
all mares were administered a single dose o f human chorionic gonadotropin (hCG) once
a follicle >35 mm in diameter was detected to facilitate ovulation. Daily blood samples
were collected for each mare throughout the experimental period via jugular veni-
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puncture. In addition, ovarian follicular development was assessed at 72-hour intervals
via transrectal ultrasonography throughout the experimental period.
Follicle Assessment and Hormone Analyses
Blood samples were collected via jugular venipuncture and immediately placed
on ice using sterile glass collection tubes (Vacutainers®, Sherwood Medical, St. Louis,
MO). They were then centrifuged at 300 x g for 15 minutes and the plasma stored in 7ml plastic tubes (Curtin Matheson, Houston, TX) and frozen within 30 minutes o f
collection. A previously validated radioimmunoassay (RIA) (Sticker et al., 1995) was
performed on the plasma samples collected every other day, beginning on day 1 o f
treatment and ending on day 35 or until ovulation was achieved to determine circulating
IGF-I concentrations for each mare within treatment group. In addition, plasma con
centrations o f FSH and LH (Thompson et a l, 1983) were analyzed from all mares.
The ovaries o f each individual mare were examined at 72-hour intervals via
transrectal ultrasonography using an Aloka 500-V ultrasound with a 5 MHz rectal probe
(Corometrics, Wallingford, CT). Each ovary was scanned beginning from dorsal to
ventral and then from lateral to medial sides, and the size of each follicle was recorded.
Follicles were assigned to developmental categories based upon their diameter at the
time o f assessment (Category I = <10 mm, Category II = 10 to 20 mm, Category III =
21 to 30 mm, Category IV = >30 mm). Once a follicle reached 30 mm, ultrasound
examinations were performed for that mare at 24-hour intervals until the follicle
reached 35 mm in diameter. At that time, 3,500 units hCG was administered (i.v.) to
induce ovulation. All mares that responded with visible ovulation/luteinization (via
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ultrasound) were additionally monitored for 10 days following ovulation to assess luteal
formation and to verify circulating progesterone levels.
Experiment 4.2
Experimental Design
Experiment 4.2 was conducted to determine if the ovulations induced by the
protocol implimented in Experiment I were fertile and capable o f producing a viable
pregnancy. A total o f 14 seasonally anovulatory mares were randomly allocated into
one o f two treatment groups. Treatment A consisted o f mares (n=9) administered 25
pg/kg eST once daily beginning on day 1 and continuing until day 28 or until ovulation
was achieved. Mares in Treatment B (n=5) were similarly administered the vehicle.
All mares were administered the same GnRHa as those in Experiment 4.1, at a
concentration o f 50 ng/kg once daily beginning on day 10 and continuing until day 28
or until ovulation was achieved.

Follicular development and circulating plasma

hormone concentrations were assessed at 72-hour intervals as previously described with
the following exception: (1) follicles were not assigned to developmental categories
since follicles o f large size (>30 mm), ovulation and pregnancy status were the only
endpoints o f importance in this experiment. Once a follicle reached 30 mm in diameter,
follicular growth was assessed at 24-hour intervals until the follicle reached 33 mm in
diameter. At that time hCG (5,000 units) was administered (i.v.) and the mare was
inseminated with at least 500 million motile spermatozoa. All mares were inseminated
with semen collected from a single stallion of proven fertility, which was the same for
all mares.

Oral altrenogest (Regu-Mate®, Hoechst Roussel Vet, Warren NJ) was

administered once daily at a concentration of 0.044 mg/kg to all mares that ovulated to
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ensure that luteal insufficiency would not inhibit the pregnancy status. All mares that
were confirmed pregnant were maintained on oral altrenogest until day 50 o f
pregnancy. Pregnancy diagnosis was performed via transrectal ultrasonography at 14
and 20 days post-ovulation in all mares that ovulated.
Experiments 4.1 and 4.2
Experimental Conditions
These experiments were conducted during the calendar months o f December,
1997 — January, 1998 (Experiment 4.1) and January, 1999 (Experiment 4.2) in south
Louisiana. The average daylength (sunrise to sunset) for both experiments ranged from
9.5 to 10.6 hours.

Also, the daily low temperature ranged from -3°C to 17°C for

Experiment 4.1 and from -7°C to 19°C for Experiment 4.2. In addition the daily high
temperature ranged from 10°C to 23°C for Experiment 4.1 and from 4°C to 27°C for
Experiment 4.2. All mares came from the same experimental herd and were penned
within the same pasture throughout the experimental period for both experiments. All
mares were maintained on ryegrass pastures and Bahia grass hay, free-choice, and
supplemented with 2.2 kg o f a commercial %% protein feed per mare per day throughout
the experimental periods.

The body condition scores for the mares used in these

experiments ranged from 4 to 7 on a scale o f 1 to 9, and were not different between
treatment groups. All mares used in Experiments 4.1 and 4.2 were determined to be
seasonally anovulatory by monitoring plasma progesterone concentrations as well as
ovarian follicular activity for at least 4 weeks prior to the initiation o f treatment. All
mares had plasma progesterone levels o f <0.5 ng/ml in addition to having no follicles
>15 mm in diameter for the 4-week period prior to the initiation o f treatment.
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Statistical Analyses.
In Experiment 4.1, the number o f follicles per mare, as well as the number of
follicles within size category per mare were analyzed using an analysis o f variance
procedure (ANOVA). Numbers o f mares ovulating per treatment group were analyzed
using a similar ANOVA procedure for both experiments. Circulating concentrations of
LH, FSH and IGF-I were analyzed across treatment groups using a split-plot ANOVA
procedure (Cochran et al., 1999).
RESULTS
Experiment 4.1
Follicular Development and Plasma Hormone Profiles
Results from Experiment 4.1 are presented in Figures 4.1 to 4.3 and Table 4.1.
There was a significant increase (P <0.05) in the total number o f ovarian follicles per
mare for mares treated with eST plus GnRHa when compared with GnRHa treatment
alone (Figure 4.1). This increase was due mostly to a significant increase (P <0.05) in
the number o f Category I (<10 mm) follicles per mare within treatment group (Figure
4.2). More importantly, the number of mares that responded to once daily eST plus
GnRHa by growing Category IV (>30 mm) follicles was greater when compared with
GnRHa treatment alone (7/10 vs. 1/10, respectively, P <0.05) (Table 4.1). In addition,
50% o f eST treated mares ovulated, which was significantly greater than the 10%
ovulating in the control group (P <0.05). Also, two additional mares luteinized without
apparent ovulation in the eST treated group, which resulted in an overall 70% o f mares
in this group giving rise to functional luteal tissue formation. This was a significant
increase over the 10% o f mares responding in the control group (P <0.05).
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Plasma IGF-I concentrations were significantly elevated (P <0.05) by day 3 o f
treatment in the eST treated group when compared with control mares (Figure 4.3).
However, there was no increase in either circulating LH or FSH concentrations between
the two treatment groups throughout the experimental period.

Plasma progesterone

concentrations were monitored in all mares that ovulated/luteinized across treatment
groups for 10 days following ovulation/luteinization to determine functional status o f
the forming luteal tissue. All luteal tissue formed in all mares across treatment groups
were determined to be functional at least through the first 10 days post-ovulation.
However, reproductive cyclic activity was not continued in any mare once treatment
was stopped.

In addition, there was no apparent effect of treatment on cyclic

recrudescence later in the year (spring) for mares in either group compared with
untreated mares from the same experimental herd.
Experiment 4.2
Follicle Development, Pregnancy Status and Plasma Hormone Profiles
In Experiment 4.2, the total number o f follicles and the number o f follicles
within follicle size categories were not recorded, since the only endpoints o f practical
importance were (1) development of large (>30 mm) follicles, (2) the number o f mares
ovulating within treatment group and (3) the number o f mares with a positive pregnancy
diagnosis. There was a significant treatment effect o f eST in conjunction with GnRHa
on the number o f mares with large follicle development (7/9 vs. 1/5, respectively, P
<0.05) (Table 4.2). Also, there was a tendency for more eST treated mares to ovulate
(P=0.1) when compared with control mares (6/9 vs. 1/5, respectively).

In addition,

while there was no statistical difference (P=0.2) in the number of mares confirmed
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pregnant between treated and control mares (5/9 vs. 1/5, respectively), the addition o f
eST in conjunction with GnRHa did not adversely effect fertility, as demonstrated by
the fact that 5 o f the 6 mares that ovulated in the eST treated group were confirmed
pregnant by 14 days post-ovulation.
As in Experiment 4.1, plasma IGF-I concentrations were elevated in eST treated
mares when compared with control mares (P <0.05, Figure 4.4). Again, no difference
was detected in plasma FSH or LH levels between treatment groups throughout the
experimental period. As before, all mares which ovulated had elevated plasma pro
gesterone concentrations for at least 10 days post-ovulation, verifying the functionality
of the forming luteal tissue in these mares. Also, there was no noticeable effect o f
treatment with eST plus GnRHa or GnRHa alone on resumption o f seasonal
reproductive cyclicity when compared with untreated mares from the

same

experimental herd.
DISCUSSION
It is well known that, during the winter, most mares exhibit an anovulatory
period. The direct cause for this can be attributed to the fact that hypothalamic GnRH
content is severely reduced causing LH output by the pituitary to be almost nonexistent
(Hart et al., 1984).

It is suspected that melatonin output from the pineal gland in

response to increasing periods o f darkness plays some function in reducing GnRH
secretion, however, the exact mechanism of this action has yet to be determined, as
there are no melatonin receptors found in the hypothalamus o f the domestic mare
(McKinnon and Voss, 1993).

It has long been known that increasing the period o f
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Table 4.1. Number o f mares per treatment group that exhibited growth o f large follicles
(>30 mm), ovulation and luteal tissue formation (Experiment 4.1)
Treatment
eST plus GnRHa
Control plus GnRHa

>30 mm follicle

Ovulation

Luteal function

7/10a
l/10b

5/10a
l/10b

7/10a
l/10b

a’bMeans within columns with different superscripts are different (P < 0.05).
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Table 4.2. Number of mares per treatment group that exhibited growth o f large follicles
(>30 mm), ovulation and pregnancy status (Experiment 4.2)
Treatment
eST plus GnRHa
Control plus GnRHa

>30 mm follicle

Ovulation

Pregnant

7/9a
l/5b

6/9
1/5

5/9
1/5

a'bMeans within columns with different superscripts are different (P < 0.05).
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Figure 4.1. Total number o f follicles (±SEM) per mare for anovulatory mares treated
once daily with eST plus GnRHa. Day 10=start o f GnRHa treatment
(Experiment 4.1). (*) Denotes significant differences within days.
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daylight can enable mares to resume normal reproductive cyclicity (Kooistra and
Ginther, 1975). At present, the most repeatable method o f hastening the onset o f the
breeding season is to increase the daylength that the mares are subjected to by exposing
them to artificial daylight (Kooistra and Ginther, 1975, Sharp et al., 1975, Cleaver et
al., 1991). Typically, mares are exposed to 16 hours per day o f “daylight” by placing
them in a lighted stall for a period of - 60 days (Sharp et al., 1975).
There are, however, two major setbacks associated with this type o f protocol,
which include: (1) the initial cost of setting up and (2) the length of time required for
the desired results to be realized. Essentially, when mares are placed under artificial
daylight, a 60 day period is required because the mares must go through the process of
vernal transition, which is a period when the reproductive system o f the mare is
preparing itself for the onset o f the breeding season (Sharp et al., 1975).

Exposing

mares to increased periods o f light per day results in increased output of GnRH from the
hypothalamus, thus increasing LH production and secretion by the pituitary (Cleaver et
al., 1991). It is interesting to note that although circulating levels of LH are elevated,
no change was detected in FSH secretion (Cleaver et al., 1991). This increase in LH
results in increased ovarian activity and resumption o f reproductive cyclicity (Sharp et
al., 1975; Oxender et al., 1977; Freedman et al., 1979).
It has been shown repeatedly that administration o f GnRH and/or one o f its
analogs can induce ovulation in seasonally anovulatory mares (Johnson, 1986; Hyland
et al., 1987; Johnson, 1987; Becker and Johnson, 1992; Swinker et al., 1993). For
example, Johnson (1987) demonstrated that hourly pulses o f GnRH cause elevated LH
levels by 11 days and ovulation within 15 days. In addition, continuous infusion of
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GnRH can also induce ovulation in seasonally anovulatory mares as much as 50% of
the time, within 15 to 30 days (Hyland et al., 1987). It has been determined that a
pulsatile mode o f GnRH administration is preferrable to continuous infusion, as
ovulation is induced in a faster, more repeatable manner (Becker and Johnson, 1992).
However, both o f these methods o f treatment are cumbersome and labor intensive, and
are not a feasible method o f inducing ovulation in a commercial sense. Therefore, other
studies have been undertaken in an effort to find a more suitable method o f GnRH
administration (Ginther and Bergfelt, 1990; Harrison et al., 1990; Fitzgerald et al.,
1993).
Harrison et al. (1990) have shown that induction o f ovulation in seasonally
anovulatory mares can be achieved via multiple daily injections o f GnRHa (2x daily).
This method o f treatment was sufficient to increase pituitary LH output and induce
ovulation in 57% o f treated mares (Ginther and Bergfelt, 1990).

Also, constant

administration o f GnRHa via a subcutaneous depot has been shown to be effective in
inducing ovulation in these mares as well (Harrison et al., 1990; Fitzgerald et al., 1993).
However, the substantial variation in response makes these methods currently unreliable
for commercial purposes (Mumford et al., 1994).

It has proposed that the primary

reason for the variation observed in the ovulatory response to these various methods of
GnRH administration is the depth of anestrous exhibited by the experimental mares
under treatment, with less results realized from mares in “deep” anestrus (Hyland et al.,
1987; Mumford et al., 1994).

“Deep” anestrus can be classified as the mare(s) in

question having (1) no follicles >15 mm in diameter and (2) plasma progesterone
concentration o f <1 ng/ml for at least four consecutive weeks. As most mares do have
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some follicular activity during the anovulatory period, it is crucial to quantify the depth
o f anestrous in order to determine the potential for success in these mares.

Other

factors, including nutrition and body condition, have also been implicated in the
frequency and depth o f seasonal anestrus exhibited in the domestic mare (Swinker et
al., 1993; Fitzgerald, 1996; Fitzgerald and Davison, 1997).
It has been demonstrated that the addition o f ST can enhance the ovarian
response to gonadotropin administration in cattle (Rieger et al., 1991) and clinically
infertile women (Owen et al., 1991b). In addition, administration o f ST increases the
number o f follicles on the ovaries of mares (Cochran et al., 1999), pigs (Spicer et al.,
1992), cows (Gong et al., 1991) and women (Owen et al., 1991a,b).

It has been

proposed that these effects are caused, at least in part, by the ability o f ST to stimulate
both local (intrafollicular) as well as systemic IGF-I production (De La Sota et al.,
1993; Bergh et al., 1994). Owen et al. (1991a) reported that IGF-I caused an increase in
the follicular response to FSH stimulation o f the granulosa cells. Also, addition o f IGFI to the culture medium of bovine granulosa cells causes an increase in the steroidogenic
index o f these cells (Schams et al., 1987). Unpublished studies from our laboratory
have demonstrated a similar effect in cultured equine granulosa cells, where addition o f
IGF-I caused a significant increase in progesterone production. It is therefore likely that
the administration of ST, either directly or indirectly through increased IGF-I, enhances
the ability o f the follicle to respond to available gonadotropins via stimulation o f the
granulosa cells, possibly through increasing the number o f FSH and LH receptors
(Homburg et al., 1988; European and Australian Multicenter Study, 1995).
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With this hypothesis in mind, Experiment 4.1 was conducted to determine if the
beneficial effect reported for ST administration could be demonstrated in the
anovulatory mare. Since one o f the major problems associated with GnRH induction o f
ovulation in these mares is the extreme variability in response, it was hypothesized that
eST administration may augment the stimulatory effects of the gonadotropins secreted
in response to administration o f GnRHa on follicular growth and development and
thereby decrease the variability seen in the response. There was a definite beneficial
effect o f treatment o f eST in conjunction with once daily GnRHa administration, as
witnessed by the increase in large follicle growth (7/10 vs. 1/10, P <0.05), ovulation
(5/10 vs. 1/10, P <0.05) and luteal formation (7/10 vs. 1/10, P <0.05) in eST-treated
mares when compared with control mares, respectively (Table 4.1). Also, as previously
reported in the horse (Cochran et al., 1999), the cow (Gong et al., 1991) and the pig
(Samaras et al., 1994), plasma IGF-I levels were elevated in mares treated with eST
plus GnRHa (Figures 4.3 and 4.4). We hypothesize that this increase in systemic IGF-I
concentrations is responsible, at least in part, for the follicular stimulatory effects
caused by eST treatment to seasonally anovulatory mares.
The effects o f ST administration on circulating gonadotropin concentrations
have been previously reported (Gong et al., 1991; Gong et al., 1996). It has been
demonstrated that Hereford x Friesian heifers treated with recombinant bovine
somatotropin (rbST) had no increase in circulating LH or FSH concentrations (Gong et
al., 1991; Gong et al., 1996). This is in agreement with the present study for the
anovulatory mare, as no differences were detected in either plasma LH or FSH levels
between treated and control mares. This further reinforces our hypothesis that ST/IGF-I
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causes its effects by acting synergistically with available gonadotropins to induce
follicular growth and development.
Based on the results observed in Experiment 4.1, Experiment 4.2 was conducted
to determine if the ovulations caused by eST plus GnRHa treatment were indeed fertile
and capable of producing a viable pregnancy.

Although there was no statistical

difference in the number o f mares conceiving per treatment group (5/9 vs. 1/5) (Table
4.2), it is clear that eST administration had no detrimental effect on oocyte quality, as 5
of the 6 mares which ovulated in the treament group were confirmed pregnant by 14
days post-ovulation. This is in agreement with previous reports in the human, where
women administered ST along with human menopausal gonadotropin (hMG) had no
detrimental effect on the fertilizability of oocytes collected for in vitro fertilization
procedures, but actually had an increase in the number o f fertilized oocytes per female
(Owen et al., 1991a; Bergh et al., 1994).
In the present study, we have demonstrated that the addition o f eST to a protocol
including once daily injections o f a potent GnRHa can enhance follicular development
and the ovulatory response in seasonally anovulatory mares.

The increase in the

ovulatory response seen in eST treated mares has potential commercial applications,
since this protocol (1) decreases the variation typically seen when administering GnRH
to anovulatory mares as well as (2) allow for a more manageable protocol o f once daily
injections to be employed. It is important to note that all mares utilized in the present
study were determined to be in “deep” anestrus based on the mares having plasma
progesterone concentrations o f <0.5 ng/ml as well as only follicles <15 mm in diameter
present on their ovaries for a minimum of four consecutive weeks prior to the initiation
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o f treatment.

Given the initial expense and labor involved in artificial lighting

regimens, as well as the variability and labor involved with traditional GnRH therapy, a
protocol including once daily injections o f eST plus GnRH could be beneficial to
commercial horse breeders.
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CHAPTER V
PRODUCTION OF LIVE FOALS FROM SPERM-INJECTED OOCYTES
HARVESTED FROM PREGNANT MARES
INTRODUCTION
In vitro fertilization (IVF) has become a frequently used treatment for infertility
in human couples (Cha et al., 1991; Trounson et al., 1994a; Palermo et al., 1996). Also,
IVF is now a commercially feasible method to recapture the reproductive potential of
valuable clinically infertile cows (Stroud and Myers, 1992; Looney et al., 1994). The
consistent production o f IVF embryos in the horse has not yet become reality, even
though adequate success rates have been reported for in vitro oocyte maturation (Del
Campo et al., 1990; Zhang et al., 1990; Hinrichs et al., 1993a,b) and sperm cell
capacitation (Vamer et al., 1987; Samper et al., 1989). To date, only one foal has been
reported as a result o f conventional IVF (Palmer et al., 1991) and there has been one
foal produced after intracytoplasmic sperm injection (ICSI) o f abattoir oocytes (E.L.
Squires, J.M. Wilson, H. Kato, A. Blaszczyk, unpublished data).
The reason(s) for poor IVF and subsequent development rates o f equine oocytes
remains unclear. Equine oocytes appear to have a thick zona pellucida compared with
those o f other species, and the time necessary for in vitro maturation (IVM) is longer
than for domestic ruminant species (Hinrichs et al., 1993a,b). Therefore, it was
suspected that the zona pellucida o f the IVM oocyte is, in part, a barrier to in vitroprepared sperm cells (Li et al., 1995). The potentially altered zona pellucida o f IVM
oocytes (Chan, 1987; Cohen et al., 1990; Trounson et al., 1994b), in addition to less
than adequate sperm cell preparation for IVF, likely contributes to poorer than expected
IVF rates in the mare.
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Live offspring have been produced in laboratory animals (Gordon and Talansky,
1986) and humans (Cohen et al., 1991, 1992) by using a simple, prefertilization zonadrilling procedure to aid sperm cells in crossing the zona pellucida. Recently, acceptable
fertilization and later stage embryo development rates were obtained consistently from
oocytes o f pregnant mares by applying a similar prefertilization zona drilling procedure
(Li et al., 1995; Meintjes et al., 1995). Pregnant mares were utilized as oocyte donors in
these studies because multiple, good quality germinal vesicle-stage oocytes could be
harvested repeatedly from a single mare, which is often not the case when using cyclic
mares as oocyte donors. However, the size o f the opening drilled into the zona
pellucida, the concentration o f sperm cells used for in vitro insemination and the time
period o f zona-drilled oocyte exposure to sperm cells may influence normospermic
fertilization rates (Choi et al., 1994).
Single intracytoplasmic or multiple subzonal microinsemination o f sperm cells
may circumvent the variables associated with prefertilization zona drilling and
minimize the possibility o f polyspermic fertilizations. In humans, ICSI has become the
method o f choice for treating male factor infertility (Ng et al., 1993; Palermo et al.,
1996) and, because o f its high efficiency and circumvention o f polyspermic
fertilization, is preferred over the subzonal sperm injection (SUZI) procedure (Palermo
et al., 1993; Van Steirteghem et al., 1993; Abdalla et al., 1995). However, in domestic
cats, SUZI first seemed to be more effective than ICSI, with one kitten being bom as a
result o f SUZI (Pope et al., 1995). It was later determined by the same researchers that
ICSI was more efficient than SUZI in domestic cats (C.E. Pope, personal
communication) with one report o f live kittens delivered from ICSI (Pope et al., 1997).
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Little is known about the optimum developmental requirements for early-stage
equine embryos. It has been shown in several species that exposure to relatively high
levels o f glucose in the culture medium can be inhibitory to embryonic development
during the first 48 hours of culture, and that culture in a medium containing little or no
glucose can enhance early embryonic development and viability (Chatot et al., 1989;
Ellington et al., 1990; FitzGerald and DiMattina, 1992).
The objectives o f this study were (1) to circumvent the possibility o f inadequate
in vitro sperm cell capacitation, in vitro zona pellucida hardening and polyspermic
fertilizations by performing ICSI or SUZI procedures on IVM equine oocytes, (2) to
evaluate the effects o f a glucose-free, phosphate-free medium on the development and
viability o f early stage equine embryos and (3) to test the viability o f these in vitroderived embryos by nonsurgical embryo transfer at the morula stage or by surgical
transfer procedures at earlier developmental stages.
MATERIALS AND METHODS
Experiment 5.1
Experimental Design
Mature oocytes, as evidenced by the presence o f a first polar body in the
perivitelline space under an inverted microscope, were randomly allocated to five
microfertilization treatments. In Treatment A, a single immobilized sperm cell was
injected directly into the ooplasm. In Treatment B, two to three motile sperm cells were
injected under the zona pellucida in the perivitelline space. Treatments C and D
consisted o f sham injection procedures, where a similar volume of 10% (w/v) polyvinyl
pyrrolidone (PVP) in Earle’s balanced salt solution (Medi-Cult, Copenhagen, Denmark)
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was injected (without containing sperm cells) either directly into the ooplasm
(Treatment C) or into the perivitelline space (Treatment D). Treatment E was a
polyspermy control group where immobilized sperm cells (n=3 to 5) were injected
directly into the ooplasm.
Oocyte Collection
During the months o f April to August in the southern United States, immature
oocytes were collected from early pregnant crossbred mares in good body condition
(days 21 to 40 o f gestation), using a repeatable noninvasive transvaginal ultrasoundguided follicular aspiration procedure as previously reported by this laboratory
(Meintjes et al., 1994, 1995). All follicles with a diameter >5 mm were punctured with
a 12-gauge single lumen needle and then rinsed up to 10 times with oocyte flushing
medium (by alternate filling and emptying). The oocyte flushing medium consisted of
phosphate-buffered saline (Gibco, Grand Island, NY) supplemented with 1% heattreated calf serum (Gibco), 2 USP units o f heparin (Steris Laboratories, Phoenix, AZ),
100 pg o f streptomycin (Gibco) and 100 units of penicillin-G (Gibco) per ml o f
medium. Follicular activity on the ovaries o f these mares was monitored by transrectal
ultrasound twice per week, and the follicles aspirated when three or more follicles >15
mm in diameter were detected. Several mares were aspirated on more than one
occasion.
In Vitro Maturation and Oocyte Preparation
After oocyte isolation and evaluation under light microscopy (200x), all oocytes
with an intact oolemma were washed in IVM medium. IVM medium consisted o f tissue
culture medium 199 (TCM-199, Gibco) with 10% estrual mare serum collected at this
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laboratory. In vitro maturation was conducted in 100 fj.1 microdroplets o f IVM medium
covered with mineral oil in a 35-mm petri dish for 36 hours at 38°C in an atmosphere o f
5% CO 2 in air. After IVM, the oocytes were stripped from the majority o f their cumulus
cells by vigorous pipetting for ~5 minutes in a 0.025% (v/v) trypsin (Sigma, St. Louis,
MO) solution to facilitate the sperm injection procedure. Mature oocytes with an
extruded first polar body were identified under light microscopy (200X) and then placed
separately in 5 pi sperm-injection microdroplets consisting o f HEPES-buffered
modified Earle’s balanced salt solution (Medi-Cult, Copenhagen, Denmark) under oil in
a 35-mm petri dish.
Semen Preparation
One ml (40 to 60 x 106 sperm cells) o f cooled, extended semen from a single
mature Arab stallion o f proven fertility was washed twice in Ham’s F-10 medium
(Gibco) at 500 x g to remove the seminal plasma and semen extender. Resuspended
sperm cells (2 ml) were treated with a 1 pM concentration o f calcium ionophore
A23187 (Sigma) for 5 minutes and then quenched with an equal volume o f Ham’s F-10
medium with 3% bovine serum albumin (Sigma). A 2 pi volume o f this final sperm-cell
suspension was placed in the same 35-mm petri dish as the prepared oocytes, but in a
centrally situated 4 pi microdroplet o f 10% PVP.
Microinsemination
A total o f 94 mature oocytes were alloted to the five microinsemination
treatments o f this experiment. Microinsemination was performed on a heated stage
under 400X magnification, using an inverted Nikon microscope (Tokyo, Japan) and two
Leitz micromanipulator units. Each of the 5 pi microdroplets (n=8), that were arranged
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in a circle around the sperm-PVP droplet in a prewarmed petri dish, contained a single
mature oocyte. The holding pipette (100 pm outside diameter) was situated on the left
and the sperm injection pipette (3-5 pm diameter) on the right. The tip o f both
microinstruments had a 30° angle to facilitate oocyte manipulation and sperm visibility
during the injection procedure. The sperm-injection needle was prefilled with 10%
PVP.
Sperm cells with good progressive motility, displaying simultaneous lateral head
movement, were selected from the sperm-PVP droplet and immobilized prior to the two
ICSI treatments (Treatments A and E). Sperm immobilization was conducted with the
tip o f the injection needle by performing a simultaneous down and lateral cut movement
initially over the proximal third o f the sperm tail. This crushing o f the sperm tail was
repeated several times further distal from the head. Interestingly, in this experiment
using equine sperm, the sperm tail did not exhibit the characteristic kinked pattern as
previously described for human spermatozoa (Dozortsev et al.. 1995; Van den Bergh et
a l, 1995).
The sperm was loaded tail first into the injection pipette by applying gentle
suction through the injection pipette. The injection pipette with the sperm cell was now
moved to an oocyte droplet without raising it from the mineral oil. Using the holding
and injection pipette, the oocyte was secured with the polar body or area o f polar
granularity at the 6 or 12 o’clock position (Palermo et al., 1996). The sperm head was
now positioned very close to the tip o f the injection needle just before penetrating the
zona pellucida. After piercing the zona, but before pushing into the ooplasm, any excess
PVP in front o f the sperm head was expelled into the perivitelline space. Once the
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injection needle was pushed into the ooplasm, gentle suction was applied until the
ooplasmic membrane ruptured, enabling a small amount o f ooplasm to be aspirated
freely into the needle (Vanderzwalmen et al., 1996). The sperm cell and the microvolume o f aspirated ooplasm was then expelled into the ooplasm and the injection
pipette was swiftly withdrawn.
The SUZI procedure (Treatment B) was similarly performed, but two or three
motile sperm cells were inserted subzonally into the perivitelline space, as has been
described previously in humans (Fishel et al., 1990). Also, sham-injection procedures
were performed similar to the ICSI and SUZI procedures, but only an equivalent
amount o f PVP (<1 pi) was injected into the ooplasm (Treatment C) or under the zona
(Treatment D) without any sperm cells.
Embryo Co-Culture and Transfer
After sperm injection, the injected oocytes were washed and cultured in groups
on a monolayer o f bovine oviduct epithelial cells in 50 pi droplets o f TCM-199 with
10% fetal bovine serum (Gibco) under mineral oil at 38°C in an atmosphere o f 5% CO 2
in air. The culture medium was changed every other day and the injected oocytes were
co-cultured for up to 7 days. Embryo development was evaluated under inverted light
microscopy (200 to 400X) at 48-hour intervals after microinsemination. All oocytes that
did not exhibit evidence o f cleavage by 72 hours after the injection procedure were
selectively removed from culture, fixed and stained with a 2% (w/v) aceto-orcein
solution (Sigma) to assess fertilization or maturation status (Meintjes et al., 1995).
All morula stage embryos (n=4) were nonsurgically transferred to synchronized
recipients (one embryo per recipient) on day 5.5 after sperm injection, using a standard
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transcervical embryo transfer procedure (Imel et al., 1981). In addition, a set o f two
embryos (one 2-cell and one 4-cell embryo) was surgically transferred to the oviduct of
each o f two recipient mares at 48 hours alter sperm injection. Surgical transfers were
performed by exteriorizing the oviduct through a flank incision, and subsequently
threading a small catheter (Wallace Embryo Transfer Catheter, Simcare Ltd., Peter
Road, Lancing, West Sussex, England) containing the embryos ~4 to 6 cm into the
lumen o f the oviduct. The embryos were then expelled into the oviduct along with 10 to
20 pi of embryo transfer medium (HEPES-buffered TCM-199 supplemented with 10%
fetal bovine serum).
Statistical Analyses
Fisher’s Exact Two-tailed Test (Metha and Patel, 1983) was used to compare the
ratios of oocytes that cleaved and proceeded to further developmental stages for the five
microinsemination treatments. In selecting this test, it was assumed that the distribution
o f oocytes collected from the mares was equal and that each individual oocyte acted
independently o f the other oocytes collected.
Experiment 5.2
Experimental Design
Experiment 5.2 was conducted in a similar manner to that o f Experiment 5.1,
with the following exceptions, only ICSI was used to fertilize mature oocytes in the
second experiment. Mature, injected oocytes (n=86) derived from pregnant crossbred
mares in good body condition were randomly allocated within mare to one of two
culture treatment groups (Treatments A and B). Treatment A consisted o f injected
oocytes (n=43) cultured for 48 hours in TCM-199 (with glucose) supplemented with
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15% fetal bovine serum at 38°C in an atmosphere o f 5% CO 2 in air. Injected oocytes in
Treatment B (n=43) were similarly cultured in a glucose-free, phosphate-free medium
(P-l™, Irvine Scientific, Santa Ana, CA) supplemented with 15% fetal bovine serum for
48 hours at 38°C in an atmosphere o f 5% CO2 in air. Co-culture was not incorporated
into in this experiment, since P-l™ medium does not maintain the development of
bovine oviduct epithelial cells.
Oocyte Collection.
Oocytes were collected during the 1997 breeding season from pregnant mares
on days 14 to 70 of pregnancy via transvaginal ultrasonography, as in Experiment 5.1,
except that

12-gauge double-lumen needles (Cook® Veterinary Products Inc.,

Bloomington, Indiana) were used to recover oocytes in this experiment. With this
method, a slight modification o f the collection procedure was necessary. Negative
pressure (90 mm Hg) was constantly applied via a vacuum pump while oocyte
collection medium (PBS plus 1% calf serum with 2 USP units o f heparin, 100 jig of
streptomycin and 100 units of penicillin-G per ml) was “pulsed” through the follicular
cavity 10 to 15 times. Adequate force was required in pulsing the incoming medium to
provide sufficient pressure to expand the follicle and to allow for the detachment o f the
oocyte from the follicular wall.
In Vitro Maturation and Oocyte Preparation
IVM o f oocytes was performed as in Experiment 5.1. However, oocytes in this
experiment were stripped o f the majority of their cumulus cells by gentle pipetting in a
solution o f 80 units/ml hyaluronidase (Sigma) in TCM-199, rather than in a solution of
0.025% trypsin as in Experiment 5.1.
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Semen Preparation
Cooled, extended semen (40 to 60 x 106 sperm cells/ml) from the same Arab
stallion was used for the ICSI procedure in this experiment. A microvolume o f this
semen (<1 pi) was placed, unwashed, into the central PVP droplet (3 pi) in the
microfertilization dish, without any prior exposure to calcium ionophore as in
Experiment 5.1.
Microinsemination
Only ICSI was performed in Experiment 5.2, and the ICSI procedure utilized
was similar to that o f Experiment 5.1. Only one sperm cell was injected into the
ooplasm o f an in vitro matured oocyte. Care was taken in assuring that the tail o f the
sperm cell was adequately crushed and that the sperm cell was completely immobilized
prior to its insertion into the ooplasm of the recipient oocyte.
Embryo Transfer
A total o f 31 embryos were surgically transferred into the oviducts o f
synchronous recipient females at 48 hours post-ICSI. The embryos were loaded into a
Wallace catheter (Simcare, Ltd.) (1 to 4 embryos/catheter) and the soft, inner portion of
the catheter was threaded 4 to 6 cm into the surgically exposed oviduct o f the recipient
female. The embryos were then gently expelled along with 10 to 20 pi o f transfer
medium (HEPES-buffered TCM-199 supplemented with 10% fetal bovine serum). All
embryos were transferred into the oviduct ipsilateral to the previously ovulated follicle.
Recipient females were subsequently monitored by ultrasonography at day 14 post
fertilization to determine pregnancy status. All recipients were treated with altrenogest
(Regu-Mate®, Hoechst Roussel Vet, Warren NJ) daily, beginning on the day o f embryo
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transfer and continuing until pregnancy was confirmed 12 to 14 days later. Pregnant
recipients were maintained on altrenogest supplementation until 120 days o f gestation.
Statistical Analyses
The statistical analyses performed in this experiment were similar to Experiment
5.1, with the ratio o f embryos cleaved and the embryonic development stages being the
parameters compared across the two culture treatments.
RESULTS
Experiment 5.1
A cleavage rate o f 39% (2-cell embryos) was obtained for ICSI-derived oocytes
and this was greater (P<0.05) than the 6% for SUZI oocytes (Table 5.1). Similarly,
more (P<0.05) ICSI oocytes developed to the 4- to 8-cell stage than did oocytes
subjected to the SUZI procedure. When more than one sperm were injected directly into
the ooplasm, 33% o f injected oocytes cleaved. This was not different from the oocytes
subjected to the ICSI or SUZI procedures, but these polyspermic fertilized oocytes
failed to develop further than the 2-cell stage. Furthermore, none o f the sham-injected
oocytes cleaved. Aceto-orcein staining o f the oocytes that did not undergo cleavage
revealed that at least 25% of SUZI-derived oocytes did not fertilize and that an
additional 13% contained a metaphase plate and a single pronucleus.
Two embryos at the 2-cell stage and two embryos at the 4- to 8-cell stage (n=4)
were surgically transferred to the oviducts o f recipient mares and, thus, did not have the
opportunity to develop to later stages in vitro. None of the morulae transferred
nonsurgically resulted in an ultrasonic detectable pregnancy by day 16 after sperm
injection. However, one of the surgical embryo transfers (2- to 4-cell embryo) resulted
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in a 16 mm embryonic vesicle in the body of the uterus on day 14 after sperm injection,
but was lost (23 mm diameter) between days 16 and 18 following sperm injection.
Experiment 5.2
A total o f 263 follicles were punctured from 20 aspiration procedures, yielding
an average o f 13 follicles punctured per procedure. O f these, 174 oocytes were collected
giving a recovery rate o f 66% (8.7 oocytes/procedure). Overall, 86 oocytes were
deemed mature by the presence o f a first polar body after maturation in TCM-199
supplemented with 10% estrous mare serum (49%). However, when degenerate oocytes
were excluded from the analysis, the maturation rate was 73%.
O f the 86 matured oocytes exposed to ICSI, 47 cleaved giving an overall
cleavage rate o f 55%. Cleavage rates differed between the two media treatment groups
(47% vs. 63% for Treatments A and B, respectively) (P<0.10) (Table 5.2). However,
there was no difference in the number o f 2-cell, 3-cell, 4-cell, 6-cell or 8-cell embryos
developing in vitro between Treatments A and B.
Since most o f the embryos produced were subsequently transferred into
synchronous recipients, it was important to establish a system o f grading these embryos
prior to transfer to determine which embryos had the greatest chance o f developing into
a viable pregnancy. The grading system was based on the rate o f embryonic
development as evaluated at 48 hours post-ICSI, and was as follows: Grade-1 = 4- to 8cell stage, with blastomeres o f even size and shape and <15% perivitelline fragments,
Grade-2 = 4- to 8-cell stage, with blastomeres of even size and shape and 15 to 30%
perivitelline fragments, Grade-3 = 4- to 8-cell stage, with blastomeres o f uneven size
and shape and >30% perivitelline fragments or 2- to 3-cell stage with <15%
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perivitelline fragments and blastomeres o f uneven size and shape, Grade-4 = 2- to 3-cell
stage, with >15% perivitelline fragments and blastomeres o f uneven size and shape.
A total o f 13 embryos were transferred from Treatment A (one Grade-1, three
Grade-2 and nine Grade-3 embryos). In Treatment B, 18 embryos were transferred
(three Grade-1, five Grade-2, seven Grade-3 and three Grade-4 embryos). The one mare
receiving the Grade-1 embryo from Treatment A was diagnosed pregnant by the
presence o f an embryonic vesicle at day 14 post-ICSI, which resulted in the birth o f a
healthy female foal, weighing 29.1 kg, at 319 days o f gestation. Similarly, two o f the
three mares receiving Grade-1 embryos from Treatment B were confirmed pregnant by
16 days post-ICSI. One of these mares lost her pregnancy between day 20 and day 35
post-ICSI, and the other pregnancy resulted in the birth o f a healthy, 27.7 kg female foal
at 328 days o f gestation.
Overall, the pregnancy rate was low for these mares (25% pregnancy/transfer,
8% pregnancy/embryo). However, when only Grade-1 embryos are considered, 75%
(three o f four) o f the mares were diagnosed pregnant by 16 days post-ICSI, and 50%
(two o f four) resulted in live births.
DISCUSSION
The consistent production o f IVF embryos in the horse will likely have valuable
commercial, research and conservational applications. Recent studies, applying
prefertilization zona-drilling (Li el al., 1995; Meintjes et al., 1995) and partial zona
removal (Choi et al., 1994), for the first time indicated that equine IVF rates may
approach those o f other domestic species and possibly humans. These studies also
implicated that inadequate sperm capacitation and/or the presence o f an in vitro zona
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Table 5.1. In vitro development o f subzonal and intracytoplasmic sperm-injected horse
oocytes

Treatment

Oocytes

2-cell

ICSI
SUZI
ICSI (s)
SUZI (s)
ICSI (psc)

36
32
10
10
6

14at
2b
-

4- to
8-cell

8- to
16-cell

Morula

ET

9at

3
1
-

3
1
-

3
1
-

lb
-

ET = embryo transfer; (s) = sham injected, PVP without sperm; (psc) = polyspermy
control, three to five sperm cells injected per oocyte.
+Two embryos from each of these groups (n=4) were surgically transferred to the
oviducts o f recipient mares and, thus, did not have the oppurtunity to develop to later
stages in vitro.
“'“’Different superscripts within the same column are different (P<0.05).
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Table 5.2. In vitro development o f intracytoplasmic sperm-injected equine oocytes
following 48 hours o f culture in either TCM-199 or P-l™ culture medium
Treatment group
Characteristic

(n)

p -r

20 (47%)a

27 (63%)b

Cell stage:
2-cell
3-cell
4-cell
6-cell
8-cell

12 (60%)
4 (20%)
4 (20%)
0 (0%)
0 (0%)

14 (52%)
5 (19%)
6 (22%)
1 (4%)
1 (4%)

Embryo grade:
Grade 1
Grade 2
Grade 3
Grade 4

1 (5%)
3 (15%)
10(50%)
6 (30%)

3 (11%)
5 (19%)
8 (30%)
11 (41%)

Cleavage rates

47

TCM-199

“’‘’Different superscripts within the same column are different (P = 0.09).
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pellucida barrier may contribute to the less than anticipated conventional IVF rates in
the horse. Although promising, these techniques will always have the possibility o f
producing polyspermic embryos. Many factors such as the size o f the opening drilled
into the zona pellucida, the concentration o f sperm cells used for in vitro insemination,
the time period o f zona-drilled oocyte exposure to sperm cells and the individual
stallion semen characteristics may be difficult to standardize and hamper consistent
normospermic IVF rates.
ICSI is now a standard procedure used for the treatment o f male factor infertility
in humans (Ng et al., 1993; Palermo et al., 1996) even when sperm cells have to be
obtained from the epididymides (Mansour et al., 1996) or testicle (Kahraman et al.,
1996). The ICSI technique also circumvents the difficulties encountered with fertilizing
human oocytes with a hardened zona pellucida, such as IVM oocytes or oocytes
obtained from patients with severe endometriosis (Ng et al., 1993).
ICSI was considered in the present study in an effort to bypass the necessity of
effective in vitro sperm cell capacitation, as well as to circumvent the zona pellucida
and oolemma barrier, while still ensuring normospermic fertilization. There was no
guarantee that SUZI may not perform better in the horse than ICSI, therefore, SUZI was
also included in the microinsemination treatment groups in Experiment 5.1. It was clear
from the data in this experiment that ICSI is the microinsemination technique of choice
in the horse, as also reported for humans (Palermo et al., 1993; Van Steirteghem et al.,
1993). It seemed that SUZI oocytes were either not penetrated by the perivitelline
inserted sperm (25% without a single pronucleus and a normal appearing metaphase II
plate) or were fertilized but not activated (13% with one pronucleus, presumably from
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sperm origin and an intact metaphase II plate). It was encouraging to note that no
polyspermic fertilized oocytes developed further than the 2 -cell stage and that none o f
the sham-injected oocytes were parthenogenically activated by the injection procedure.
The cleavage rate o f ICSI oocytes in this study (39% and 55% for Experiments
5.1 and 5.2, respectively) seemed to be lower than the cleavage rate o f the best spermtreatment group (79%) in a previous prefertilization zona-drilling study by our
laboratory (Li et al., 1995). Reasons for this lower cleavage rate may include the
learning curve necessary to perform ICSI efficiently with adequate crushing o f the
sperm tail (Dozortsev et al., 1995; Van den Bergh et al., 1995), damage to the injected
oocytes (Palermo et al., 1996) and the possibility that some cleaved polyspermic
embryos were included in the prefertilization zona-drilling group. However, the
cleavage and embryo developmental rates obtained by ICSI in this study appear to be an
improvement on rates from previous conventional equine IVF studies (Del Campo et
al., 1990; Palmer et al., 1991; Grondahl et al., 1995) and compare favorably with other
recent ICSI studies in the horse (Dell’Aquila et al., 1997), the cow (Goto et al., 1996;
Mutsuro et al., 1996) and the cat (Pope et al., 1995, 1997). The data presented in Table
5.1 suggests that there was a marked decline in ICSI embryos between the 4- to 8 -cell
stage and the 8 - to 16-cell stage. This is due to the removal o f four embryos (two 2-cell
and two 4-cell embryos) from culture for the surgical intraoviductal transfer to
synchronized recipients. For the same reason, the morula/blastocyst development rate
between this and the previous prefertilization zona-drilling studies (Li et al., 1995;
Meintjes et al., 1995) cannot be compared.
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In Experiment 5.2, cleavage rates for ICSI oocytes were higher when the
oocytes were cultured for 48 hours in P-l™ medium when compared with TCM-199
(63% and 47%, respectively) (P=0.09). This is in agreement with previous reports on
the detrimental effects o f high levels o f glucose present in the culture medium for early
stage mouse (Chatot et al., 1989), cow (Ellington et al., 1990), hamster (Seshagiri and
Bavister, 1989) and human embryos (FitzGerald and DiMattina, 1992). For example,
Chatot et al. (1989) found that medium containing a relatively high level o f glucose
inhibited the development o f 1-cell mouse embryos during the first 48 hours o f culture,
but not after 48 hours. In fact, the addition of glucose to the culture medium on day 3 of
culture significantly improved development o f mouse embryos to the blastocyst stage,
suggesting that the toxic effects o f glucose is short-lived in murine embryos (Chatot et
al., 1989).
Similarly, Ellington et al. (1990) determined that a high glucose level in the
culture medium is inhibitory to bovine embryos during the first 48 hours o f culture and
that culturing these embryos in a glucose-free medium facilitated the development of
the embryos through the

8 -cell

stage. In addition, it has been shown in both cattle

(Ellington et al., 1990) and humans (FitzGerald and DiMattina, 1992) that culturing
early stage embryos in medium without glucose significantly improves embryo quality.
In contrast, Watson et al. (1994) found no difference in cleavage rates o f ovine embryos
cultured in medium without glucose. In addition, it has been demonstrated that glucose
levels had no effect on the development of ovine embryos past the in vitro block
developmental stage (McGinnis and Youngs, 1992).
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Even though no statistical differences were detected between the culture
treatments for early embryonic development and embryo quality, it is apparent that
embryos cultured in a low glucose environment were not inhibited in their development,
since this was the only group to produce both 6 - and 8 -cell embryos at 48 hours postICSI (Table 5.2). Also, two pregnancies were established from the transfer o f two
Grade-1 embryos cultured in the P-l™ medium (low glucose), with one pregnancy
resulting in a live birth.
Results from this study indicate that intracytoplasmic sperm injection should not
be overlooked as the method o f choice for the production o f in vitro equine embryos.
Although no pregnancies resulted from the nonsurgical morula-stage embryo transfers,
oocytes aspirated from pregnant mares were viable and capable o f establishing four
pregnancies after in vitro maturation, ICSI, in vitro culture and intraoviductal embryo
transfer, with two live births resulting at days 319 and 328 o f gestation, respectively.
Also, previous reports have suggested that multiple, good quality oocytes can be
collected repeatedly from early pregnant mares (Li et al., 1995; Meintjes et al., 1995).
The benefit o f using the pregnant mare as an oocyte donor is that the oocytes can be
collected uniformly at the germinal vesicle stage, which allows for known, fixed IVM
intervals resulting in larger quantities o f good quality oocytes available for IVF. In
addition, oocyte retrieval in this study was improved using the double-lumen needles
when compared with previous reports using a single-lumen needle system (Meintjes et
al., 1995).
The present study provides strong evidence that ICSI o f oocytes derived from
pregnant mares can be a viable alternative for the production o f gametes for assisted
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reproduction and the treatment of clinical infertility in valuable mares, and that ICSI
may have application in the conservation o f endangered equids. This study, to our
knowledge, is the first report of the production of live foals derived from in vitromatured equine oocytes collected from pregnant mares.
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CHAPTER VI
DEVELOPMENT OF A PROTOCOL USING ALTRENOGEST AND eST FOR
OVARIAN STIMULATION IN THE DOMESTIC MARE FOR USE IN
TRANSVAGINAL OOCYTE ASPIRATION PROCEDURES FOR THE
PRODUCTION OF IN VITRO-DERIVED EQUINE EMBRYOS
INTRODUCTION
The routine production o f in vzTro-derived equine embryos has not yet become a
reality, even though an acceptable number o f oocytes can be repeatedly collected from
live mares, with successful in vitro maturation (IVM) o f the oocytes followed by
intracytoplasmic sperm injection (ICSI) (Cochran et al., 1998, 2000). Since the first
report of a foal being bom from in vitro fertilization (Palmer et al., 1991), only one
other report has been published on the production of IVF-derived foals (Cochran et al.,
1998). In that study, Cochran et al. (1998) demonstrated that pregnant mares could be
used as oocyte donors, and that ICSI could be performed on these oocytes in order to
produce live foals. Since conventional IVF rates for horses remains low (Palmer et al.,
1991; DelFAquila et al., 1996), ICSI appears to be the method o f choice for the
production o f equine embryos in vitro (Dell’Aquila et al., 1997; Cochran et al., 1998;
2000 ).
However, one o f the biggest obstacles to establishing an efficient IVF procedure
for horses has been the inability to “superstimulate” domestic mares to produce high
numbers o f good quality oocytes, which is routinely performed in many domestic
animals and in women. It has been demonstrated in cows (Manikkam et al., 1997) and
horses (Ginther and Bergfelt, 1992) that follicular waves continue throughout early
pregnancy, and that these animals may serve as oocyte donors for IVF (Meintjes et al.,
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1995).

Meintjes et al. (1995) first demonstrated that pregnant mares could be

effectively used as oocyte donors, and that they could provide high numbers of good
quality oocytes when the oocytes were collected repeatedly using an ultrasound-guided
approach. One possible explanation for the success realized when using oocytes derived
from pregnant mares is that follicular waves that occur during pregnancy show a
reduced occurrence o f follicular dominance (Ginther and Bergfelt, 1992), caused by the
continuously elevated levels o f progesterone, which in turn reduces the negative effects
that the dominant follicle exerts on its subordinates.

Oral altrenogest, a synthetic

progestin, has been shown to suppress the occurrence o f dominant follicles in mares
(Lofstedt et al., 1989), with no effect on subsequent fertility o f the treated mares once
administration was discontinued (Sigler et al., 1989). It is believed, therefore, that by
treating mares daily with altrenogest, a “pseudopregnant” state could be induced during
which follicular dominance would be minimized and oocyte collections could be
performed with a high rate of success.
It has been well established that administration o f somatotropin (ST) increases
follicle number in horses (Cochran et al., 1999), cattle (Carter et al., 1998), pigs (Spicer
et al., 1992), rabbits (Yoshimura et al., 1994) and women (Owen et al., 1993). It is
believed that the ability of ST to increase follicle number is caused, at least in part,
through its ability to increase circulating IGF-I concentrations (Owen et al., 1993;
Yoshimura et al., 1994), as it is well known that ST is a potent stimulator o f IGF-I
production (Owen et al., 1993; Gong et al., 1997; Cochran et al., 1999).
Therefore, the purpose o f the present study was twofold:

(1) to develop a

protocol for IVF in horses using oral altrenogest treatment to reduce follicular
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dominance and allow for a higher number o f good quality oocytes to be collected per
mare, followed by IVM and ICSI o f the collected oocytes and (2) to determine if daily
administration o f equine somatotropin (eST) could increase the number o f follicles
available from these altrenogest-treated mares.
MATERIALS AND METHODS
Experimental Design
A total o f 18 mares in good body condition (body condition scores ranged from
5 to

8

on a scale o f 1 to 9), from the same experimental herd, were randomly allocated

to one o f two treatment groups during the breeding season o f 1998.

Treatment A

consisted o f mares (n=9) treated with 0.044 mg altrenogest (Regu-Mate®, Hoechst
Roussel Vet., Warren, NJ) per kg body weight for a total o f 51 days (day 1 = first day o f
treatment). Mares in Treatment A also received a single daily injection o f 25 pg eST
(EquiGen™, BresaGen, Thebarton, South Australia) per kg body weight beginning on
day 1 and ending on day 51. Mares in Treatment B (n=9) were similarly treated with
altrenogest in addition to the eST vehicle beginning on day 1 and continuing for 51
days.

All experimental animals were administered either altrenogest plus eST or

vehicle for a preliminary period of 21 days. This was performed to allow for a possible
“priming” effect o f eST on follicular development, as well as to subject the mares to a
period o f time (which is approximately equal to one estrous cycle) of progesterone
dominance. This time o f progesterone dominance was used in order to allow for more
synchronous development o f follicles within a follicular wave.
On day 21, all mares were subjected to a follicle ablation procedure, during
which all follicles >5 mm in diameter were punctured follicular fluid was collected via a
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transvaginal ultrasonographic procedure. This was performed to (1) remove all atretic
follicles that may be present on the ovaries of each mare and (2 ) induce a new wave of
follicular growth for subsequent oocyte collection procedures.

After the follicle

ablation procedure was performed, mares from both treatment groups were maintained
on their respective treatment protocols, and oocyte collection procedures (n=3/mare)
were performed at 10-day intervals. Plasma samples were collected at 72-hour intervals
on all mares via jugular venipuncture for the duration o f the treatment period to assess
plasma IGF-I concentrations in response to eST administration.
Oocyte Collection
Oocyte collection procedures were performed at 10-day intervals following the
follicle ablation procedure on day 21 o f treatment. This time interval was chosen based
upon the approximate interval o f follicular wave emergence and growth in the domestic
mare. Oocyte collections were performed as previously described by Cochran et al.
(1998).

Briefly, a 12-gauge double-lumen stainless steel needle (Cook® Veterinary

Products Inc., Bloomington, IN) was inserted through the vaginal wall via a
transvaginal ultrasonic transducer attached to a needle guide. Negative pressure (90 mm
Hg) was constantly applied using a vacuum pump while oocyte collection medium
(PBS plus 2% calf serum with 2 USP units of heparin and 100 units o f penicillin-G/ml)
was pumped through the follicle cavity up to 10 times. Sufficient pressure was applied
by the incoming medium to expand the follicle and to allow for the detachment o f the
oocyte from the follicular wall. The flushing medium was then collected into a 500 ml
container and the contents were searched for oocytes contained therein.
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Oocyte Maturation and Micromanipulation
After oocyte recovery, all oocytes with an intact oolemma were washed in in
vitro maturation (IVM) medium. IVM medium consisted o f tissue culture medium 199
(TCM-199, Gibco) with 10% estrual mare serum collected at this laboratory. In vitro
maturation was conducted in 35 pi microdroplets o f IVM medium covered with mineral
oil in a 35-mm petri dish for 36 hours at 38°C in an atmosphere o f 5% CO 2 in air. After
IVM, the oocytes were stripped from the majority o f their cumulus cells by vigorous
pipetting for 2 to 3 minutes in TCM-199 containing 80 units o f hyaluronidase per ml
(Sigma, St. Louis, MO) to facilitate micromanipulation. Oocytes with an extruded first
polar body (Mil) were identified under light microscopy (200X) and then placed
separately into 5 pi microdroplets consisting o f HEPES-buffered TCM-199 under
mineral oil (Sigma). All Mil oocytes were then subjected to the ICSI procedure as
previously described (Cochran et al., 1998).
Embryo Culture and Transfer
After micromanipulation, all oocytes were placed in 35 pi microdrops o f P-l™
medium (Irvine Scientific, Santa Ana, CA) and cultured for 48 hours at 38°C in an
atmosphere o f 5% CO2 in air under oil. Embryonic development was then assessed and
embryos were either surgically transferred into synchronous recipient mares (n=3) or
allowed to develop additionally in vitro for up to 3.5 days (n=71). After 72 hours o f
culture, all remaining embryos were transferred into Blastocyst

medium (Irvine

Scientific) for the remainder o f the culture period. At day 5.5, all morula-stage embryos
(n=4) were transferred nonsurgically into synchronous recipient mares.
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Statistical Analysis
The numbers o f small- (5 to 10 mm), medium- (11 to 25 mm) and large- sized
(>25 mm) follicles were recorded per mare during each oocyte collection procedure and
were analyzed across treatment groups. In addition, the number o f oocytes collected
per mare was analyzed for all mares across treatment groups using ANOVA (Cochran
et al., 1999). Also, the percentage o f oocytes reaching metaphase II after 36 hours of
culture, as well as the cleavage rate o f injected oocytes and embryonic development,
were analyzed across treatment groups for mares in Treatments A and B via ANOVA
(Cochran et al., 1999).
RESULTS
Follicle Populations, Oocyte Collections and Plasma IGF-I Levels
The effects o f eST on altrenogest-treated mares are presented in Table 6.1.
There was no effect of collection procedure (first, second or third collection) on any
parameter measured, thus, data were pooled across the three collection procedures per
mare per treatment. Daily administration o f eST to altrenogest-treated mares had no
effect on the number o f small (1.40 ± 0.30 for both Treatments A and B), medium (3.3
± 0.42 vs. 3.7 ± 0.64, Treatments A and B, respectively) or large follicles (1.37 ± 0.23
for both Treatments A and B) per mare per oocyte collection (10-day intervals).
Furthermore, there was no difference in the total number of follicles per mare per
oocyte collection for altrenogest-treated mares with or without eST (6.15 ± 0.65 vs. 6.52
± 0.76 for Treatments A and B, respectively). However, when the total follicle number
per mare was analyzed following

21

consecutive days o f treatment (first follicle

ablation), mares treated with altrenogest plus eST had significantly more follicles per
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mare when compared with contemporary control mares (22.9 ± 2.5 vs. 13.9 ± 2.5 for
Treatments A and B, respectively).
Unfortunately, this increase in follicle number was not maintained once oocyte
collections began at 10-day intervals (Table 6.1). Also, there was no difference in the
number o f oocytes collected per mare per oocyte collection for mares treated with
altrenogest with or without eST (4.4 ± 0.56 for both Treatments A and B). Finally,
there was a definite increase in circulating plasma IGF-I levels for altrenogest-treated
mares given eST when compared with contemporary control mares (P<0.05, Figure
6 . 1).
Oocyte Maturation, Embryo Cleavage and Embryonic Development
Results o f oocyte maturation, embryo cleavage and embryonic development are
summarized in Table 6.2.

There was no effect on the percent o f oocytes reaching

metaphase II after 36 hours of IVM for mares with or without eST (73% vs. 58% for
Treatments A and B, respectively). In addition, cleavage rates were similar (44% vs.
58%) for altrenogest-treated mares with or without eST, respectively. A total o f 74
ICSI-derived equine embryos were produced from this experiment (35 and 39 from
Treatments A and B, respectively).
The majority o f these embryos (n=71) were cultured in vitro for up to 5.5 days,
with three embryos being surgically transferred into the oviducts o f two synchronous
recipient mares after 48 hours of culture in order to attempt to establish that oocytes
collected from mares treated in this fashion were fertile and capable o f producing live
foals. The pregnancy did not continue in the mare receiving the single embryo at 48
hours post-ICSI. However, the mare that received two embryos at 48 hours post-ICSI
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was diagnosed pregnant with twins at day 14 post-ICSI, and one embryonic vesicle was
immediately crushed to prevent complications related to twin conceptuses in the mare.
Incidentally, both embryos were collected from a single mare in the control group. This
pregnancy resulted in the birth o f a healthy female foal, weighing 30.5 kg, after 339
days o f gestation.
To our knowledge, this is the first report of a foal produced from oocytes
collected from altrenogest-treated mares, followed by IVM and ICSI.

Also, this

represents the first incidence, to our knowledge, o f a twin pregnancy resulting from the
transfer of in v/7ro-produced equine embryos. There was no treatment effect on
subsequent embryo development past the 2-cell stage (Table 6.2). Furthermore, none o f
the mares receiving morula-stage embryos at day 5.5 (n=4) resulted in a pregnancy.
DISCUSSION
One o f the largest obstacles to developing a repeatable protocol for IVF in the
horse is the inability to collect high numbers o f good quality oocytes from donor mares.
The major problem is that most attempts to superstimulate the equine ovary to produce
a large number o f follicles has met with very limited success (for review see Ginther,
1992).

Therefore, if multiple oocytes are to be collected from a single collection

procedure, researchers must utilize the available follicles present at the time o f
collection to achieve the desired results.
In mares, the ovaries undergo periods of follicular growth and development
termed “follicular waves”. This is true for other farm animal species as well (Lucy et
al., 1993; Pursley et a l , 1993), except for the pig (Ryan et al., 1994). The majority o f
mares have

1

to

2

waves o f follicular growth per interovulatory interval, each lasting
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10

Table 6.1. Effect o f eST administration to altrenogest-treated cyclic mares on follicular
populations
Small
follicles

Medium
follicles

Large
follicles

Total
follicles

Follicle
ablation*

eST

1.40 (±0.30)

3.30 (±0.42)

1.37 (±0.23)

6.15 (±0.65)

22.9a (±2.5)

Control

1.40 (±0.30)

3.70 (±0.64)

1.37 (±0.23)

6.52 (±0.76)

13.9b (±2.5)

Treatment

a'bMeans within columns with different superscripts are different (P < 0.05).
*The follicle ablation procedure was performed at day 21 o f treatment to remove any
atretic follicles and to promote a new wave of follicular growth.
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Table 6.2. Oocyte maturation, cleavage and early embryonic development for
altrenogest-treated cyclic mares with and without eST
Treatment
eST
Control
Treatment
eST
Control

Maturation
73%
58%
2 to 4 cell
35
39

Cleavage
44%
58%

4 to 8 cell
25
28

8

to 16 cell
19
19

16 to 32 cell
7
6
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Figure 6.1. Plasma IGF-I concentrations (±SEM) for altrenogest-treated mares
administered once daily injections o f eST. (*) Denotes significant
differences within days.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

51

days (Ginther, 1992; Buratini et al., 1997). One particular problem with attempting to
collect oocytes from the follicles of cyclic mares is that, during most waves o f follicular
growth, one follicle is selected to become dominant over the other follicles within that
wave, and that dominant follicle (DF) produces substances that inhibit the growth and
development o f the subordinate follicles (SF) within the same follicular wave (Ginther,
1992). Therefore, if one is to collect multiple oocytes from a cyclic mare, one must
realize that the majority o f the oocytes will come from these SF and may or may not be
viable.
During periods o f progesterone dominance, such as pregnancy, both cattle
(Ginther et al., 1989), and mares continue to show follicular wave emergence and
growth (Ginther and Bergfelt, 1992). However, the incidence o f follicular dominance is
reduced, possibly due to decreased LH pulse frequency from the pituitary caused by
elevated plasma progesterone concentrations (Adams et al., 1992a).

Bergfelt et al.

(1991) demonstrated that, in cattle, anovulatory follicular waves continued at least to
day 100 in both pregnant and progesterone-treated control cows. The fact that these
follicular waves were anovulatory demonstrates the ability o f progesterone treatment to
inhibit DF development.

Similar findings were reported for cows by Ginther et al.

(1989), where the diameter o f the largest follicle was lower in pregnant cows compared
with nonpregnant controls. In addition, other studies have demonstrated the ability o f
pregnant cattle to continue follicular development through to parturition (Manikkam et
al., 1997).
In mares, follicular waves have been documented to occur during vernal
transition (Ginther, 1990), during reproductive cyclicity (Buratini et a l , 1997) and
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during pregnancy (Ginther and Bergfelt, 1992). Also, it has been shown that oocytes
collected from pregnant donor mares are viable and capable o f producing live foals
(Cochran et al., 1998). However, utilizing pregnant donors is o f little use in subfertile
mares, since it is very difficult to attain a viable pregnancy in this population o f mares.
Therefore, in the present study, we attempted to induce a “pseudopregnant” state in
cyclic mares by administering altrenogest once daily. Although we did not attempt to
identify individual waves o f follicular activity in these mares, it was evident that
follicular growth and development continued through to day 51 o f treatment, as
evidenced by the number of follicles available for aspiration per oocyte collection
procedure in the present study.

In addition, it has been demonstrated in cattle that

follicle ablation can induce a new wave o f follicular growth (Bergfelt et al., 1997; Bo et
al., 1995), so it is not unreasonable to assume a similar phenomenon occurs in mares.
Also evident from this work is that oocytes collected from altrenogest-treated mares are
viable and capable o f producing live offspring.
The administration o f ST has been shown to increase the number o f follicles in
cattle (Lucy et al., 1993), pigs (Spicer et al., 1992), women (Owen et al., 1993), rabbits
(Yoshimura et al., 1994) and mares (Cochran et al., 1999). It is believed that ST causes
these effects, at least in part, through its ability to increase circulating IGF-I
concentrations (Owen et al., 1993; Gong et al., 1997; Cochran et al., 1999). In the
present study, eST administration to altrenogest-treated mares did cause a significant
increase in plasma IGF-I levels (Figure 6.1). However, this treatment did not increase
the number o f aspiratable follicles per mare when mares were subjected to oocyte
collections at

1 0 -day

intervals.
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Interestingly, when data were analyzed for the number o f aspiratable follicles
following 21 consecutive days o f eST treatment (first follicle ablation), there was a
marked increase in the total number o f follicles >5 mm in diameter on the ovaries o f
altrenogest-treated mares administered daily injections o f eST (Table 6.1). The reasons
for this are unclear, but possibly include a prolongation o f the atretic phase of follicle
development (Cochran et al., unpublished data). Results supporting this hypothesis are
reported by Chun et al., 1996, where the authors show that IGF-I is a potent regulator o f
granulosa cell apoptosis, decreasing the apoptotic index of cultured granulosa cells by
45%. This then could lead to the follicle remaining on the ovary for a longer period o f
time, thereby, resulting in increased follicle numbers after a prolonged period o f
treatment.

Unfortunately, the increase in follicle numbers was not maintained once

oocyte collections were begun at

1 0 -day

intervals, which may limit the effectiveness o f

eST administration for purposes o f oocyte collections at regular intervals in the
domestic mare. Further studies are needed in this area o f follicular growth and
developm ent
Another explanation for the apparent lack of eST treatment to effect follicle
numbers in the present study may revolve around the production o f IGF-I binding
proteins (IGFBP), which limit the bioavailability of circulating, as well as follicular,
IGF-I. There are at least 5 IGFBP currently identified, each o f which having a different
molecular size and a different binding capacity. In general, the low molecular size
IGFBP (IGFBP-2, -4, -5) seem to have a higher affinity to IGF-I than does the larger
IGFBP-3 (Mondschein et al., 1991). Interestingly, follicular fluid from small, as well as
atretic, follicles contain higher amount o f low molecular weight IGFBP, and larger,
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dominant follicles contain more IGFBP-3 (Mondschein et al., 1991; Echtemkamp et al.,
1994b). Therefore, changes in follicle growth and atresia could be regulated more by
IGFBP ratios than by IGF-I itself (Monget et al., 1993; Echtemkamp et al., 1994b).
Increasing IGFBP in follicular fluid have been shown to inhibit IGF-I-stimulated
progesterone production by the granulosa cells in pigs (Samaras et al., 1995) and in
cattle (Spicer et al., 1999).

Also, ST administration has been shown to not only

increase circulating and follicular IGF-I, but also to increase the production o f IGFBP
(Armstrong et al., 1996a).

In the mare, at least 4 IGFBP have been identified,

corresponding to IGFBP-2, -3, -4, and -5 (Gerard et al., 1998). It is therefore possible
that prolonged administration o f eST to altrenogest-treated mares in the present study
could have led to a build up o f IGFBP, which would have inhibited the effects o f IGF-I
on follicle growth and development.
In the present study, oocyte collections performed at 10-day intervals on
altrenogest-treated mares with or without eST yielded an average o f 4.4 (± 0.56)
oocytes per mare per collection procedure. This appears to be an improvement over
previous reports using pregnant donors (Meintjes et al., 1995). However, Cochran et al.
(2000) reported a recovery o f 8.7 oocytes per mare per collection using pregnant mares
as oocyte donors. In the latter study, however, mares were not subjected to repeated
collection procedures at regular intervals and therefore many of the collected oocytes
came from atretic follicles, which is one o f the points o f concern in developing an
efficient protocol for oocyte collection in the mare.
However, when compared with the traditional approach of using cyclic donor
mares, with collection o f only the pre-ovulatory follicle o f an in v/vo-matured oocyte,
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this technique seems favorable. This is due to the fact that, with ~80% recovery rate for
preovulatory follicle collections, and the fact that only ~80% o f those oocyte collected
would be at metaphase II, performing oocyte collections from 10 mares would yield
only between

6

and 7 mature oocytes. With our approach, ~30 mature oocytes could be

recovered from these same

10

mares, which would give a much higher chance o f

success. Also, there was no difference in the number o f oocytes collected per mare
from each collection procedure in the present study, so these numbers o f oocytes could
be attained for at least three consecutive collection procedures.
Another obstacle in improving equine IVF is the seemingly lowered success o f
IVM when compared with other domestic species. Successful IVM rates ranging from
15 to 60% have been reported, which is considerably lower than the 80 to 90% noted
for cow IVM (Meintjes et al., 1995; Goudet et al., 1997; Goudet et al., 1998a). It seems
that there is a significant correlation in follicle size and success o f IVM for equine
oocytes, as oocytes collected from larger follicles have a better chance o f reaching
metaphase II in culture than those collected from small follicles (Goudet et al., 1997).
When using pregnant donor mares, 50 to 60% of the collected oocytes reached Mil
(Meintjes et al., 1995), and the success rate was highest with oocytes collected from 10
to 15 mm follicles (Goudet et al., 1998b).
The addition o f serum to the IVM medium has been shown to increase the
number o f oocytes reaching metaphase II in culture in the mare (Willis et al., 1991). In
addition, adding 100 ng/ml o f ST to the culture medium increases maturational rates o f
bovine oocytes (Izadyar et al., 1997). In the present study, there was no effect of ST
administration to altrenogest-treated mares on oocyte maturation following 36 hours o f
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culture in vitro (Table 6.2). However, the percent o f oocytes reaching metaphase II
tended to be higher (P=0.1) for altrenogest-treated mares receiving daily eST (73% vs.
58%, respectively). This suggests the possibility o f an effect o f either ST and/or IGF-I
on oocyte competence in the mare. Further studies are needed to determine if there is
any beneficial effect o f increased ST/IGF-I on in vitro maturation in the domestic mare.
Another problem with equine IVF is that conventional in vitro fertilization
procedures have not shown much success to date. Only one foal has ever been reported
from conventional IVF (Palmer et al., 1991). However, in several studies in which
relatively large numbers o f oocytes were used, the fertilization rates for IVF in horses
has remained low (less than 20%) (Palmer et al., 1991; Li et al., 1995; D ell’Aquila et
al., 1996).

In humans, it has been stated that the best indicator of IVF outcome is

related to ovarian response to gonadotropins (Roest et al., 1996). Since the admin
istration o f exogenous gonadotropins has little effect on ovarian follicular development
in the horse, this may be one indication of a species-specific problem associated with
IVF.
Since the advent o f ICSI in treating male-factor infertility in humans (Palermo et
al., 1992), ICSI has become a valuable tool in human infertility clinics. It has been
shown in subfertile women that ICSI can lead to higher fertilization rates when
compared with conventional IVF (94% vs. 72% respectively) (Pisarska et al., 1999).
Also, fertilization can be achieved independent o f sperm characteristics (Palermo et al.,
1995), and there is no difference in detectable embryonic defects when comparing ICSI
to conventional IVF in humans (Govaerts et al., 1996). In the horse, ICSI has been
shown to be the method o f choice for IVF procedures compared with other forms o f
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micromanipulation (Cochran et al., 2000), and it yields fertilization rates superior to
that o f conventional IVF (Dell’Aquila et al., 1997).
Also, unlike other domestic species such as cattle, no additional oocyte
activation procedures are necessary to induce acceptable fertilization rates. This is
important since artificial activation o f the oocyte can lead to the development of
parthenogenic embryos, which have a severely limited chance o f producing live
offspring. Also, the injection procedure itself is inadequate in inducing parthenogenic
embryonic division in the equine oocyte (Cochran et al., 2000). In a previous study
using pregnant oocyte donors, an overall cleavage rate o f 55% was demonstrated when
ICSI w as the method o f fertilization (Cochran et al., 2000). Also, live foals have been
produced from oocytes collected from pregnant mares and subjected to ICSI procedures
(Cochran et al., 1998). Thus, it seems that if a routine protocol for producing equine
embryos in vitro is to become a reality, ICSI should be considered the method o f choice
for fertilization o f the oocyte.
Finally, since there has been very limited success with equine IVF, developing a
culture system for early equine embryos has not been feasible up to this point. Reports
from other species have shown a detrimental effect of the presence o f glucose in the
culture medium during early embryonic development in mice (Chatot et al., 1989),
cattle (Ellington et al., 1990), hamsters (Seshagiri et al., 1989) and humans (Fitzgerald
and DiMattina, 1992). Also, Cochran et al. (1998; 2000) have shown that utilization of
a glucose-free medium (P-l™), which is currently used in human IVF procedures,
yields superior cleavage rates when compared with TCM-199, which contains glucose.
Although the difference noted may or may not be related to glucose content, since the

133

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

two media types exhibit other differences, P-l™ medium was chosen as the initial
culture medium for the present experiment. This culture medium is designed only for
the first 72 hours o f culture following fertilization, at which time a second media type
(Blastocyst™ medium) is used to allow for embryonic development up to the blastocyst
stage.
There was no difference in either cleavage rates or embryonic development
between the two treatment groups in the present experiment (Table 6.2). Unfortunately,
no blastocysts were produced in the present study, and the nonsurgical transfer o f four
morula stage embryos did not result in any pregnancies. However, in an effort to verify
that oocytes collected from altrenogest-treated mares were viable and capable of
producing live offspring, three embryos were surgically transferred into the oviducts of
two synchronous recipient mares at 48 hours o f development. The mare receiving one
embryo did not become pregnant. However, the mare that received two embryos was
diagnosed pregnant with twins at 14 days post-fertilization via transrectal ultra
sonography. One embryonic vesicle was immediately crushed, and the other continued
to develop and resulted in the birth o f a healthy female foal at 339 days of gestation.
In summary, we have demonstrated that a protocol including treatment o f mares
with oral altrenogest, with a follicle ablation procedure performed at day 2 1 followed by
oocyte collections at 10-day intervals, with IVM and ICSI performed on the collected
oocytes, can be utilized to produce in vitro-derived equine embryos with a high degree
o f success. Furthermore, while culturing these in v/fra-produced embryos to the morula
stage did not result in a successful pregnancy being established, transfer o f these
embryos at earlier embryonic developmental stages can result in the production of
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normal, healthy offspring. This is the first report, to our knowledge, o f successful in
vitro fertilization o f equine embryos following a protocol o f daily oral altrenogest to
induce pseudopregnancy.

In addition, this is the first report o f twin pregnancies

resulting from the transfer o f IVF-derived equine embryos.
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CHAPTER VII
EFFECTS OF eST ON EQUINE GRANULOSA CELL PROLIFERATION AND
PROGESTERONE PRODUCTION I N VITRO
INTRODUCTION
In recent years, the effects o f somatotropin (ST) administration on reproductive
function in domestic species has become a major area o f investigation. Currently, it is
not know whether these effects are caused as a direct result o f ST enhancement, or
indirectly through elevated IGF-I. It has been shown, however, that both ST (Sirotkin
et al., 1998a) and IGF-I (Foster et al., 1995) are stimulatory to granulosa cells cultured
in vitro.

For example, Behl and Pandey (1999) demonstrated that IGF-I increases

progesterone production by caprine granulosa cells, and IGF-I has similar effects in
porcine (Xia et al., 1994) and bovine granulosa cells (Spicer and Echtemkamp, 1995).
Also, the addition o f IGF-I to the culture medium causes a significant increase in
granulosa cells proliferation in cattle (Armstrong et al., 1996b) and sheep (Mariana et
al., 1998). In addition, it has been demonstrated that ST causes similar effects (Spicer
and Enright, 1991), and it increases the production o f IGF-I from the granulosa cells
(Siroikin et al., 1998a). It has been shown that granulosa cells do contain receptors for
ST (Sharara and Nieman, 1994), but it has yet to be determined if the effects o f ST
administration to cultured granulosa cells are entirely IGF-I mediated.
In the horse, there is little information available as to the effects o f ST and/or
IGF-I on reproductive activity. It has been shown that daily administration o f equine
ST (eST) to increases the number o f small follicles visible on the ovaries o f cyclic
mares, with a concomitant increase in circulating IGF-I concentrations (Cochran et al.,
1999). However, whether these effects are caused directly by eST, indirectly through
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IGF-I, or through a combination of both are unclear. Therefore, the purpose o f the
present study was to determine the effects o f eST and IGF-I on cell proliferation and
steroid production o f equine granulosa cells cultured for 24 hours in vitro.
MATERIALS AND METHODS
Granulosa cells were collected from all follicles ranging from 20 to 40 mm in
diameter from six cyclic pony mares. Granulosa cells samples were then pooled, and
the total number o f viable cells available for culture was calculated from a subsample o f
the pooled collection.

Treatments for the present study consisted o f (A) TCM-199

(Gibco, Grand Island, NY) plus 3 mg/ml BSA (Sigma, St. Louis, MO), which served as
the control medium, (B) control medium plus 100 ng/ml eST (EquiGen, BresaGen,
Thebarton, South Australia), (C) control medium plus 100 ng/ml eST plus 30 pg/ml
anti-IGF-I antibody (Sigma), (D) control medium plus 100 ng/ml human recombinant
IGF-I (Sigma) and (E) control medium plus 100 ng/ml human recombinant IGF-I plus
30 |ig/ml anti-IGF-I antibody. Treatments were replicated using Nunc four-well culture
dishes (n=4 wells/Treatment).

Granulosa cells were seeded at a concentration o f

150,000 viable cells/well for each of the five Treatment groups and allowed to culture
for 24 hours at 38°C in an atmosphere o f 5% CO 2 in air. A total volume o f 500 pi o f
each medium type was placed into the respective wells.
After 24 hours o f in vitro culture the medium was removed from each culture
well and centrifuged at 300 x g to remove all granulosa cells remaining in suspension.
Each medium sample was then stored in individually labeled 0.05 ml centrifuge tubes
and frozen until analysis of progesterone concentrations by RIA. After removal o f the
medium, each well was treated with 0.025% trypsin to facilitate the detachment o f all
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proliferating granulosa cells from the bottom o f each culture well. The granulosa cells
were then collected to determine the number o f proliferating granulosa cells per well
per treatment. The concentration of progesterone, as well as the number o f proliferating
granulosa cells per well per treatment, were analyzed using a split-plot ANOVA
procedure (Cochran et al., 1999).
RESULTS
The results o f in vitro culture o f equine granulosa cells with eST and IGF-I are
summarized in Table 7.1.

There was an increase in the number o f proliferating

granulosa cells after 24 hours of culture in all media supplemented with either eST or
IGF-I relative to control media (P<0.05).

In addition, the steroidogenic activity o f

equine granulosa cells as measured by in vitro progesterone production was enhanced in
all media supplemented with either eST or IGF-I (P<0.05), irrespective o f anti-IGF-I
antibody content.
Interestingly, there was no detectable increase in IGF-I production in equine
granulosa cells treated with eST alone when compared with control medium, as RIA
analysis revealed no detectable IGF-I in either treatment group. The fact that the antiIGF-I antibody had no effect on neither eST nor IGF-I stimulated cell proliferation or
progesterone production suggests that there was insufficient antibody present to bind all
available IGF-I, and that eST stimulated cell proliferation and progesterone production
may be caused by a direct effect of eST alone.
DISCUSSION
Results from the present study clearly indicate that both eST and IGF-I enhance
granulosa cell proliferation and steroid production in equine granulosa cells cultured in
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Table 7.1. Effects o f eST and IGF-I treatment to equine granulosa cells cultured for
24 hours in vitro
Treatment

Number of Cells

P4 Production

A. Control
B. eST
C. eST plus anti-IGF-I

43,750a (±15581)
117,500b (±15581)

2.13a (±0.93)
6.72b (±0.93)
7.14b (±0.93)
6.05b (±0.93)
5.97b (±0.93)

D. IGF-I
E. IGF-I plus anti-IGF-I

129,375b (±15581)
113,437b (±15581)
150,562b (±15581)

a'bMeans within columns with different superscripts are different (P<0.05).
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vitro (Table 7.1). These data are in agreement with previous reports in rats (deMoura et
al., 1997), pigs (Xia et al., 1994), cattle (Schams et al., 1988; Armstrong et al., 1996;
Khamsi and Armstrong, 1997), sheep (Mariana et al., 1998) and goats (Behl and
Pandey, 1999). For example, Armstrong et al. (1996) demonstrated that in cultured
bovine granulosa cells, IGF-I addition to the culture medium markedly increased both
cell proliferation as well as progesterone production.

In this study, it was also

determined that IGF-I acted in synergism with FSH, as addition o f FSH and IGF-I
enhanced the response in the granulosa ceils over that o f either FSH or IGF-I alone
(Armstrong et al., 1996). This same synergistic effect o f IGF-I with FSH has also been
demonstrated in the rat, where addition of IGF-I caused a 3-fold increase in
progesterone production by cultured granulosa cells over FSH alone (deMoura et al.,
1997). It was concluded from that experiment that the primary role for intrafollicular
IGF-I is to enhance the responsiveness o f the granulosa cells to available gonadotropins
(deMoura et al., 1997).
In humans, IGF-I has been shown to increase estradiol, but not progesterone,
production by granulosa cells cultured in vitro (Mason et al., 1993; Foster et al., 1995).
This same effect has been shown in cultured porcine follicles (Siroikin et al., 1998a)
and granulosa cells (Howard and Ford, 1994), where intrafollicular estradiol production
was increased with the addition o f IGF-I to the culture medium. The reason for the
difference in which steroid is produced by in vitro cultured granulosa cells remains
unclear, but is likely due to the specific culture conditions and/or the duration of culture
o f the granulosa cells.

For instance, Bemdtson et al. (1995) reported that the

gonadotropin concentrations must be carefully regulated to maintain follicular-phase
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steroid production (estradiol) by cultured bovine granulosa cells. Also, these authors
state that in v/Tro-cultured granulosa cells usually produce more progesterone than
estradiol due to a change in cellular type during culture, as the granulosa cells generally
more closely resemble luteal cells (Bemdtson et al., 1995). In addition, it is well known
that during follicular atresia and/or luteinization, estradiol production by the granulosa
cells is diminished, while progesterone production increases (Gerard and Monget,
1998). It was for this reason that, in the present study, progesterone production was
chosen as a representation o f the steroidogenic activity o f cultured equine granulosa
cells. Regardless of which specific steroid is measured, the fact remains that IGF-I does
enhance steroid production in in v/Vro-cultured granulosa cells o f virtually every species
studied to date.
It has been well documented that granulosa cells contain receptors for both ST
(Sharara and Nieman, 1994), as well as for IGF-I (Spicer and Echtemkamp, 1995;
Stewart et al., 1997).

Therefore, it is likely that many o f the effects on ovarian

follicular growth and development are IGF-I mediated, since treatment o f granulosa
cells with ST causes increased IGF-I production by the granulosa cells (Xia et al., 1994;
Samaras et al., 1996; Siroikin et al., 1998a,b).

However, it has yet to be clearly

demonstrated whether these effects are entirely IGF-I mediated, or whether there is a
direct effect of ST on granulosa cells proliferation and steroid production.

In the

present study, while cellular proliferation as well as steroid production were enhanced
by ST and IGF-I relative to control medium (Table 7.1), the apparent lack o f sufficient
binding o f the anti-IGF-I antibody to available IGF-I leaves this question unanswered.
However, the inability o f eST to increase the concentration o f IGF-I in the medium in
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this study suggests that some o f these effects may be independent of IGF-I and could be
caused by direct stimulation o f the granulosa cells by ST. Alternatively, an increase in
intracellular IGF-I to be utilized in an autocrine fashion by the granulosa cells cannot be
ruled out.
Apoptosis, or regulated cell death, is thought to be the primary mechanism
through which granulosa cells are destroyed within the follicle, which then results in
follicular atresia (Kaipia and Hsueh, 1997). One possible explanation for the observed
effects on follicle numbers in live animals treated with ST could include a model for
attenuation o f granulosa cells apoptosis through increased intrafollicular IGF-I, thereby,
increasing the functional life o f the follicles. This hypothesis is supported by the results
o f Guthrie et al. (1998), where it was demonstrated that IGF-I prevented spontaneous
apoptosis in cultured porcine granulosa cells. Also, while FSH is the best suppressor of
apoptosis in the granulosa cells (60% suppression), IGF-I has been shown to be very
effective in suppressing apoptosis o f cultured granulosa cells in the rat (45%
suppression) (Chun et al., 1996). This provides yet another possible model for the
influence that ST and IGF-I have on reproductive function in mammalian species, and
may provide a partial explanation for the results seen with in vitro culture o f granulosa
cells, since the prevention o f apoptosis would lead to a greater number o f viable
granulosa cells available to then cause an increase in cellular proliferation and steroid
production.
In conclusion, results from the present study in equine granulosa cells confirm
those data from earlier reports in other domestic species that both ST and IGF-I enhance
cell proliferation as well as steroid production following in vitro culture. However, the
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question remains as to whether these effects are entirely IGF-I mediated or whether
there is a direct effect of ST on the granulosa cells. Further studies are needed in order
to clarify this. Also, an alternative method for studying the effects of ST and IGF-I on
granulosa cells function, such as intrafollicular treatment as described by Gastal et al.
(1995), may be more beneficial in determining the actual effects of these growth factors
in the live animal when compared with those o f in vitro studies centering around the
culture o f isolated granulosa cells in a foreign environment.
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CHAPTER VIII
THE EFFECTS OF eST ON FOLLICULAR DEVELOPMENT AND PLASMA
AND FOLLICULAR FLUID HORMONE PROFILES IN CYCLIC MARES
TREATED FOR ONE ESTROUS CYCLE
INTRODUCTION
It is well known that somatotropin (ST) and insulin-like growth factor-I (IGF-I)
are intricately involved in mammalian reproductive physiology. In recent years, this
area o f reproductive biology has come under intense investigation in most domestic
species and in humans. It has been demonstrated that administration o f exogenous ST
increases follicle numbers on the ovaries o f women (Owen et al., 1991a), cattle (Lucy et
al., 1993), pigs (Echtemkamp et al., 1994a) and mares (Cochran et al., 1999). The
precise mechanism o f action for ST on ovarian follicular development is not currently
known, however, it is believed that ST causes these effects, at least in part, through
stimulation of IGF-I, although a direct effect o f ST on follicular growth is possible
(Gong et al., 1991).

Furthermore, since many o f the studies involving ST admin

istration are representative o f animals with supraphysiologic circulating concentrations
o f ST, a pharmacologic, rather than a physiologic, effect may have been seen.
However,

in

studies

involving

hypophysectomized

ewes,

where

both

gonadotropins and ST are absent, it was determined that gonadotropin treatment alone
was insufficient in stimulating follicle growth, and that ST was required in addition to
gonadotropins for normal ovarian folliculogenesis to take place (Eckery et al., 1997).
Also, in Ames dwarf mice, a condition in which no somatotrophs develop within the
adenohypophysis, which further causes an absence o f ST production, a significant
reduction in gonadotropin secretion and follicular development was noted, and
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administration o f ST reversed these effects (Bartke et al., 1996). It can therefore be said
that ST production and secretion is required for normal reproductive processes to take
place.
It is well known that ST stimulates hepatic IGF-I production, and that animals
receiving ST administration have elevated intrafollicular IGF-I (Gong et al., 1991;
Monget et al., 1993), but whether these increases in intrafollicular IGF-I are a result o f
increased production of IGF-I within the follicle, or if the excess IGF-I is a product o f
the plasm a is not fully understood. However, it has been demonstrated that granulosa
cells do possess the capacity to produce IGF-I (Xia et al., 1994), and that IGF-I mRNA
is highest in pre-ovulatory follicles (Yuan et al., 1998), which suggests that the
increased intrafollicular IGF-I is, at least in part, produced locally within the follicle by
the granulosa cells.

This is important, since several studies have demonstrated the

synergistic actions o f IGF-I on gonadotropin stimulation of ovarian follicles in both
humans and rats (Homburg et al., 1988; European and Australian Multicenter Study,
1995; deMoura et al., 1997). For example, in in v/7ro-cultured rat granulosa cells, the
response to FSH administration was trebled when IGF-I was given (deMoura et al.,
1997). Also, IGF-I increases LH receptor numbers in rat granulosa cells, which would
enhance the follicular response to available LH (Liu et al., 1998). It is therefore likely
that ST administration causes some o f its effects on follicular development through
increasing systemic and intrafollicular IGF-I, thereby, enhancing the ability o f the
growing follicle(s) to respond to available gonadotropins.
It is currently not known whether the increases noticed in ovarian follicle
numbers resulting from ST administration are a result of increased follicular activation
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o f gonadotropin-independent follicles, or whether a different mechanism, such as
delaying follicular atresia is involved.

It is well known that follicular growth and

development occurs in “waves” in many domestic species, and that by increasing the
number o f follicles recruited into a follicular wave one could then possibly increase the
ovulation rate (Lucy et al., 1993; Ginther and Bergfelt, 1993; Buratini et al., 1997).
The problem with this approach is that the recruitment o f small antral follicles
into a follicular wave occurs at a time when the follicles are not gonadotropin-sensitive,
and at the present time, it is not fully known what factors are involved in follicle
activation and recruitment into a follicular wave. It is possible that ST and/or IGF-I
may enhance follicular activation and recruitment, but if this is the case, then ST
administration should be carried out for a relatively long (1 to 3 months) duration
(Bergh et al., 1994). Conversely, ST/IGF-I may act through a different mechanism to
increase ovarian follicle numbers, such as by either rescuing follicles from the process
o f atresia, or by prolonging the atretic process through preventing apoptosis o f the
follicular granulosa cells. These possibilities should not be overlooked, since they are
the two most common methods for FSH stimulation in ovarian superstimulation
treatments (Mihm et al., 1997).
In the domestic mare, little has been published as to the importance o f ST/IGF-I
in ovarian follicular growth and development.

In one study, Cochran et al. (1999)

demonstrated that cyclic mares receiving eST had increased numbers o f small follicles
present on their ovaries at 3 and 5 days after treatment and on the first day o f standing
estrus. However, this is the only study published to date demonstrating any effects of
eST administration on reproductive function in cyclic mares. It was not known from
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this study whether the effects seen by the authors were caused by an increase in the
number o f follicles recruited into a follicular wave or whether ST administration
delayed or prolonged the follicular atretic process in eST-treated mares.
The purpose o f the present study was, therefore, to determine the effects o f eST
administration to cyclic mares for one estrous cycle on (1) follicular wave parameters,
(2) growth and atresia of individual follicles and (3) plasma and follicular fluid
concentrations o f IGF-I, estradiol and progesterone.
MATERIALS AND METHODS
A total o f 10 reproductively sound cyclic mares o f mixed breeds, all in good
body condition, were randomly allocated into one of two treatment groups. Treatment
A consisted o f mares (n=5) administered 25 pg eST (EquiGen, BresaGen Ltd.,
Thebarton, South Australia) per kg body weight once daily for one complete estrous
cycle (day 1 = first day of treatment; corresponds to day 1 post-ovulation). Mares in
Treatment B (n=5) were similarly administered a sodium borate solution, which served
as the vehicle for the eST.

Follicle development and plasma and follicular fluid

hormone profiles were monitored over a total of three estrous cycles in order to
establish normal parameters for each mare, as well as to determine if any carryover
effects would be seen from eST administration (Pre-Treatment = Cycle A, Treatment =
Cycle B, Post-Treatment = Cycle C).
E xperim ental Procedures
Follicle growth and developmental patterns were monitored via transrectal
ultrasonography in all mares as previously described by Cochran et al. (1999). Briefly,
a 5 MHz linear transducer was inserted into the rectum of each mare and consecutive
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sagittal sections o f each ovary were photographed using a thermal printer attached to
the ultrasound machine. Each follicle present was identified, and measurements were
taken o f each individual follicle at its maximum diameter three times per week. The
diameter o f each follicle was plotted over time for each mare in order to determine a
follicular growth and development profile for each mare. These measurements were
taken beginning on day 1 post-ovulation o f Cycle A (pre-treatment) and continuing until
the day o f ovulation o f Cycle C (post-treatment) for all mares.
A follicular wave was defined as all follicle development beginning with the
time the largest follicle was retrospectively identified until this follicle reached its
maximum diameter and ovulated. The number o f follicular waves per mare per cycle
and the number o f follicles per wave per mare per cycle was analyzed to determine if
eST administration would effect any o f these parameters. Also, the interval o f growth
for each follicle, defined as the time in days that a follicle was retrospectively identified
until it reached its maximum diameter, was analyzed for each mare within treatment. In
addition, the interval o f follicular atresia, which was defined as the time in days a
follicle reached its maximum diameter until it was no longer identifiable by ultrasound,
was analyzed per mare within treatment for each estrous cycle studied. Finally, the
number o f ovulations per mare per treatment group was analyzed for all estrous cycles
as well.
Plasma and follicular fluid samples were collected 12 to 24 hours prior to
ovulation for each estrous cycle (Cycles A, B and C; n=3 collection procedures/mare)
for mares in both treatments. From each mare, 0.5 ml o f follicular fluid was collected
via transvaginal ultrasound-guided follicular aspiration from (1) two follicles <10 mm
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in diameter, (2) one follicle 10 to 20 mm in diameter and (3) the pre-ovulatory follicle
present at the time o f collection.

Plasma samples were collected via jugular veni

puncture from each mare on the day o f follicular fluid collection.

All plasma and

follicular fluid samples were placed in individually labeled 15-ml conical tubes, frozen
within 30 minutes o f collection and stored until RIA was performed to determine the
concentrations o f IGF-I (Sticker et al., 1995), estradiol and progesterone.
Statistical Analysis
The number o f follicular waves per mare per treatment group as well as the
number o f follicles per follicular wave were analyzed using ANOVA (Cochran et al.,
1999). In addition, the number of ovulations per mare per treatment and the number of
days o f follicular growth and atresia per follicle were analyzed with a similar ANOVA
procedure (Cochran et al., 1999).

Finally, plasma and follicular fluid IGF-I

concentrations were analyzed using a split-plot ANOVA (Cochran et al., 1999).
RESULTS
Follicular Development
The effects o f daily eST administration to cyclic mares on follicle populations
are presented in Table 8.1. All mares exhibited one or two waves of follicle growth per
estrous cycle regardless of treatment, and there was no effect of treatment with eST on
the number o f follicular waves per mare per cycle, the total number o f follicles per
follicular wave or the length (in days) o f follicle growth in the present study. However,
administration with eST did effect the number o f days required for follicular atresia to
be completed, as follicles from mares in Treatment A remained on the ovaries for a
longer duration than those from mares in Treatment B during the treated cycle (Cycle
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B), but not for the pre- or post-treated cycles (Cycles A and C) (8.78 ± 0.64 vs. 6.39 ±
0.56 for Treatments A and B, respectively, P<0.05).
Also, mares treated with eST ovulated

more follicles (P<0.05) than

contemporary control mares during Cycle B, but not during Cycles A and C,
demonstrating a positive effect o f eST on large follicle development (1.6 ± 0.1 vs. 1.0 ±
0.1, respectively). There were no detectable effects o f eST administration on follicular
parameters in the post-treated cycle (Cycle C) in the present study, suggesting a
relatively short-lived effect o f eST administration on ovarian follicular dynamics in the
domestic mare.
Hormone Profiles
Analysis o f plasma and follicular fluid steroid concentrations (estradiol and
progesterone) revealed no detectable differences between treated and control mares for
any o f the estrous cycles studied.

However, plasma IGF-I was elevated in mares

receiving eST during Cycle B when compared with control mares (610.7 ± 56.1 vs.
221.3 ± 56.1 for mares in Treatments A and B, respectively), but not for Cycles A and
C (Figure 8.1). Also, follicular fluid collected from pre-ovulatory follicles 12 to 24
hours prior to ovulation had higher IGF-I levels (471.1 ± 44.3 vs. 269.7 ± 44.3 for mares
in Treatments A and B, respectively) in eST-treated mares than in control mares during
Cycle B (Figure 8.1).
Finally, mares in Treatment A had higher IGF-I concentrations in the follicular
fluid from pre-ovulatory follicles when compared with follicular fluid from small (<10
mm) or medium (10 to 20 mm) follicles within the same mares (Figure 2) during Cycle
B. This was not detected in untreated control mares, as no differences were detected in
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Table 8.1. Effect o f eST administration to cyclic mares on follicular atresia and
ovulatory response
Time o f atresia (days)

Ovulations/mare

A. eST

8.78a ± 0.64

1.6“ ±0.1

B. Control

6.39b ± 0.56

1.0b±0.1

Treatment

iLbMeans within columns with different superscripts are different (P<0.05).
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Figure 8.1. Plasma and follicular fluid IGF-I concentrations (±SEM) for cyclic mares
administered once daily injections o f eST. (*) Denotes significant
differences between treatment groups.
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Figure 8.2. Follicular fluid IGF-I concentrations (±SEM) for small, medium and pre
ovulatory sized follicles from cyclic mares administered once daily
injections o f eST. (*) Denotes a significant difference.
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follicular fluid IGF-I concentrations between small, medium or pre-ovulatory follicles
(Figure 8.2).
DISCUSSION
The importance of ST and IGF-I on reproductive function in domestic species
and humans has become a major research focus in reproductive biology over the past
decade. It has been clearly demonstrated that ST administration increases the number
o f visible follicles on the ovaries of cows (Gong et al., 1991; Lucy et al., 1993; Gong et
al., 1996), women (Owen et al., 199al), pigs (Spicer et al., 1992; Echtemkamp et al.,
1994a) and mares (Cochran et al., 1999). Also, perifused rabbit ovaries exposed to ST
responded with increased follicle numbers, as well as with higher intrafollicular IGF-I
concentrations (Yoshimura et al., 1994). In addition, ST is a potent stimulator o f both
systemic and intrafollicular IGF-I in virtually all species studied to date (Hugues et al.,
1991; Owen et al., 1991a,b; Echtemkamp et al., 1994a,b; Yoshimura et al., 1994; Gong
et al., 1997).
In vitro studies using cultured granulosa cells have demonstrated that most o f
the effects seen with ST administration, such as steroid production and cellular
proliferation, are IGF-I mediated, since the addition o f anti-IGF-I antibodies can negate
the positive effect o f ST administration (Gong et al., 1991). However, Izadyar et al.
(1997) demonstrated that some o f the positive effects demonstrated by ST admin
istration on cumulus expansion and oocyte maturation were the result o f a direct effect
on ST and not mediated by IGF-I. It is therefore likely that the effects noted from
administration o f exogenous ST arise from both a direct effect of ST on follicular
granulosa cells, as well as an indirect effect through increased IGF-I production.
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Unfortunately, the exact mechanism through which ST/IGF-I exerts its effects
on follicle development is not fully understood. Although it is known that both ST and
IGF-I are mediators o f gonadotropic actions on the follicular cells, enhancing the
response o f the granulosa cells to available gonadotropins (Yoshimura et al., 1994), this
is an insufficient explanation as to how ST/IGF-I is able to increase the number o f
small, presumably gonadotropin-independent follicles of treated animals.
Therefore, one of the goals o f the present study was to determine if eST
administration to cyclic mares would result in an increase in the number o f follicles
recruited into a follicular wave. The exact mechanism o f early follicle activation and
recruitment into a follicular wave is thought to be gonadotropin-independent, but is
poorly understood at present (Britt, 1988). Although, growing evidence suggests that
various growth factors and/or changes in local ovarian blood flow could begin the
process (Staigmiller, 1982; Driancourt et al., 1991; Gutierriz et al., 1997; Bao and
Garverick, 1998).
In this study, there was no effect o f eST on the number o f follicles per follicular
wave between treated and control mares. Furthermore, there was no difference in the
number o f follicular waves per estrous cycle between treated and control mares, as all
mares exhibited either one or two waves o f follicle growth per cycle studied, as has
been previously reported for cyclic mares (Buratini et al., 1997).

Therefore, it is

unlikely that the increase in follicle numbers demonstrated previously for cyclic mares
administered eST (Cochran et al., 1999) is a result o f an increase in the number o f
small, gonadotropin-independent follicles available for recruitment into a follicular
wave.
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Previous reports in rats (Chun et al., 1996) and pigs (Guthrie et al., 1998) have
suggested that one mechanism o f action for ST/IGF-I may be to decrease the apoptotic
index o f the granulosa cells, thereby, prolonging the time required for a follicle to
complete the atretic process. Chun et al. (1996) demonstrated that, while FSH was the
best suppressor o f granulosa cell apoptosis (60% suppression), IGF-I was a close
second in suppression (45%), with very minimal suppression seen from other growth
factors and gonadotropins. It is well known that the major mechanism o f action o f FSH
in superstimulation protocols is to “rescue” follicles already in the growth stage from
the process of atresia, which is precipitated by spontaneous apoptosis of the granulosa
cells. It is therefore likely that this could be one mechanism for the ability o f ST/IGF-I
to increase the number of follicles in treated subjects. In the present study, it was
determined that eST administration caused a significant increase in the number o f days
required for the completion o f atresia of the follicles in treated mares (Table 8.1).
Therefore, we conclude that a prolongation o f follicular atresia, rather than an increase
in small follicle growth, is likely the mechanism through which ST/IGF-I causes greater
numbers of small- and medium-sized follicles to be present on the ovaries o f treated
mares.
ST administration has also been shown to improve the ovulatory response in
cattle (Rieger et al., 1991), as well as women (Owen et al., 1991a), undergoing ovarian
superstimulation protocols. It has been demonstrated that these effects are partly the
result o f an ability o f ST and IGF-I to work in synergy with available gonadotropins,
enhancing the follicular response to available gonadotropins (Homburg et al., 1988;
Owen et al., 1991b; Hugues et al., 1991; Yoshimura et al., 1994; European and
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Australian Multicenter Study, 1995;

deMoura et al., 1997).

This can partially be

explained by the role o f intrafollicular IGF-I on dominant follicle selection.

It is

currently believed that changes in bioavailable intrafollicular IGF-I are, in part,
responsible for the process o f dominant follicle selection in mammalian species (Owen
et al., 1991b). As follicles grow and mature, the ratio o f IGF-I:IGF-I binding proteins
(IGFBP) changes within the follicle, allowing more IGF-I to be available to bind to the
granulosa cells and, thereby, enhance the response o f these cells to available
gonadotropins (Monget et al., 1993; De La Sota et al., 1996; Funston et al., 1996; Yuan
etal., 1998).
One possible explanation for the synergy exhibited between IGF-I and
gonadotropins could be due to an increase in the number o f gonadotropin receptors on
the granulosa cells o f the growing follicles, allowing for more gonadotropin binding to
the receptors and, thus, an increased growth response (Zhang et al., 1987). Beam and
Butler, (1997) demonstrated that in postpartum dairy cows that had ovulated during the
first 2-week interval postpartum had at least 40% greater plasma concentrations o f IGFI compared with those cows not ovulating early postpartum, further suggesting the
importance o f IGF-I in reproductive function. In the present study, administration of
eST to cyclic mares caused a significant increase in the number o f ovulations per mare
during Cycle B (treatment cycle) when compared with contemporary control mares or
with the same mares during both the pre- and post-treatment cycles (Cycles A and C,
respectively, [Table 8.1]).

In addition, previous studies from our laboratory have

demonstrated that seasonally anovulatory mares respond to gonadotropin therapy at a
much greater frequency when eST is added to the treatment regimen. These results are
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in agreement with the current hypothesis that increased intrafollicular IGF-I
concentrations are able to enhance gonadotropic actions on follicular cells.
In the present study, only fluid from pre-ovulatory follicles showed increased
IGF-I concentrations in response to eST treatment (Figure 8.1). The intrafollicular IGFI concentrations o f pre-ovulatory follicular fluid was parallel to, but less than, plasma
IGF-I levels (Figure 8.1), as has been previously reported for humans (Monget et al.,
1993).

Also, there were no differences in intrafollicular IGF-I concentrations from

small, medium or pre-ovulatory follicles in untreated control mares (Figure 8.2). This is
in agreement with previous reports in women (Tapanainen et al., 1992; Thierry Van
Dessel, et al., 1996) and cattle (Spicer and Enright, 1991), where no difference was
detected in intrafollicular IGF-I across follicle sizes. However, other reports in cattle
(Mihm et al., 1997) and women (Rabinovici et al., 1990) have shown the opposite, that
there is indeed higher amounts o f IGF-I present in the follicular fluid o f large follicles
when compared with small- and medium-sized follicles. At present, it is still not known
which case will prove to be correct, but the fact remains that, even if there are no
differences in absolute values of intrafollicular IGF-I, there are differences in the
amounts o f bioavailable IGF-I between small, medium and pre-ovulatory follicles due
to changes in intrafollicular IGFBP production (Owen et al., 1991b).
It is currently believed that the increase in intrafollicular IGF-I seen during ST
administration comes from an increase in both local as well as systemic production o f
IGF-I. This is due to the fact that, although ST administration causes increased hepatic
production o f IGF-I (Gong et al., 1997), which could filter into the follicular cavity via
circulation through the plasma, ST treatment also causes a significant increase in IGF-I
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production by the granulosa cells within the follicle (Yoshimura et al., 1996a). Using
perifused rabbit ovaries, Yoshimura et al. (1996a) demonstrated that approximately
three times more IGF-I mRNA was stimulated in follicular granulosa cells exposed to
ST when compared with those follicles that were not exposed to ST. This verifies that
follicular cells do have the capacity to produce and secrete IGF-I in response to ST
stimulation, and that this production was at least partially responsible for the increase in
follicular fluid levels o f IGF-I in these perifused rabbit ovaries (Yoshimura et al.,
1996a). Interestingly, it has been demonstrated in cattle that granulosa cells from pre
ovulatory follicles contain much greater amounts of IGF-I mRNA than cells from
smaller follicles, further suggesting an important role o f intrafollicular IGF-I on
dominant follicle selection (Yuan et al., 1998).

Also, it has been shown that

immunization o f cattle against somatotropin releasing factor lowers intrafollicular IGFI, as a result o f the diminished capacity to produce and secrete ST (Kirby et al., 1993;
Stanko et al., 1994).
It has been demonstrated that ST administration can increase intrafollicular
steroid concentrations in cattle (Spicer and Enright, 1991), women (Tapanainen et al.,
1992) and pigs (Echtemkamp et al., 1994a). Increases in intrafollicular estradiol and
progesterone can be brought about through the ability o f IGF-I to increase 3 P*
hydroxysteroid dehydrogenase and aromatase enzyme mRNA in the granulosa cells o f
treated subjects (Tapanainen et al., 1992).

However, while some studies show an

increase in intrafollicular estradiol (Echtemkamp et al., 1994b; Howard and Ford, 1994)
or progesterone (Xia et al., 1994), others have reported that treatment with ST produces
no detectable increases in intrafollicular estradiol and progesterone secretion (Spicer et
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al., 1992; Tapanainen et a l, 1992). In the present study, there was no effect o f eST
administration to cyclic mares on either plasma or follicular fluid concentrations of
estradiol or progesterone. In addition, there was no effect o f time (Cycle A vs. Cycle B
vs. Cycle C) on either plasma or intrafollicular steroid levels in this study. Further
studies are needed using cyclic mares to confirm these findings.
In summary, we have demonstrated that the administration o f eST does effect
reproductive function in cyclic mares. Although no effect was seen in the number of
follicles recruited into a follicular wave or the number o f follicular waves per estrous
cycle, it was determined that eST treatment to cyclic mares did cause a prolongation of
the follicular atretic process, allowing the regressing follicles to remain on the ovaries
for a longer period o f time.
As expected, plasma IGF-I concentrations were elevated in eST-treated mares,
and intrafollicular IGF-I was higher in pre-ovulatory follicles as well. This could be the
reason for the increase in ovulation rate noticed in mares administered eST during
Cycle B (treatment cycle). There were, however, no differences in plasma or
intrafollicular concentrations o f estradiol or progesterone between treated and control
mares in this study. The present study provides strong evidence as to the importance of
ST and IGF-I on reproductive processes in the domestic mare, and partially explains
some of the underlying mechanisms involved in dominant follicle selection and growth.
Further studies are needed in this area o f equine reproductive physiology to evaluate
these effects further.
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CHAPTER IX
SUMMARY AND CONCLUSIONS
Treatment o f domestic species and women with somatotropin (ST) has been
shown to have dramatic effects on follicular growth and development at the level o f the
ovary. To date, little has been reported as to the effects o f ST administration to the
domestic mare.

In the present series of experiments, it was demonstrated that ST

administration increases ovarian follicles in both cyclic as well as seasonally
anovulatory mares. This is similar to the findings reported for other species, where ST
administration caused a higher number of ovarian follicles to be detectable via
ultrasound during the ST treatment period. The mechanism o f action o f ST on ovarian
follicular dynamics has yet to be conclusively established.

In the mare, as in other

species, a significant rise in peripheral as well as intrafollicular IGF-I was detected as a
result o f ST treatment, and it is currently believed that this excess IGF-I is, at least in
part, responsible for the ovarian effects that occur with ST administration.

Since a

higher number o f ovarian follicles was found with ST administration to both cyclic and
anovulatory mares, in the present study, we hoped to identify the mechanism o f action
of these effects.

Also, we wished to attempt to incorporate these findings into a

practical scheme to improve the fertility o f the domestic mare.
In cyclic mares, it was noticed that administration o f equine ST (eST) not only
significantly increased the number of ovarian follicles present during the treatment
interval, but it also increased the number of ovulations per mare when compared with
untreated control animals. Since no effects were noticed in circulating plasma gonado
tropin concentrations, it was hypothesized that ST administration, primarily through
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increasing circulating IGF-I levels, enhanced the ability of the follicles to respond to
available gonadotropins, thus enabling more follicles to respond to these gonadotropins
by growing to larger sizes. In addition, it was determined that the ST treatment to
cyclic mares did not effect the number o f follicles recruited into the cohort o f follicles
that make up a follicular wave. Rather, ST administration caused a delay in the atretic
response o f the ovarian follicles, prolonging the period of time required for the follicles
to completely regress.
This would explain why increased numbers o f ovarian follicles are typically
noted in animals treated with ST, since, after ST administration, the affected follicles
would be present on the ovaries for a longer period o f time and would therefore appear
to be more numerous when evaluating the ovaries via ultrasound. This mechanism of
action should come as no surprise, since this is very similar to the mechanism o f action
o f FSH, which is thought to “rescue” follicles from the atretic process, so that increased
numbers o f follicles can be made available for the harvesting o f multiple
oocytes/embryos from treated individuals.
There was no clear relationship detected as to the ability o f ST to stimulate
above normal concentrations o f steroid hormones circulating in the blood. In general,
ST administration had no effect on circulating steroid hormone levels in treated mares,
but did increase intrafollicular steroid concentrations in large-sized follicles. Also, as
demonstrated in other species, both ST and IGF-I exposure significantly increased
steroidal output by in vitro cultured equine granulosa cells, demonstrating the ability of
both hormones to stimulate granulosa cell steroidogenesis. As to the effects o f ST/IGF-
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I on gonadotropin production and secretion, there was no evidence o f any effect o f
elevated ST or IGF-I on circulating FSH or LH concentrations in any animal studied.
In seasonally anovulatory mares, it was determined that ST administration
caused a significant increase in the number o f ovarian follicles. However, only follicles
less than 15 to 20 mm in diameter were detected in these mares, which would severely
limit the use of this hormone in a practical setting.

Therefore, since treatment of

various species with ST has been shown to cause an enhancement o f the growing
follicles to available gonadotropins, it was hypothesized that treatment o f seasonally
anovulatory mares with GnRHa in addition to ST may cause an increase in the
ovulatory response o f these mares to the GnRHa.
This proved to be the case, since ST administration in addition to GnRHa
treatment significantly increased the number of mares that grew large, pre-ovulatorysized follicles, as well as increased the number of mares ovulating when compared to
mares treated with GnRHa alone. In addition, the ovulations detected in mares treated
with GnRHa plus ST were determined to be fertile, since pregnancies and live births
were accomplished using this treatment regimen. It is also o f importance that once
daily ST treatment was utilized in conjunction with once daily GnRHa treatment to
induce ovulation in seasonally anovulatory mares.

This is the first report, to our

knowledge, of the induction o f ovulation in seasonally anovulatory mares using only
once daily injections o f GnRHa.

We have demonstrated that ST administration can

enhance the follicular response to available gonadotropins in seasonally anovulatory
mares, and that treatment o f these mares with ST allows for a more predictable, less
variable ovulatory response.
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One o f the primary goals o f this research was to develop an ovarian stimulation
protocol for the collection o f oocytes from mares for use in in vitro fertilization
techniques. Once a repeatable method o f producing equine embryos and foals with in
vitro methods was developed (e.g., ICSI), a method o f increasing the number o f viable
oocytes collected from individual mares was evaluated. It was determined that ST
administration did not increase the number o f available ovarian follicles in altrenogesttreated mares when oocytes were collected from these mares at regular 10-day intervals.
However, when the mares were treated for 21 consecutive days prior to oocyte
collection, there was a significant increase in the number of ovarian follicles available
for collection when compared with control mares treated only with altrenogest.
This further implies that the ovarian effects noted with ST treatment are
enhanced by a prolongation o f follicular atresia, rather than an increase in the number of
new, developing follicles within a follicular wave.

If ST administration caused its

effects by increasing the number o f follicles within a follicular wave, then it would be
expected that mares treated in this fashion would have a higher number o f ovarian
follicles available for aspiration at any time during the treatment period. Since oocyte
collections were performed at 10-day intervals in the present study, which coincide with
the approximate interval o f follicular wave growth in the domestic mare, it can be
concluded that no increase in the number o f follicles within a follicular wave occurred
in ST-treated animals, as no differences in ovarian follicle numbers were detected
between treated and control mares. It should be noted, however, that a method o f
repeatably producing equine embryos in vitro, which were capable o f producing live
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foals, was developed in conjunction with a protocol that allows for multiple oocytes to
be collected from individual mares at a given time.
In addition, it was demonstrated that most of the effects o f ST administration at
the level o f the ovary is due primarily to increased IGF-I exposure o f the follicular
granulosa cells. This was shown in vitro by culturing equine granulosa cells in the
presence o f either ST or IGF-I. In both cases, the cellular response was similar, with
both hormones stimulating cellular proliferation as well as cellular steroid production to
a similar degree.
In summary, we conclude that ST administration to the domestic mare enhances
the ovarian response both directly and indirectly through IGF-I by stimulating granulosa
cell function and by enhancing the responsiveness of the granulosa cells to available
gonadotropins, possibly by increasing gonadotropin receptors within these cells.
Finally, it was determined that the increases in ovarian follicular numbers detected with
ST administration were primarily a result o f prolonging the atretic process by the
ovarian follicles as a direct result o f ST treatment. Further studies are needed in this
area o f equine follicular dynamics to elucidate more thoroughly the mechanism o f
actions o f ST and IGF-I in the equine ovary.
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